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ABSTRACT 
In recent years, some outbreaks of bacterial infection in neonatal intensive care units 
have been traced to powdered infant formula contaminated with Cronobacter species, 
causing life-threatening diseases such as necrotizing enterocolitis and meningitis. 
This study for the first time presents growth data and whole genome comparisons for 
five different species of Cronobacter after the taxonomic revision by Iversen et al. 
(2008). Growth data for  28 bacterial strains across 21 bacterial species in casein- and 
whey-dominant infant formula at temperatures 21, 27, 37, 41 and 44
o
C were 
determined, covering category A and B organisms as defined by WHO 2006. The data 
revealed potential of some Cronobacter species to grow at 44
o
C, posing a significant 
risk of infection by the bacterium when following the current formula preparation 
guidelines. The results were presented to the Food Standards Agency with the aim to 
update the current risk assessment model and improve infant formula preparation 
guidelines.  
The first sequenced Cronobacter genome (C. sakazakii BAA-894) was used to 
construct a 384,030 probe oligonucleotide tiling DNA microarray covering its 4 Mb 
chromosome and plasmids pESA2 (31 kb) and pESA3 (131 kb). Comparative 
genomic hybridization (CGH) was undertaken on five C. sakazakii strains, and 
representatives of four other Cronobacter species. CGH highlighted 15 clusters of 
genes that were divergent or absent in more than half of the tested strains. Six of these 
were of probable prophage origin; other regions included type VI secretion systems, 
the O-antigen gene locus, a tellurite resistance cluster, a fimbriae cluster, and a copper 
resistance operon cop. The CGH analysis highlighted the role of horizontal gene 
transfer, as a significant part of the variable gene pool was due to acquisition of 
mobile DNA.  A number of genes unique to Cronobacter species associated with 
neonatal infections (C. sakazakii, C. malonaticus and C. turicensis) were identified. 
These included a copper and silver resistance operon cus linked to invasion of the 
blood-brain barrier by neonatal meningitic strains of Escherichia coli. By comparing 
the neonatal intensive care unit outbreak strains with less virulent strains and by 
analysis of the variable regions, we identified a list of putative virulence factors that 
may improve our limited  understanding of Cronobacter’ s pathogenesis.  
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1. INTRODUCTION 
Cronobacter spp. (formerly Enterobacter sakazakii) are Gram-negative, peritrichous 
rods belonging to the Enterobacteriaceae family, producing characteristic yellow 
colonies on TSA agar (Figure 1).  The organism has been associated with infections in 
all age groups, and with outbreaks of necrotizing enterocolitis, meningitis and 
septicaemia in pre-term, low birth neonates with exceptionally high mortality rates 
ranging from 40 to 80 percent. In recent years, some outbreaks of bacterial infection 
in neonatal intensive care units have been traced to rehydrated powdered infant 
formula (PIF) contaminated with Cronobacter (Biering et al. 1989, Caubilla-Barron et 
al. 2007). In 2002, the International Commission for Microbiological Specifications 
for Foods ranked the organism as a “severe hazard for restricted populations, life 
threatening or substantial chronic sequelae of long duration” and the organism joined 
the group of the most dangerous food pathogens such as Listeria monocytogenes or 
Clostridium botulinum. The FAO/WHO (2008) have estimated the annual incidence 
of Cronobacter infection over the period 1992-2007 to 17.6 per million population for 
neonates and 2.06 per million population for infants aged 1-11 months. Cronobacter 
infections have been documented in infants and young children up to 3 years of age, 
with at least 120 cases and 27 deaths (FAO/WHO 2008). The number of 
Cronobacter-related infections is likely to be significantly under reported, however, 
and the incidence is believed to be more common (FAO/WHO 2008).  Better 
understanding of the virulence of this opportunistic pathogen is warranted to ensure 
the safety of products designed for the most vulnerable part of our population, 
neonates.  
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1.1. Literature review 
This section will cover the brief history of Cronobacter, its environmental and clinical 
sources and its prevalence in the environment, and describe the challenges of the 
classification of this fascinating organism into the microbial taxonomic scheme. It 
will then cover the pathogenesis of the diseases caused by the bacterium and a 
summary of research into the virulence factors involved in the onset of the diseases. 
Finally, it will focus on the factors that contribute to Cronobacter’s remarkable 
persistence in powdered products, as well as the control measures designed to ensure 
the safety of powdered breast milk substitutes. 
 
          
Figure 1. Culture morphology of Cronobacter. Left: Cronobacter sakazakii 
colonies on Trypticase Soy Agar; source:  
http://www.enterobactersakazakiiblog.com/articles/e-sakazakii-information/. 
Right: Cronobacter colonies on Violet Red Bile Glucose Agar; source: own 
culture.  
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1.1.1 History 
In 1929, Pangalos reported a yellow-pigmented bacterium that caused a septicemia in 
an infant (Pangalos 1929). However, the first account mentioning a “yellow 
pigmented Enterobacter cloacae” as the causative agent in meningitis was published 
much later, in 1961, when Urmenyi and Franklin described two cases of terminal 
neonatal meningitis that occurred in England in 1957 (Urmenyi & Franklin 1961). 
Since then cases have been reported worldwide.  In 2001, a male infant was admitted 
to a neonatal intensive care unit (NICU) because of low birthweight and respiratory 
problems. After 11 days the baby developed symptoms of meningitis and despite 
being given intravenous antibiotics it died 9 days later. Cronobacter was cultivated 
from the cerebrospinal fluid and further 10 cases of Cronobacter infection were 
reported on the neonatal unit (Himelright et al. 2002). All 10 cases were associated 
with the use of powdered formula. After the cultivation of Cronobacter from an 
unopened can of the same product, the manufacturer voluntarily recalled the batch in 
March 2002 and further recalls followed (Himelright et al. 2002). 
Since then, contamination of powdered infant formula by Cronobacter has come 
under considerable attention of international regulatory bodies aiming to ensure the 
safety of this product, as well as the attention of research groups worldwide.  The 
FAO/WHO 2004 expert committee recommended that research should be promoted to 
gain a better understanding of the taxonomy, ecology, virulence and other 
characteristics of Cronobacter, and since then remarkable progress has been made in 
the knowledge of the organism. As powdered infant formula is not a sterile product, 
this potential vector of infection has been in the spotlight of regulatory authorities, as 
well as media.  It should be noted, however, that such neonatal infections are rare, and 
not all have been associated with reconstituted formula ingestion. Despite the fact that 
the focus of regulatory bodies is on the safety of PIF and other breast milk substitutes, 
the majority of cases of Cronobacter infection occur in fact in adults (FAO/WHO 
2008).  
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1.1.2 Sources of the organism 
Cronobacter is a ubiquitous organism that is present in a wide range of environments, 
including water, soil, and a variety of processed foods and fresh produce. The main 
reservoir of the organism still remains unclear, however. Iversen & Forsythe (2003) 
and more recently, Schmid et al. (2009) suggested a possible plant origin of the 
organism. Cronobacter is most commonly isolated from dried herbs and spices and is 
extremely resistant to dry stress, which are both expected characteristics of plant 
organisms.  
The bacterium has been isolated from a wide range of clinical samples including 
cerebrospinal fluid, blood, bone marrow, sputum, urine, faeces and hospital 
environment. Many of the reported cases have been linked with the use of powdered 
infant formula (FAO/WHO 2004, Forsythe 2005, FAO/WHO 2006,) and hence the 
organism is considered an infant formula pathogen. Whether the contamination of the 
formula product is of intrinsic or extrinsic character is often unclear, however. The 
bacterium has also been isolated from factories producing milk powder and household 
vacuum cleaning bags (Kandhai et al. 2004) and from household utensils used for 
reconstitution of PIF (Muytjens & Kollee 1990, Bar-Oz et al. 2001, Block et al. 2002). 
Due to the ubiquitous presence of Cronobacter and its extreme resistance to dry 
conditions (Caubilla-Barron et al. 2007) contamination of food products including 
powdered infant formula is difficult to avoid.   
     
 
1.1.2.1  Environmental sources and food contamination 
Since the organism does not belong to the normal animal and human gut flora, it was 
hypothesized that it contaminates food primarily through soil, water, and vegetables 
and that flies and rodents may be a secondary vector of contamination (Iversen & 
Forsythe 2003). Hamilton and colleagues were the first to isolate Cronobacter from 
the midgut of the larvae Stomoxys calcitrans feeding on blood of livestock and other 
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domesticated animals, as well as humans (Hamilton et al. 2003). Interestingly, S. 
calcitrans is found in all countries reporting Cronobacter infections. Molloy and 
colleagues examined 518 samples from dairy farms, meat abattoirs and retail food 
stores for the presence of Cronobacter (Molloy et al. 2009). They isolated the species 
from 33 (6.4%) samples, but did not isolate the organism from cattle or pig faecal 
samples, or from dairy farm environment. The authors concluded that animal carriage 
is not contributing to the transmission of the pathogen and that raw milk is not the 
main source of infant formula contamination. Molloy et al. (2010) investigated 
whether Cronobacter can survive passage through a model of the bovine rumen and 
abomasums, and in bovine faeces in the farm environment. They concluded that 
Cronobacter spp. are unlikely to be shed in bovine faeces, but that the organism 
survives well in the farm environment. 
Iversen and Forsythe (2003) hypothesized that the Cronobacter species might be of 
plant origin. Some physiological traits of the organism such as production of a 
polysaccharide capsule (Schmid et al. 2009, Hurrell et al. 2009a), production of 
yellow pigment (Lehner et al. 2006) and its extreme desiccation resistance (Caubilla-
Barron et al. 2007, Osaili & Forsythe 2009) may enable the bacteria to stick to plant 
leaves, offer protection against oxygen radicals and help to survive dry periods.  In 
order to provide evidence for the plant origin of Cronobacter, Schmid et al. (2009) 
investigated biochemical traits associated with plant microorganisms in nine strains 
representing five Cronobacter species. All strains were able to solubilise mineral 
phosphate, produce indole acetic acid and produce siderophores. In addition, the 
strains were able to endophytically colonise tomato and maize roots. The authors 
concluded that plants may be the natural habitat of Cronobacter spp. and that the 
rhizosphere might act as a reservoir of the bacterium (Schmid et al. 2009).    
The unique ability of Cronobacter to survive dry stress enables it to survive on 
various types of dry materials, which contributes to the reservoir of the organism in 
the environment. Furthermore, it has been documented that some starches and 
proteins derived from plants that are added to powdered infant formula without 
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additional heat treatment can act as a source of contamination of these products 
(FAO/WHO 2004, FAO/WHO 2006).  
 
1.1.2.2  Breast milk substitutes 
According to the definition by Codex Alimentarius (1981), breastmilk substitutes are 
products intended for infants who do not have access to breastmilk. In most cases, 
infant formulas are used as breastmilk substitutes for normal healthy infants under 6 
months, and are formulated in accordance with the appropriate Codex standards. 
Infant formula is a breast-milk substitute designed to satisfy the nutritional 
requirements of infants during the first months of life up to the introduction of 
complementary feeding. Human milk fortifiers are powdered supplements which can 
be added to expressed human milk if nutritional needs cannot be satisfied by human 
milk alone. This can include thickening agents as well as mineral supplements.   
Cronobacter was first associated with contaminated breast milk substitutes by 
Muytjens et al. in 1983, when it was isolated from prepared milk formula and formula 
reconstitution equipment during a study of eight cases of meningitis and sepsis 
(Muytjens et al. 1983). In 1988 it was reported that 52.2% (n=141) powdered infant 
formula samples from 35 countries were contaminated with Enterobacteriaceae, with 
14% containing Cronobacter (Muytjens et al. 1988). While the source of 
contamination in Cronobacter-related outbreaks has not always been confirmed, 
breast milk substitutes have been epidemiologically or microbiologically established 
as the source of infection in many cases (Muytjens et al. 1983, Biering et al. 1989, 
Simmons et al. 1989, Clark et al. 1990, Muytjens & Kollee 1990, van Acker et al. 
2001, Weir 2002, Iversen & Forsythe 2003). A strong link between the presence of 
Cronobacter in formula milk and an outbreak of Cronobacter infection has been 
established by Centers for Disease Control (CDC) following the outbreak in a 
neonatal intensive care unit (NICU) in Tennessee in 2001, when a neonate died from 
Cronobacter-induced meningitis and further 10 cases of Cronobacter colonisation 
were found on the same unit (Centers for Disease Control (CDC) 2002). Later 
investigation revealed that the formula fed to the infant in Tennessee was a formula 
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not intended for neonates. Iversen and Forsythe (2004a) reported that 2.4% (n=82) 
powdered infant formulae, 10.2% (n=49) dried infant foods, 4.2% (n=72) milk 
powders, and 32.8% (n=122) herbs and spices contained Cronobacter.  In 2009, an 
international survey for Cronobacter and related organisms in powdered infant 
formula, follow up formula and infant foods was conducted by 8 laboratories in 7 
countries in response to the FAO/WHO 2008. In total, 290 products were analysed 
using a standardised procedure and Cronobacter was isolated from 3% (n=91) follow 
up formulae and 12% (n=199) infant foods and drinks (Chap et al. 2009). In another 
study, Cronobacter was isolated from just 1.4% (n=69) infant formulae and milk 
powders (Jaradat et al. 2009). The level of reported contamination is typically very 
low, under 1 CFU/g. 
Miled-Bennour et al. (2010) analyzed 150 isolates previously identified as 
Cronobacter using the ISO/TS 22964 standard method, out of which 70% were 
isolated from the PIF production environment and 20% from PIF. Biochemical testing 
for indole production, malonate utilization and acid production from dulcitol and 
methyl-α-D-glucoside indicated that 82.5% of the strains were C. sakazakii, 8% C. 
malonaticus, 5% C. muytjensii, 3% C. dublinensis, and 1.5% C. turicensis. However, 
of the 47 strains isolated from PIF products or samples from PIF production plants, 
91.5% were C. sakazakii, and 8.5% were C. malonaticus, which shows the prevalence 
of C. sakazakii  and C. malonaticus in PIF factories and PIF products. Similar results 
were reported in other studies (Mullane et al. 2008a, Healy et al. 2009).  
Powdered infant formula is not a sterile product and hence can contain viable bacterial 
cells. The contamination of formula products can be intrinsic, occurring during the 
manufacturing process, or extrinsic from equipment used for its reconstitution. The 
possible sources of intrinsic PIF contamination include a wide range of dry blended 
raw material and other environmental sources associated with the factory environment 
(Drudy et al. 2006). In summary, due to prevalence of Cronobacter in the milk-
processing environment and its ability to persist in powdered products such as PIF, 
stringent microbiological criteria need to be adapted to ensure safety of these products.  
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1.1.2.3 Clinical sources 
Cronobacter has been isolated from a wide range of clinical sources including 
cerebrospinal fluid, blood, bone marrow, sputum, urine, appendix, intestinal and 
respiratory tracts, eye, ear, wounds, ear and breast abscess, and faeces (Gurtler et al. 
2005); and from various formula preparation utensils (Clark et al. 1990,  Bar-Oz et al. 
2001, Block et al. 2002).  
Most reports on Cronobacter outbreaks have implicated infant formula or the hospital 
environment as a source of contamination, and therefore the main focus of regulatory 
bodies has been the safety of breast milk substitutes and equipment used for its 
preparation. Recent studies, however, have highlighted other sources of infection. 
During one outbreak at a neonatal intensive care unit (NICU) in Greece, Cronobacter 
was isolated from throat swabs of neonates colonised by the bacterium, but it was not 
present in their blood (Arseni et al. 1987). This suggests that neonatal throat flora can 
act as a source of contamination of the hospital environment and possibly other 
neonates.  One of our recent studies done in collaboration with Aston University, 
Nottingham City Hospital and Queens Medical Centre has identified enteral naso-
gastric feeding tubes used at neonatal care intensive units as a possible source of 
microbial infection. Moreover, C. sakazakii was isolated from tubes of neonate that 
was not fed FIP (Hurrell et al. 2009b). This study has also highlighted the issue of 
biofilm formation on the surface of enteral tubes, which can significantly increase the 
risk of contamination of the infant feed. Another study examining biofilm formation 
of Cronobacter, other Enterobacteriaceae and Acinetobacter on different types of 
enteral tubes was undertaken by our group at Nottingham Trent University (Hurrell et 
al. 2009b).  
The ubiquitous nature of Cronobacter and its ability to form biofilms on surfaces 
commonly used in formula preparation such as glass, some forms of plastic and 
stainless steel (Iversen & Forsythe 2003, Forsythe 2005) mean an increased risk of 
contamination of prepared feeds by the bacterium, especially if hygienic practices are 
not followed. 
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1.1.3 Taxonomy 
The taxonomical classification of the organism now known as Cronobacter has 
proven to be somewhat of a challenge. First the bacterium was known as yellow-
pigmented Enterobacter cloacae, then as Enterobacter sakazakii and finally, 
Cronobacter spp. A variety of other confusing names used for this organism reflect 
the taxonomic uncertainty connected with Cronobacter:  ‘Urmenyi and Franklin 
bacillus’, ‘yellow coliform’, ‘yellow Enterobacter’ and ‘pigmented cloacae A 
organism’.   
The bacterium was first believed to be a yellow-pigmented variety of Enterobacter 
cloacae, one of the many causative agents of infant meningitis. In 1974, Brenner et al. 
showed that yellow-pigmented strains of E. cloacae had less than 50% sequence 
identity with non-pigmented strains and it was suggested that yellow pigmented E. 
cloacae should comprise a new species (Brenner 1974). In 1980, a comparison of 
‘Enterobacter sakazakii‘ to the type strains of the genera Enterobacter and 
Citrobacter by DNA-DNA hybridization (Farmer 1980) revealed 41% similarity to 
Citrobacter freundii  and 54%  similarity to E. cloacae, respectively. Since the 
organism was also phenotypically closer to Enterobacter cloacae, it was assigned to 
the Enterobacter genus (Farmer 1980). Farmer and colleagues designated it a new 
species and named it after the Japanese bacteriologist Riichi Sakazaki (Farmer 1980).  
“E. sakazakii” was later distinguished from E. cloacae based on differences in 
pigment production, biotype assignment and antimicrobial resistance (Farmer 1980, 
Izard et al. 1983). More recent analysis of both partial 16S rDNA and hsp60 gene 
sequencing showed that ‘E. sakazakii’ isolates formed at least four distinct clusters 
(Iversen et al. 2004c), and the authors concluded that the clusters may in fact 
represent different closely related species. The clusters included the 15 different 
biogroups previously defined by Farmer (1980) based on biotyping, and a 16th 
biogroup was added in subsequent work (Iversen et al. 2006). However, full 
taxonomic revision required considerable further analysis. In 2007, a re-classification 
of “Enterobacter sakazakii” into a new genus Cronobacter based on DNA-DNA 
hybridization and phenotyping was proposed (Iversen et al. 2007) and revised in 2008 
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(Iversen et al. 2008). The new genus harbours five distinct species: Cronobacter 
sakazakii, C. malonaticus, C. turicensis, C. muytjensii, C. dublinensis and a possible 
sixth Cronobacter group, currently named ‘genomospecies I’ that only includes two 
strains. The genus would derive its name from a Greek mythological god Kronos, who 
was said to swallow his children at birth. With a few exceptions, the former biotypes 
and genomogroups correspond with the new species (Baldwin et al. 2009). 
Distinguishing between the two species C. sakazakii and C. malonaticus is still 
problematic, however.   
All Cronobacter species have been associated with clinical infections in infants or 
adults and are considered pathogenic (FAO/WHO 2008). However, it is plausible that 
some species are more virulent to neonates, as determined by in vitro virulence 
studies (Townsend et al. 2007a, Townsend et al. 2008a). To date, isolates from 
infected neonates have been limited to C. sakazakii, C. malonaticus and C. turicensis, 
although not all “E. sakazakii” isolates have been classified according to the new 
nomenclature.  
  
1.1.4 Molecular typing methods 
Although it is possible to differentiate all six Cronobacter species by biochemical 
profiling (Iversen et al. 2008), molecular methods are being increasingly used as a 
more rapid and reliable tool to study bacterial genomic diversity and to track sources 
of infection. Cronobacter species have been successfully characterized by random 
amplification of polymorphic DNA (RAPD), ribotyping, pulsed-field gel 
electrophoresis (PFGE), multiple-locus variable-number tandem-repeat analysis 
(MLVA) and multiple-locus sequencing technique (MLST). Among these, PFGE  is 
considered the gold standard for genetic typing (Nazarowec-White, Farber 1999, 
Mullane et al. 2008a) and is recommended to be used in surveillance and 
investigations of sources of outbreaks. Terragno et al. (2009) analysed 23 
Cronobacter isolates by PFGE and showed that both enzymes used, XbaI and SpeI, 
generated discrete DNA band patterns that discriminated all the isolates analyzed. 16S 
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rDNA sequences have been traditionally used to determine phylogenetic relationships 
between organisms including Enterobacteriaceae.  16S rDNA sequencing is of 
limited use for more closely related organisms, however, because of minor differences 
in the rDNA sequence. 16S rDNA gene sequencing can distinguish between 5 
Cronobacter spp., but difficulties can arise whilst trying to separate C. sakazakii and 
C. malonaticus species. As an example, automated ribotyping results defined groups 
of Cronobacter strains which corresponded to biochemical testing of the strains 
(Miled-Bennour et al. 2010). However, at least three strains clustered outside the 
expected group defined by biochemical testing.  The authors concluded that due to the 
limited discrimination of the 16S rDNA sequencing method at the intra-species level, 
other typing methods should be considered as the standard method for Cronobacter 
strains identification. Sequencing of protein coding genes is a useful, more 
discriminatory alternative to ribotyping especially if sequences from multiple protein-
coding genes are used.  In collaboration with University of Warwick, our group 
developed a full MLST scheme based on sequences of 7 loci (Baldwin et al. 2009). 
The Cronobacter MLST analysis is based on 7 housekeeping genes;  ATP synthase 
beta chain (atpD), elongation factor G (fusA), glutaminyl-tRNA synthetase (glnS), 
glutamate synthase large subunit (gltB), DNA gyrase subunit B (gyrB), translation 
initiation factor IF-2 (infB) and phosphoenolpyruvate synthase A (ppsA).  This MLST 
scheme is accessible online (http://pubmlst.org/cronobacter/) and has been designed to 
cover all Cronobacter species.  The MLST analysis has revealed a remarkably strong 
clonal nature in Cronobacter.  For example, it showed that some sequence types were 
primarily associated with infant formula (ST3) or were primarily composed of clinical 
isolates (ST8). This indicates that there may be a source of Cronobacter which is not 
PIF associated and therefore focusing on PIF analysis after a Cronobacter outbreak 
may lead to oversight of the true source of the infection.   
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1.1.5 Pathogenesis and virulence factors  
The majority of reported infections caused by Cronobacter occur in adults. These 
comprise a wide range of symptoms, from conjunctivitis, biliary sepsis, urosepsis and 
appendicitis to wound infection and pneumonia; infections in neonates include infant 
meningitis and necrotizing enterocolitis (Gurtler et al. 2005). At least 120 cases of 
Cronobacter-related infections and 27 deaths were reported in infants and young 
children up to 3 years of age (FAO/WHO 2008). Infections by Cronobacter can have 
a very severe outcome, particularly for neonates and the immuno-compromised. 
Although very rare, infections by Cronobacter spp. are a cause for public health 
concern due to their extreme severity and resulting mortality and morbidity. Although 
Cronobacter can cause infection in all age groups (FAO/WHO 2008), neonates and 
infants less than 2 months old, premature infants and those with underlying medical 
conditions are at the highest  risk (FAO/WHO 2006, Bowen & Braden 2006). A 
newborn infant has a sterile gastrointestinal tract that is quickly colonised by bacteria. 
Furthermore, being less acidic than that of adults, the stomach of newborns, especially 
of those born prematurely, can enable the survival of Cronobacter cells. Most 
documented outbreaks of Cronobacter infection occurred in hospitals at neonatal 
intensive care units. However, Adamson & Rogers (1981) reported separate cases of 
previously healthy infants admitted to hospital with meningitis caused by 
Cronobacter, showing that infection can also be acquired in the home environment. 
Finally, some Cronobacter infections occurred in adults, namely wound infections or 
bacteraemia. Adult patients at increased risk include those previously treated with 
antibiotics, immuno-compromised and elderly patients, those with medical implants 
or with acute, chronic, or serious illnesses (Pitout et al. 1997, Sanders & Sanders 
1997). 
 
1.1.5.1 Infant meningitis 
Infant meningitis can be caused by a variety of bacterial pathogens, including 
Cronobacter and its close relatives Enterobacter cloacae and Citrobacter koseri.  
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Cronobacter-related meningitis is characterized by a mortality rate of 40-80% 
(Iversen & Forsythe 2003) and generally a very poor clinical outcome (Figure 2). The 
bacterium causes cystic changes, abscesses, fluid collection, brain infarctions, 
hydrocephalus, necrosis of brain tissue and liquefaction of white cerebral matter 
(Iversen & Forsythe 2003). Patients surviving Cronobacter-related meningitis often 
suffer from severe neurological sequelae, such as hydrocephalus, quadriplegia and 
retarded neural development (Lai 2001). The infection usually arises between the 
fourth and fifth day after birth and it can be fatal within hours to days following the 
first clinical signs (Muytjens et al. 1983). Compared with patients suffering from 
Cronobacter-induced enterocolitis, infants in whom meningitis developed tend to 
have normal gestational age and birth weight (Bowen & Braden 2006). 
 
Figure 2. Magnetic resonance scan of neonatal brain. The darker area is cerebral 
matter that has been liquefied as a result of Cronobacter infection. Source: (Farber & 
Forsythe 2008) 
 
1.1.5.2  Necrotizing enterocolitis 
Necrotizing enterocolitis is caused by several different pathogens. It is the most 
common gastrointestinal disease in newborns, affecting approximately 2-5% of 
premature neonates and leading to death in 10-55% cases (Peter et al. 1999). It is 
characterized by ischaemia, bacterial colonisation of the intestinal tract, and increased 
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levels of proteins in the gastrointestinal lumen. Cronobacter has been implicated as a 
causative agent of necrotizing enterocolitis (NEC), but its role in the pathogenesis of 
the disease is somewhat unclear.  There are some reports of Cronobacter isolations 
from babies who developed NEC (van Acker et al. 2001, Caubilla-Barron et al. 2007). 
NEC is ten times more common in babies fed with formula milk compared with those 
fed with breast milk (Lucas & Cole 1990). This suggests that there is an association 
between Cronobacter occurrence and NEC, although until recently, the organism has 
not been conclusively proven to cause the disease and the pathogenesis of NEC is still 
poorly understood.   
Hunter et al. (2008) demonstrated that C. muytjensii induces nitric oxide (NO) 
production in infected intestinal epithelial cells and that the NO production is 
responsible for the apoptosis of the intestinal cells. The increased NO production was 
due to the production of an isoform of NO synthase, iNOS (inducible NO synthase), 
which is only expressed during inflammation.  The iNOS expression was suppressed 
when Lactobacillus bulgaricus, a probiotic bacterium commonly used in yoghurt 
cultures, was added prior to infection with the Cronobacter. It was also demonstrated 
that L. bulgaricus pretreatment protects against the loss of microvillus structure and 
other structural changes in the intestinal epithelial cells caused by Cronobacter. This 
was confirmed by an in vivo study, when pretreatment of rat pups with L. bulgaricus 
decreased the degree of intestinal cell injury caused by Cronobacter (Hunter et al. 
2009). The authors also showed that Cronobacter induces apoptosis by the expression 
of tumor necrosis factors, apoptotic genes and iNOS genes, and that the expression of 
these genes was suppressed when the cell lines were pretreated with L. bulgaricus.  It 
is of note, however, that these two studies have been in fact done with a single strain 
of C. muytjensii which has not been associated with neonatal infection, and has not 
been extended to cover other Cronobacter species. 
  
1.1.5.3 Virulence studies 
Still very little is  known about virulence factors and pathogenicity of Cronobacter. It 
is known that Cronobacter strains and species vary in their virulence, as determined 
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by epidemiological studies and in-house mammalian tissue culture (Caubilla-Barron 
et al. 2007, Townsend et al. 2007a, Townsend et al. 2008a), but the mechanisms of 
virulence are unknown.  The bacterium is believed to invade the tissues using 
pathogenic secretory factors (elastases, glycopeptides, endotoxins, collagenases and 
proteases), which increases the permeability of the blood-brain barrier and allows the 
bacterium to gain access to the nutrient-rich cerebral matter (Iversen & Forsythe 
2003). Some reports suggest a similarity between the tropism of Cronobacter and 
Citrobacter koseri for invasion and infection of the central nervous system (Willis & 
Robinson 1988, Burdette & Santos 2000). Kline (1988) also noted that brain 
abscesses caused by Cronobacter and Citrobacter koseri were morphologically 
similar and may be due to similar virulence mechanisms.   Pagotto et al. (2003) were 
the first to describe putative virulence factors for Cronobacter when they found that 
enterotoxin analogue compounds were produced by 4/18 strains in a suckling mouse 
assay.  The authors found that the lethal dose was 10
8
 CFU per mouse for all strains 
when injected intraperitoneally, but only two Cronobacter strains caused death when 
given orally.  However, FAO/WHO (2004) have proposed a much smaller tentative 
oral dose for neonates ranging from 10
3
 to 10
8
 CFU.  Although the production of 
enterotoxin by some Cronobacter strains described by Pagotto et al. (2003) is widely 
acknowledged, the genes encoding the putative toxin have yet to be identified. The 
type strain ATCC 29544
T
 showed no enterotoxin production in the study, which also 
suggests that there are considerable differences in virulence among Cronobacter 
strains, and some strains may be non-pathogenic.  Kothary et al. (2007) characterized 
a zinc metalloprotease zpx unique to 135 Cronobacter strains tested, which could 
allow the bacterium to penetrate the blood-brain barrier and cause meningitis. 
Townsend et al. (2007b) used the neonatal rat model to study translocation of 
Cronobacter and other bacteria from the gut to deeper tissues following endotoxin 
(LPS) administration. The authors suggested that LPS may enhance the translocation 
of bacteria from the blood to the CNS within 24 h, but the mechanism which LPS 
utilizes to enhance bacterial translocation across the gut and blood brain barrier was 
not clear.  It was hypothesized that  the ingested LPS may disrupt the intestinal wall 
barrier and promote bacterial invasion in necrotizing enterocolitis and sepsis, and 
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subsequently weaken the blood brain barrier leading to meningitis (Townsend et al. 
2007b). 
Townsend et al. (2007a) showed that Cronobacter can attach to intestinal Caco2 cells 
and survive in macrophages. The authors provided evidence   that Cronobacter can 
enter the CSF circulation and suggested that the organisms cause a massive influx of 
inflammatory
 
cells into the ventricles and meninges, breaking down adhesion
 
junctions and thus gaining access to the brain parenchyma.
 
This study showed for the 
first time that Cronobacter is able to invade capillary endothelial cells and persist in 
macrophages
 
up to 96 h. It also confirmed that the ability to cross blood-brain barrier 
and cause CNS infection varied significantly between the strains. Kim and  Loessner 
(2008b) suggested that the invasion of Cronobacter to Caco-2 cells may be receptor-
mediated, as the bacterial invasion showed characteristics of saturation kinetics. The 
authors also concluded that bacterial de novo protein synthesis was required for 
invasion.  In the same study, pretreatment of Caco-2 cells with an actin 
polymerization inhibitor resulted in decreased invasiveness of Listeria monocytogenes 
and Salmonella Typhimurium, but enhanced the invasiveness of Cronobacter. The 
authors hypothesized that this enhancement was due to the disruption of tight junction, 
a membrane-associated structure that acts as a barrier against the molecular exchange 
between epithelial cells. This was confirmed when the disruption of the tight junction 
by EGTA significantly increased the invasive properties of Cronobacter.  
Townsend et al. (2008a) studied seven Cronobacter strains associated with the largest 
reported NICU outbreak with the most reported deaths to date.  All strains were able 
to attach to and invade the intestinal cell line Caco2 more than E. coli K12 and 
Salmonella Enteritidis, while two strains, both associated with fatal cases of 
meningitis and NEC, showed the highest invasion rates.  These two strains also 
showed acquired extended spectrum β-lactamase activities. Two strains were also able 
to replicate within macrophages, while all other strains survived inside macrophages. 
Hunter et al. (2009) examined the effects of C. muytjensii on intestinal epithelial cells 
IEC-6 an in vivo on formula fed rat pups subjected to hypoxia. The rat pups subjected 
to Cronobacter, formula feeding and hypoxia had 70% mortality compared to 40% 
mortality of the pups subjected to formula feeding and hypoxia alone.  Electron 
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microscopy revealed that Cronobacter induced morphological changes in the gut 
associated with infection such as villus disruption and formation of gaps in the 
epithelium.  The bacterium induced apoptosis both in vivo and in vitro, in the 
intestinal cells and in enterocytes of rat pups. As the organism failed to invade the 
intestinal cells in vitro, the authors hypothesized that the bacterium causes intestinal 
tissue damage by binding to the enterocytes and inducing apoptosis. A limitation of 
this study, however, is that it used a single C. muytjensii strain, which was not 
associated with neonatal infection, and that the study was not extended to cover other 
Cronobacter species. 
Despite the viruence studies examining the organism´s effect on tissue culture cell 
lines or in vivo models of NEC, there is still very little information on the genetic 
basis of Cronobacter’s virulence. Several studies highlighted the role of the outer 
membrane protein OmpA in the invasion of both intestinal epithelial and brain 
microthelial cells (Singamsetty et al. 2008, Mittal et al. 2009b, Wang & Kim 2002, 
Kim et al. 2010). Singamsetty et al. (2008) showed that Cronobacter strains with 
deletion of ompA gene had significantly lower invasion in HBMEC than the wild type 
strain. The authors also concluded that invasion of intestinal epithelial cells by the 
bacterium requires microfilaments, whereas invasion of HBMEC requires 
microtubules.   Mittal et al. (2009a) showed that C. muytjensii carrying ompA gene 
could survive inside myeloid dendritic cells, whereas C. muytjensii with deleted ompA 
was killed within 2 hours upon infection, although ompA- cells did not enter the 
dendritic cells. Complementation of ompA- cells with a plasmid carrying ompA 
restored the ability of C. muytjensii to persist in dendritic cells. The authors 
demonstrated that ompA was required for the survival inside, but not for the invasion 
of, dendritic cells. As before, this study was  limited to a single strain of C. muytjensii, 
however. In a following in vivo study using the same C. muytjensii strain, Mittal et al. 
(2009b) confirmed that the expression of OmpA is crucial for the onset of meningitis 
using the rat pup model, when 100% of rat pups infected by OmpA+ Cronobacter 
suffered meningitis, and none of the rats infected with OmpA- developed the disease.  
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1.1.6 Antibiotic susceptibility 
When an infection by Cronobacter occurs, it is essential to provide rapid antibiotic 
treatment. Although the bacterium tends to be more sensitive to most antibiotics 
compared to other Enteriobacteriaceae, its increasing resistance to some antibiotics 
causes concern.  Cronobacter-related infections have been traditionally treated with 
ampicillin combined with gentamycin or chloramphenicol (Lai 2001). Unfortunately, 
the organism has developed resistance to ampicillin (Muytjens et al. 1983, Lai 2001) 
and gentamicin use is limited as it fails to reach sufficient concentrations in the 
cerebro-spinal fluid (Iversen & Forsythe 2003). In 1980, all strains tested by Farmer et 
al. were susceptible to ampicillin (Farmer 1980).  Lai (2001) described five cases of 
Cronobacter infection in which one or more of the isolates were resistant to ampicillin 
and most cephalosporins of 1
st
 and 2
nd
 generation; and in 2008, Kim et al. (2008a) 
reported frequent resistance of Cronobacter food isolates to ampicillin and cephalotin.    
For this reason, the shift to carbapenems or 3
rd
 generation cephalosporins with an 
aminoglycoside or trimethoprim with sulfamethoxazole was proposed. This treatment 
improved the outcome of Cronobacter meningitis, but it also caused the increase in 
resistance to these antimicrobials (Lai 2001). It was reported that all Cronobacter 
strains associated with an outbreak at a NICU in France were sensitive to 
ciprofloxacin, amikacin, gentamicin, imipenem, piperacillin, and trimethoprim and 
resistant to doxycycline. Two strains (n=31)  were resistant to cefpodoxime, 
ceftazidime, and chloramphenicol (Caubilla-Barron et al. 2007).  
First reports concerning the ability of Cronobacter to produce β-lactamases gave 
conflicting results. However, the presence of β-lactamases in Cronobacter was  
reported in a study by Pitout et al. (1997) when all tested strains were positive for 
Bush group 1 ß-lactamase (cephalosporinase). Lai (2001) reported increasing β-
lactamase production among Cronobacter strains. Similarly, Block et al. (2002) 
reported that all Cronobacter isolates tested were β-lactamase positive. However,  
Stock and Wiedemann (2002), did not find any evidence β-lactam production in the 
35 Cronobacter strains tested.  Cronobacter spp, are phenotypically a very diverse 
group of bacteria that currently includes five distinct species. The discrepancy in the 
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results might be due to the different selection of the tested strains, as well as due to 
the limited number of strains used, as well as differences in the experimental protocol. 
Also, some Enterobacter strains express β-lactamases at very low levels, which might 
have not been detectable by the methods used.  Two strains isolated from fatal cases 
in a Cronobacter outbreak in France  were shown to possess  ESBL activity, which 
may have been acquired by horizontal transfer from other Enterobacteriaceae, since it 
was absent in the other strains of the same pulsetype included in the study (Caubilla-
Barron et al. 2007). 
 
1.1.7 Contamination of powdered infant formula  
Due to the ubiquitous nature of Cronobacter and its remarkable resistance to 
desiccation and heat, contamination of desiccated products including powdered milk 
formula is a persistent problem. Effective control measures, as well as improved 
reconstitution practices must be in place to ensure safety of the products. By 
definition, powdered infant milk formula (PIF) is a relatively hostile environment for 
the survival of microorganisms. There are two main reasons why the survival and 
growth of microorganisms is suppressed in this environment:  heat treatment of PIF 
and the low water activity of the product.  Powdered infant formula is treated by 
pasteurization, which is designed to reduce the living microbial flora in the product.  
However, Cronobacter and other Enterobacteriaceae are being frequently isolated 
from such products, which can be due to the imperfection in the heat propagation 
during the pasteurization process, or due to post-processing contamination. For these 
reasons, the thermotolerance of Cronobacter, its desiccation resistance, as well as its 
ability to form biofilms and adhere to surfaces are of great concern.   
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1.1.7.1 Thermal resistance 
Cronobacter was originally considered a very thermotolerant organism, and it was 
even believed that it could be able to survive the pasteurization process. In one of the 
earliest studies, Nazarowec-White and Farber (1999) reported that Cronobacter was 
the most thermotolerant organism among Enterobacteriaceae. Later studies by 
Breeuwer et al. (2003), Barron & Forsythe (2007) and Osaili & Forsythe (2009) 
demonstrated that Cronobacter was not particularly thermotolerant, but that the 
organism has the ability to adapt to heat stress following exposure to desiccation 
stress. 
There appears to be considerable variability in thermotolerance of Cronobacter. 
Buchanan et al. compared thermal resistance of Cronobacter strains with other 
Enterobacteriaceae and the D-value measured for “E. sakazakii 607” was 10 times 
greater than that for “E. sakazakii 51329” (C. muytjensii) (Edelson-Mammel & 
Buchanan 2004). A subsequent comparison of the thermal resistance of 12 
Cronobacter strains confirmed that the organism’s thermal resistance was highly 
variable between different strains. The isolates exhibited an almost 20-fold divergence 
in thermal resistance, with the strain “E. sakazakii ATCC 51329” (C. muytjensii) 
being the least resistant, and a clinical isolate the most resistant.  The new taxonomic 
scheme provides an explanation for such divergence in thermal resistance; what was 
previously considered as large intra-species variation became variation between 
different species of the Cronobacter genus.  
Most earlier investigations used Cronobacter cultures of non-stressed cells grown in 
nutritionally rich reconstituted PIF under optimal growth conditions. As it is known 
that exposure to stress factors can increase the thermal resistance of bacteria (Pagan et 
al. 1997) and that the contamination of PIF often involves dry materials, it is 
beneficial to assess the heat resistance of cells that have been exposed to desiccation 
stress. Chang et al. (2010) investigated the influence of growth phase, growth 
temperature, heat shock, pH and water activity of treatment medium on the heat 
resistance of Cronobacter. The authors found that heat shock significantly enhanced 
the bacterium’s  resistance to all the lethal stresses assessed. For example, survival of 
the heat-shocked Cronobacter cells was approximately 752 times that of the 
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nonshocked cells, and after 36 h of exposure to high osmotic environment, the 
survival of the heat-shocked cells was approximately 119 times that of the control 
cells. The maximum increase in thermotolerance was reported after 15 min at 47 °C, 
with a 2.5-fold increase in D51 value compared to non heat-shocked cells. In 
accordance with other studies, it was found that the heat resistance was highly strain-
dependent. The acidification of the culture medium resulted in decreased heat 
tolerance, whereas the decrease in water activity of the media resulted in increased 
heat tolerance. As Cronobacter cells showed a greater heat tolerance in real food 
products than in laboratory media, the authors concluded that the heat treatment 
designed based on laboratory media would offer insufficient reduction of the 
microbial load in foods and that these treatments should be validated in alimentary 
products.  
It is also important to note that heat resistance of bacteria can be greatly influenced by 
the composition of the heating medium. For instance, the higher fat content in PIF can 
cause the increased thermal resistance of Cronobacter in reconstituted PIF compared 
to saline, due to the lower heat conductivity of fat (Kim & Park 2007b). 
 
1.1.7.2 Desiccation tolerance 
Many bacterial species are unable to survive in PIF due to the product's low water 
activity. Cronobacter has an unusual ability to stay alive when exposed to dry 
conditions, as it was shown to persist in the powder for more than 2.5 years (Barron & 
Forsythe 2007). In general, bacteria protect themselves from increasing osmolarity by 
the rapid intracellular accumulation of ions, mainly K+, followed by the accumulation 
of compatible solutes such as proline, glycine, betaine, and trehalose (Kempf & 
Bremer 1998). Breeuwer et al. (2003) demonstrated that in the stationary phase, 
Cronobacter strains are relatively resistant to osmotic and dry stress compared with 
other strains of the Enterobacteriaceae group such as Salmonella and E. coli. In dried 
stationary cells the trehalose concentration increased more than five-fold and such 
accumulation was not observed in dried stationary E. coli. Furthemore, addition of 
trehalose to the growth medium of exponential phase Cronobacter improved its 
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survival after drying (Breeuwer et al. 2003). Barron and Forsythe (2007) prepared 
desiccated cultures of 10 Cronobacter strains and 17 strains of other 
Enterobacteriaceae to study their persistence in powdered infant formula for a period 
of 2.5 years. It was found that the organisms could be divided into four groups 
according to their persistence in dessicated state, with C. sakazakii strains surviving 
the longest. Five of the 10 Cronobacter strains were still recoverable after two years. 
Two of the five persistent strains were capsulated, and the only Cronobacter strains 
that could be recovered after 2.5 years were capsulated. The authors concluded that 
capsule production can have a role in persistence in dry environments over long 
periods of time. This was further supported by the fact that the capsulated strains of K. 
oxytoca, E. vulneris, and Pantoea spp. persisted in the powdered formula over two 
years, whereas none of the Cit. koseri or E. cloacae non-capsulated strains survived. 
Gurtler & Beuchat (2007b) monitored the survival of Cronobacter spp. in infant 
formula under different storage conditions for up to 12 months. In both products the 
Cronobacter spp. survived better at low water activities and a low storage temperature 
(4°C). Interestingly, the organism persisted less in infant formulas with higher water 
activities (0.43–0.50) compared with lower water activities (0.25–0.30). The 
persistence of the bacterium in infant formulas decreased with increasing storage 
temperature (4, 21 and 30 °C) and the survival rate was not affected by the 
composition of the formula (i.e. milk-based or soy-based). In an extensive study by 
several collaborating laboratories, Beuchat et al. (2009) examined various factors 
affecting growth and survival of Cronobacter in infant formula and other foods.  The 
organism survived better in dried formula and cereal at low aw (0.25–0.30) than at 
high aw (0.69–0.82) and at 4 °C compared to 30 °C. The composition of infant 
formulas did not significantly affect the rate of growth. Riedel and Lehner (2007) 
examined the changes in protein synthesis following desiccation and osmotic stress in 
“C. sakazakii z236” and found an array of genes that were up-regulated during the 
response to desiccation, including cold-shock protein CspC, DNA repair proteins, 
superoxide dismutase and outer membrane proteins OmpA and OmpC, possibly 
linked to transport of compatible solutes similar to trehalose.  
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Interestingly, powdered infant formula and other milk based products may contain 
substances that have a protective effect on bacteria exposed to desiccation during the 
manufacturing of such products.  For example, neither nisin or lactoferrin, natural 
substances known for their antimicrobial effect in food products, had detectable 
bactericidal activity against Cronobacter spp. in reconstituted PIF, whereas the same 
Cronobacter strains were sensitive to both nisin and lactoferrin in peptone water (Al-
Nabulsi et al. 2009). The authors concluded that this might be due to the presence of 
divalent cations such as Ca
2+
 and Mg
2+
, which may protect the bacteria by causing 
changes in the spatial structure of lactoferrin and by stabilising the bacterial 
membrane, or by high concentrations of iron in PIF, which can reverse the 
bacteriostatic effect of lactoferrin. Dancer et al. (2009) examined the resistance of 
Cronobacter to different stress factors including heat, drying and decreased water 
activity. In accordance with previous studies, the authors demonstrated that 
Cronobacter was much more resistant to environmental stresses compared to other 
members of Enterobacteriaceae. The most heat-resistant strains were also the most 
resistant to drying. The authors concluded that the potential cross-resistance of 
Cronobacter strains can increase the likelihood of its persistence in powdered infant 
formula.  
The increased resistance to osmotic stress of Cronobacter strains compared to other 
Enterobacteriaceae points towards inherent bacterial mechanisms that help the 
organisms to resist dry stress. Given the possible plant origin of Cronobacter spp. it is 
plausible that these mechanisms originally evolved as survival strategies specific to 
plant-associated organisms. 
 
1.1.7.3 Biofilm formation and capsule production 
Biofilms have been defined as sessile communities of bacterial cells attached to a 
surface or to each other, usually embedded in polymeric substances produced by the 
bacteria (Marshall 1992). Biofilm formation is known to enhance the resistance of 
cells to environmental stresses and to provide protection against sanitizers (Marshall 
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1992). Cronobacter organisms often produce a heteropolysaccharide capsule 
composed of glucuronic acid, D-glucose, D-galactose, D-fucose and D-mannose; 
strains from NICU outbreaks have been reported to produce so much capsular 
material that on milk agar plates the colonies will drip onto the lid of inverted Petri 
dishes (Caubilla-Barron et al. 2007). Interestingly, this material has been patented for 
use as a thickening agent in foods (Harris & Oriel 1989, Scheepe-Leberkuhne & 
Wagner 1986).  This capsular material could facilitate the organism’s attachment to 
plant surfaces and, combined with a tolerance to desiccation, enable the organism to 
colonize plant material and survive harsh environmental conditions. Production of 
heteropolysaccharide capsule is also known to promote survival of the bacterium in 
foodstuffs for long periods of time (Iversen & Forsythe 2003, Lehner et al. 2005). 
Iversen and Forsythe (2003) suggested that the capsule produced by Cronobacter 
might also increase the organism’s ability to attach to surfaces and to form biofilms. 
In a later study by Hurrell et al. (2009a) it was shown that biofilm formation did not 
correlate with capsule production, however.    
Kim et al. (2007a) examined survival of Cronobacter dried on the surface of stainless 
steel and exposed to 43% relative humidity with varying temperature and  medium, as 
well as  survival of Cronobacter cells in biofilm.  The authors reported that some of 
the cells in biofilms survived under all test relative humidities for up to 42 days.Their 
findings indicate that infant formula provides protection against desiccation for cells 
attached to a steel surface, as well as cells in biofilms. Kim et al. (2006) reported that 
Cronobacter did not form biofilms on stainless steel or tubes at 25 °C in sterile tryptic 
soy broth or lettuce juice. However, the pathogen did form biofilms on surfaces of 
both materials immersed in infant formula. This indicates that the ability of 
Cronobacter to form biofilms is affected by the composition of the media, and that it 
is enhanced by substances present in infant formula.  The infant formula composition 
can also increase Cronobacter’s resistance to disinfectants, as shown by  Kim et al. 
(2007a), who examined the effect of thirteen disinfectants commonly used in infant 
formula preparation areas. Populations of Cronobacter cells suspended in water (ca 7 
log CFU/ml) decreased to undetectable levels (< 0.3 log CFU/ml) within 1–5 min of 
treatment with disinfectants, whereas numbers of cells in reconstituted PIF diminished 
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by only 0.02–3.69 log CFU/ml after treatment for 10 min. Furthermore, cells attached 
to stainless steel were less resistant to disinfectants. Cronobacter is able to adhere to 
silicon, latex and polycarbonate and to a lesser extent to stainless steel (Iversen & 
Forsythe 2003). Furthermore, Cronobacter has been reported to attach and form 
biofilm on glass and polyvinyl chloride (Lehner et al. 2005). All of these materials are 
commonly used for infant-feeding and food preparation equipment, and, if 
contaminated, may increase the risk of infection. 
 
 
  
1.1.8 Safety of breast milk substitutes  
Although the level of PIF contamination does not usually exceed 1 CFU per 100g, in 
2007 WHO concluded that it was not possible to assess the contribution of the 
hygiene abuse and extended hold of reconstituted formula at non-refrigerated 
temperatures to infections by Cronobacter and that it must be assumed that even low 
contamination below 3 cfu/100g can lead to disease (WHO 2007). During the 
manufacture of PIF, Cronobacter can gain access from the environment, from the 
ingredients added or as a post processing contamination. In one of the methods used 
for producing powdered milk substitutes, individual ingredients are heat-treated 
before spray-drying and blending of the product take place. This method is prone to 
bacterial contamination as the drying and the blending are often the principle 
contamination sites for dried products (Iversen & Forsythe 2003). Furthermore, due to 
the survival of the cells at elevated temperatures and the capacity to grow up to 47
o
C, 
Cronobacter has a competitive advantage compared with other members of 
Enterobacteriaceae. The bacterium then becomes more dominant in the warm and dry 
environment of the PIF factory and its presence further increases the risk of post-
processing contamination. 
 In 2004, the European Food Safety Authority (EFSA) reviewed the known facts 
about Cronobacter and categorized it together with Salmonella as an organism with a 
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clear evidence of causality and concluded that there was a need to reduce its 
prevalence in PIF (EFSA 2004). In 2007, it was suggested that monitoring 
Enterobacteriaceae in the processing environment and in the product would be useful 
in reducing the prevalence of Cronobacter (EFSA 2007). However, 
Enterobacteriaceae direct count does not always detect Cronobacter presence in the 
PIF samples, possibly due to the low cell number and injury to the organism during 
dessication (Forsythe 2005). Therefore, specific test methods for the recovery of 
dessication-stressed Cronobacter cells  have been developed. Since 2008, the Codex 
Alimentarius Commission (Codex Alimentarius Commission (CAC) 2008) 
microbiological criteria are applied to PIF products intended for under 6 month of age. 
The Codex Alimentarius Commission requirement is to test thirty 10g quantities for 
presence/absence of Cronobacter. The current recommended ISO standard method 
(ISO 21528-1:2004) for detection of Cronobacter includes an enrichment step in EE 
("Enterobacteriaceae Enrichment") broth, but according to an earlier study (Iversen & 
Forsythe 2007), growth of some strains of Cronobacter is inhibited in this broth, 
which can lead to false negative results. Later Joosten et al. (2008) observed 
inhibition of growth in EE for 9 (9.3%) strains, including seven C. sakazakii and one 
C. malonaticus strain. The authors evaluated an alternative method which omits the 
EE enrichment step and proposed the revision of the standard ISO method. Previous 
FAO/WHO expert meetings on the microbiological risk assessment of powdered 
infant formula have recommended the reconstitution of PIF with water no less than 
70°C, and use of the reconstituted product within 2 hours (FAO/WHO 2004, 
FAO/WHO 2006).  The use of high reconstitution temperature should reduce the 
viability of Cronobacter spp. and Salmonella serovars; short storage period would 
limit the growth of any surviving microorganism, and therefore this procedure would 
reduce the risk of neonatal infection through the consumption of contaminated 
formula. 
Recently, another product was highlighted as a potential source of Cronobacter 
infection – follow-up formula (FUF). To meet the increased nutritional needs of older 
infants, FUF often contains a variety of dry blended ingredients which have been 
linked to Cronobacter contamination. Although FUF is designed for infants above 6 
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months, international surveys reveal that it is given to infants less than 6 months or 
even less that 1 month old (FAO/WHO 2008). Given the fact that there is no hygiene 
control requirement for testing FUF for Cronobacter, FUF can be potentially 
hazardous if consumed by susceptible neonates. The FAO/WHO meeting held in 2008 
reviewed this matter in order to establish microbiological critera for FUF, but 
concluded that no microbiological criteria were required (FAO/WHO 2008).    
 
1.1.9 Control methods 
Several research groups have proposed the use of different substances to limit growth 
of Cronobacter in PIF. Nair et al. (2004) showed that monocaprylin can be effective 
at inactivation of Cronobacter in PIF stored at refrigeration temperature and Gurtler 
& Beuchat (2007c) demonstrated the inhibitory effect of the lactoperoxidase system 
on Cronobacter stored at 21, 30 and 37°C. Lee & Jin (2008) investigated the effect of 
natural antimicrobial compounds on inactivation of Cronobacter and concluded that 
the combination of diacetyl with nisin had the greatest synergistic effect. 
Wakabayashi et al. (2008) tested the susceptibility of Cronobacter to several metal-
bound forms of bovine lactoferrin and lactoferrin-derived peptide lactoferricin B. The 
authors reported that four Cronobacter strains were inhibited by hydrolysed 
lactoferrin, Cu-lactoferrin, apo-lactoferrin and lactoferricin B, but not to Fe-lactoferrin. 
The authors concluded that bovine lactoferrin-related compounds may be used for the 
inhibition of Cronobacter in foods. However, as the organism was not inhibited by 
Fe-lactoferin, this strategy would be limited to foods that do not contain iron and thus 
unsuitable for use in PIF.  
In an interesting study, Zhao et al. (2008) isolated five bacteriophages of Cronobacter 
from sewage, one of which could lyse 24 (89%) of Cronobacter strains tested. The 
authors concluded that these bacteriophages could be potentially used in typing or 
treatment of Cronobacter infection. This idea has not been further explored, however. 
Amalaradjou et al. (2009) reported that trans-cinnamaldehyde (0.5%), which is one of 
the major components of bark extract of cinnamon, reduced Cronobacter count to 
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undetectable levels by 4 h of incubation at 37 or 23
 o
C and 10 h of incubation at 8 or 
4
o
C, respectively. The authors proposed that trans-cinnamaldehyde could potentially 
be used to inactivate Cronobacter in reconstituted PIF. However, this compound has 
general antimicrobial activity and could therefore upset the neonatal gut flora leading 
to serious infections. Al-Holy et al. (2010) reported a more than 5-log reduction in 
Cronobacter count after 2 h and a complete elimination by the end of the storage 
period when lactic acid was applied together with copper (II). The authors 
hypothesized that lactic acid in the dissociated form may chelate copper (II) ions, thus 
allowing them to penetrate through the cytoplasmic membrane and exert toxicity 
against Cronobacter.  Lactic acid is a weak organic acid which has been extensively 
used as antimicrobial agent in foods. Its undissociated form can penetrate the 
cytoplasmic membrane, which reduces the intracellular pH and disrupts the 
transmembrane proton motive force and it can also permeabilize the outer membrane 
of Gram-negative bacteria for other antimicrobial agents (Alakomi et al. 2000). 
 
1.2. General aims  
Cronobacter  has been  known as a separate species since 1980, and has been the 
focus of an intensive scientific research only since 2003. Between 2003 and 2007, our 
knowledge of the organism then known as Enterobacter sakazakii, significantly 
advanced, especially in the fields of physiology and detection methods.  Reliable 
identification methods were developed and control measures were put in place to 
increase the safety of product designed for neonates. Pioneering works examining the 
organism’s remarkable persistence in the environment, as well as various aspects of 
the bacterium virulence both in vitro and in vivo, were published. The knowledge 
about the genetic make-up of this fascinating organism was still very limited, however, 
as there was no genome of ‘E. sakazakii’ sequenced at that time, and molecular 
biology research was primarily aimed at developing improved detection methods and 
phylogenetic classification of ‘E. sakazakii’ strains. The re-classification of “E. 
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sakazakii” into five new Cronobacter species in 2008 raised queries on the previous 
identification methods for the organisms and the published works in general, as the 
experimental data were obtained for uncertain Cronobacter species. Previous studies 
on ‘E. sakazakii’ will be difficult to interpret unless the strains are re-examined and 
re-classified according to the current taxonomic structure. There is a strong need to 
obtain robust data reflecting the taxonomic diversity of Cronobacter that would 
provide insight into the species behaviour in products intended for neonatal 
consumption, as well as its mechanisms of pathogenicity, which are largely unknown 
to date.    
In response to the FAO-WHO (2006) recommendations, the Food Standards Agency  
UK (FSA) funded our group at NTU to investigate the survival and growth of 
Cronobacter and other Enterobacteriaceae in infant formula during reconstitution and 
storage, in order to update the current risk assessment for Cronobacter in PIF 
(http://www.who.int/foodsafety/micro/jemra/assessment/esakazakii/en/index.html). 
This required the determination of death rates at temperatures >50°C and growth rates. 
I undertook the measurements of the growth rates and lag times, whilst Dr. J. 
Caubilla-Barron measured the death rates. My research focussed on Cronobacter 
growth in infant formula and breast milk with respect to iron availability (external 
supervisor Dr. J. Hobman). However, during my second year of research, I was 
offered the opportunity to construct and analyse a Cronobacter microarray based on 
the C. sakazakii BAA-894 genome sequenced by Prof. M. McClelland. Consequently, 
my thesis does not necessarily reflect a progression in research of one topic, but 
instead gives an initial study in the context of control of Cronobacter infection in 
neonates through potentially contaminated PIF, and subsequently, a detailed 
exploration of the organism’s genome and comparative analysis with other 
Cronobacter strains and species. This forms a highly novel and unique investigation 
of Cronobacter which covers the topics related to infant formula safety, as well as 
exploration of the detailed genomic architecture of this remarkable pathogen.  In 
conclusion, the  diversity of the Cronobacter group, highlighted by the recently 
adopted taxonomy scheme, will be addressed with respect to growth behaviour in 
powdered infant products and via microarray whole genome analysis, as well as in 
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silico genome comparisons both within Cronobacter, and within the 
Enterobacteriaceae family.  
I have been appropriately recognised for my contribution to additional studies in the 
research team: i) in vitro biofilm formation in enteral feeding tubes (Hurrell et al. 
2009a); ii) showing that enteral feeding tubes from neonatal intensive care units may 
act as loci for bacterial colonisation (Hurrell et al. 2009b). These have not been 
included in this thesis as they were not the main focus of my research.  
 
 
1.3. General materials and methods 
1.3.1 Media and reagents 
Ampicillin    Sigma-Aldrich, Dorset, UK 
Arabinose(L-)    Sigma-Aldrich, Dorset, UK 
Chloramphenicol   Sigma-Aldrich, Dorset, UK 
Glycerol    Fisher Scientific, Loughborough, UK 
Glucose    Sigma-Aldrich, Dorset, UK 
Isopropyl Alcohol   Sigma-Aldrich, Dorset, UK 
LB Agar    Fisher Scientific, Loughborough, UK 
LB broth    Fisher Scientific, Loughborough, UK 
NaOH     Sigma-Aldrich, Dorset, UK 
Na2EDTA    Sigma-Aldrich, Dorset, UK 
Nutrient Broth    Fisher Scientific, Loughborough, UK 
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Phenol/Chloroform/IsoamylAlcohol Sigma-Aldrich, Dorset, UK 
SDS     Sigma-Aldrich, Dorset, UK 
Sucrose    Sigma-Aldrich, Dorset, UK 
Tryptone    Oxoid, Hamphshire, UK 
Tris base     Sigma-Aldrich, Dorset, UK 
TSA     Oxoid, Hamphshire, UK 
TSB     Oxoid, Hamphshire, UK 
Yeast extract    Oxoid, Hamphshire, UK 
VRBGA    Oxoid, Hamphshire, UK 
 
1.3.2 Molecular biology kits and reagents, biochemical kits 
DNA ladder (1 kb)    Promega, Southampton, UK 
EcoRV     Sigma-Aldrich, Dorset, UK 
Gel loading dye    Promega, Southampton, UK 
Genomic DNA Buffer Set   Qiagen, Crawley, UK 
GoTaq Hot Start Polymerase   Promega, Southampton, UK 
ID32 E     Bio Merieux, France 
One Shot Top10 chem. comp. E. coli  Invitrogen, Paisley, UK 
Phusion Polymerase Finnzymes, Hitchin, UK 
Sigma GenElute    Sigma-Aldrich, Dorset, UK 
SYBR Safe     Invitrogen, Paisley, UK 
Qiagen Genomic tip – 100/G   Qiagen, Crawley, UK 
Qiagen Spin Miniprep   Qiagen, Crawley, UK 
Qiaquick PCR purification kit  Qiagen, Crawley, UK 
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TAE Buffer     Geneflow, Fradley, UK 
T4 DNA ligase    Promega, Southampton, UK 
 
 
1.3.3 Preparation of media 
Glycerol Yeast Tryptone (GYT) Medium 
To make 100 ml of GYT, 10 ml of glycerol was mixed with 0.125 grams of yeast 
extract and 0.25 grams of tryptone. The media was autoclaved (121
o
C, 15 min) and 
stored at room temperature until required.  
 
Luria-Bertani Agar (LB agar) 
Twenty grams of LB agar base were resuspended in 500 ml of distilled water and 
autoclaved (121
o
C, 15 min). The agar was allowed to cool to 55
o
C and approximately 
20 ml was poured into sterile Petri dishes. The plates were then stored at room 
temperature until required, for a maximum of 1 week. 
 
Luria-Bertani Broth (LB broth) 
Twelve point five grams of Luria-Bertani base were resuspended in 500 ml of distilled 
water. The mixture was autoclaved (121
o
C, 15 min) and stored at room temperature 
until required.  
 
Trypticase Soy Agar (TSA) 
Twenty grams of trypticase soy agar base were resuspended in 500 ml of distilled 
water and autoclaved (121
o
C, 15 min). The agar was allowed to cool to 55
o
C and 
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approximately 20 ml was poured into sterile Petri dishes. The plates were then stored 
at room temperature until required, for a maximum of 1 week. 
 
Trypticase Soy Broth (TSB) 
Fifteen point zero grams of TSB  base were resuspended in 500 ml of distilled water. 
The mixture was autoclaved (121
o
C, 15 min) and stored at room temperature until 
required.  
 
Violet Red Bile Glucose Agar (VRBGA) 
Nineteen point three grams of VRBGA base were resuspended in 500 ml of distilled 
water. The mixture was autoclaved (121
o
C, 15 min) and stored at room temperature 
until required.  
 
1.3.4  Preparation of media with antibiotics 
Addition of Ampicillin to LB Agar and LB Broth 
A 10 mg/ml stock solution of ampicillin in sterile distilled water was filter sterilized 
using a 0.2 µm filter. The sterile antibiotic solution was added to LB agar or LB broth 
to a final concentration of 200 µg/ml. The plates were stored at room temperature for 
a maximum of 1 week. 
 
Addition of Chloramphenicol to LB Agar and LB Broth 
A 2 mg/ml stock solution of chloramphenicol in sterile distilled water was filter 
sterilized using a 0.2 µm filter. The sterile antibiotic solution was added to LB agar or 
LB broth to a final concentration of 35 µg/ml. The plates were stored at room 
temperature for a maximum of 1 week. 
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Addition of Kanamycin to LB Agar and LB Broth 
A 2.5 mg/ml stock solution of kanamycin in sterile distilled water was filter sterilized 
using a 0.2 µm filter. The sterile antibiotic solution was added to LB agar or LB broth 
to a final concentration of 50µg/ml. The plates were stored at room temperature for a 
maximum of 1 week.
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2. FOOD STANDARDS AGENCY PROJECT: 
BACTERIOCIDAL PREPARATION OF 
POWDERED INFANT FORMULAIntroduction 
2.1.1 Aims 
The ability of Cronobacter to attach to surfaces, to form biofilms and its extreme 
resistance to dry stress contribute to the risk of powdered infant formula 
contamination by the bacterium.  Moreover, the composition of PIF seems to have a  
strong protective effect on the survival of Cronobacter. Finally, high levels of heat-
stable lipopolysaccharide (endotoxin) present in infant formula may enhance the 
translocation of Cronobacter across the gut and blood–brain barrier and increase the 
risk of bacteraemia in neonates (Townsend et al. 2007b). This highlights the 
importance of safety testing of PIF, as well providing adequate guidance for safe 
reconstitution practices. 
Breast milk substitutes including powdered infant formula (PIF) and milk fortifiers  
are not manufactured as sterile products and have to conform to the microbiological 
specifications recently revised by Codex Committee for Food Hygiene (Codex 
Alimentarius Commission (CAC) 2008), which demand presence/absence testing of 
thirty 10 g quantities of the product. Limiting the intrinsic contamination of PIF 
products by statutory microbiological criteria is one way to reduce health risks 
associated with PIF ingestion. However, at the very low levels of contamination, 
Cronobacter may still be present in the product after the microbiological testing and 
bacterial multiplication following reconstitution can lead to infection.  In 2007, the 
WHO published the ‘Safe preparation, storage and handling of powdered infant 
formula Guidelines’ (WHO 2007) and recommended reconstituting of PIF with water 
at temperatures greater than 70°C, which should provide strong bacteriocidal effect.  
This recommendation was supported by several studies on thermal resistance of 
Cronobacter where it was shown that using water at 70
o
C for reconstitution of PIF 
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had caused reductions in Cronobacter populations greater than 4 log (Edelson-
Mammel & Buchanan 2004, Shaker et al. 2008). If this procedure is widely 
implemented, it could considerably reduce Cronobacter in PIF. From the combined 
results of our survey published in the FSA report (Caubilla-Barron et al. 2009) 
undertaken by other members of our team, it is apparent that there are various PIF 
reconstitution practices in place and there is a need for a robust risk model that would 
provide scientific basis for the new formula reconstitution guidelines.  
The current risk assessment for Cronobacter in PIF (FAO/WHO 2006) 
(http://www.who.int/foodsafety/micro/jemra/assessment/esakazakii/en/index.html) is 
based on limited studies with a single Cronobacter sakazakii strain and needs to be 
updated. As it is reasonable to expect variation in growth behaviour both between 
Cronobacter species and between strains of the same species, there is a need to obtain 
growth data for diverse Cronobacter species as defined in the taxonomic 
reclassification by Iversen et al. (2008).  It is also useful to obtain growth data for 
other potentially pathogenic bacteria that may occur in PIF products. This chapter 
examines the growth behaviour of Cronobacter spp., Salmonella, other 
Enterobacteriaceae and Acinetobacter sp. at a temperature range 21 – 44oC. Along 
with the results from a study on heat inactivation of Cronobacter and other 
Enterobacteriaceae undertaken by Dr. Juncal Caubilla-Baron as a part of the same 
study, the results were used to create a new risk assessment for Cronobacter in PIF 
and provided to the Food Standards Agency UK. 
The organisms used in our study were defined by (FAO/WHO 2004, FAO/WHO 
2006) as ‘category A’ organisms with clear evidence of causality between infant 
infection and infant formula contamination (Salmonella serovars and Cronobacter spp) 
or ‘category B’ organisms for which the causality was plausible, but not yet 
demonstrated (Enterobacter cloacae, Citrobacter koseri, Citrobacter freundii, 
Klebsiella oxytoca, Klebsiella pneumoniae, Pantoea agglomerans, Escherichia 
vulneris,  Escherichia coli, Hafnia alvei, Serratia marcescens, and Acinetobacter 
baumannii). Moreover, all the organisms chosen for the study are frequently being 
isolated from breast milk substitutes (unpublished NTU data). Most strains used in 
this study were isolates from PIF or milk products and some clinical or environmental 
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strains have been used where necessary. Enterobacter hormaechei and Enterobacter 
cancerogenus were included in the study although there is no evidence that they have 
caused infections via contaminated PIF.  These organisms are frequently being mis-
classified as E. cloacae and so would not be reported as such.  However, E. 
hormaechei strains have been isolated from enteral feeding products and powdered 
infant formula (Townsend et al. 2008b) and have been shown to be of clinical 
significance due to the report of several outbreaks of sepsis in neonatal intensive care 
units in Brazil and the United States (Wenger et al. 1990, Campos et al. 2007). 
Townsend et al. (2008b) also reported a neonatal outbreak of E. hormaechei that was 
originally misclassified as Cronobacter spp.  
The temperatures 21, 27, 37, 41 and 44
o
C were chosen because they reflect a wide 
spectrum of PIF reconstitution, cooling and storage practices, as shown in Figure 2. 
The upper temperature range is useful for modelling growth of bacteria that have 
survived reconstitution at raised temperatures, and also for formulae for which lower 
rehydration temperatures have been recommended on the packaging.  The lower 
temperatures are relevant for modelling bacterial growth in prepared feeds that are 
stored at room temperature prior to the feeding. The infant formulae tested were two 
most-commonly used types of breast milk substitutes, casein- and whey-dominant 
infant formulae.   
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 Figure 2. Example growth profile of Cronobacter in infant formula over a range of 
temperatures reflecting refrigeration, reconstitution and storage practices. 
 
2.1.2 Growth rates of Cronobacter and other 
Enterobacteriaceae in powdered infant formula  
The majority of existing studies examining growth of Cronobacter in PIF were 
published before the taxonomic reclassification by Iversen et al. (2008) and were 
therefore determined for uncertain Cronobacter species. Most of the early studies 
examined growth of Cronobacter in media other than PIF, and later studies focussed 
predominantly on growth behaviour of Cronobacter cells subjected to various forms 
of stress (Edelson-Mammel & Buchanan 2004, Kim & Park 2007b, Lin & Beuchat 
2007, Gurtler & Beuchat 2007b, Beuchat et al. 2009, Chang et al. 2010). There is a 
general lack of data describing growth of other potentially pathogenic 
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Enterobacteriaceae in PIF, and to our knowledge, no comparison of the growth rates 
of different members of Enterobacteriaceae in reconstituted PIF has been published. 
Iversen et al. (2004a) reported a mean doubling time for Cronobacter  in PIF of 13.7 
h at 6 ºC, 1.7 h at 21ºC and 19-21 min at 37ºC. In another similar study, the mean 
doubling times were determined as 13.7 h at 6
o
C, 1.3 h at 21
o
C and 22.0 min at 37
o
C 
(NTU, unpublished data).  In a study by Gurtler & Beuchat (2007a) different types of 
reconstituted PIF inoculated with Cronobacter spp. were stored at 4, 12, 21, and 30°C 
and populations were monitored for up to 72 h.  Cronobacter spp. did not grow in 
formulae stored at 4
o
C and growth was not particularly influenced by the composition 
of PIF. The most extensive study on growth behaviour of non-stressed Cronobacter 
cells in PIF was published by Lenati et al. (2008). The authors examined the growth 
of 9 strains of Cronobacter in breast milk, human breast milk with fortifiers and 
powdered infant formula at 10, 23 and 37 °C. The Cronobacter strains studied 
included clinical, environmental and food isolates, but as this study was published 
prior to the taxonomic reclassification by Iversen et al. (2008), they were not assigned 
to separate Cronobacter species. Lenati and colleagues reported the following 
generation times of Cronobacter in PIF: 29.5 h for clinical isolates and 18.3 h for 
environmental isolates at 10
o
C, 42.6 min for isolates from all sources at 23
o
C; and 
17.4 min for all isolates at 37
o
C. For all isolate sources, the average generation times 
were shorter for cells grown in PIF than in breast milk and breast milk with fortifiers. 
The reported lag times were: 126.6 h for clinical and 59.0 h for environmental isolates 
grown at 10
o
C, from 3.9 to 4.7 h at 23
o
C and from 2.2 to 3.0 h at 37
o
C. At all 
temperatures, growth of Cronobacter in PIF produced higher population densities 
than growth in breast milk or breast milk with fortifiers. Due to the growth of 
Cronobacter in PIF at 10
o
C the authors suggested that powdered infant formula 
should not be stored at room temperature for longer than 4 h and that proper 
reconstitution practices, as well as temperature control are needed to control 
Cronobacter. Kandhai et al. (2006) used a clinical, environmental, and food isolate, as 
well as the ATCC 29544
T
 type strain to investigate the lag time, specific growth rate, 
and maximum population density of Cronobacter strains grown in PIF. The authors 
reported a specific growth rate of 2.3 h and lag times lag ranging from 83.3 h at 10 °C 
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to 1.73 h at 37 °C. The growth phase of the cells had no effect on the specific growth 
rates or lag times (Kandhai et al. 2006). 
 
 
2.2. Materials & Methods 
2.2.1 Bacterial strains and their maintenance 
All strains used in this study were stored at -80
o
C in Nutrient Broth with 10% (v/v) 
glycerol, subcultured on Trypticase Soy Agar and checked for purity. The list of 
strains is provided in Table 1. 
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Table 1. Bacterial strains used in the FSA study 
Organism Strain  Source Additional comment 
Acinetobacter genomosp. 13 415 Cheese and chive dip, UK 
 Citrobacter freundii 153 Infant formula milk, Korea 
 Citrobacter koseri 598 Infant formula milk 
 Cronobacter dublinensis 582 NCTC 9844 
 Cronobacter malonaticus 1212 LMG 23826 Species type strain 
Cronobacter malonaticus 685 CDC 
 Cronobacter muytjensii 3 ATCC 51329 Species type strain 
Cronobacter sakazakii 1 ATCC 29544 Species type strain 
Cronobacter sakazakii 2 ATCC 12868 
 Cronobacter sakazakii 114 Unknown 
 Cronobacter sakazakii 658 ATCC BAA-894 Genome sequenced strain 
Cronobacter sakazakii 767 Fatal meningitic strain  Isolated from trachaea 
Cronobacter turicensis 57 Milk powder, UK 
 Enterobacter cloacae 49 ATCC 13047 Isolated from spinal fluid 
Enterobacter cancerogenus 806 Neonatal enteral feeding tube 
 Enterobacter hormaechei 790 Neonatal enteral feeding tube 
 Escherichia coli 605 Unknown 
 Escherichia coli 780 Neonatal enteral feeding tube 
 Escherichia coli 796 Neonatal enteral feeding tube 
 Escherichia vulneris 52 Milk powder, UK 
 Hafnia alvei 236 Cow udder 
 Klebsiella oxytoca 379 ATCC 43155 
 Klebsiella pneumoniae 273 Spice 
 Pantoea ananatis 44 Infant milk formula, Korea 
 Salmonella Enteritidis 358 NCTC 3046 
 Salmonella Senftenberg 1188 NCTC 9959 
 Salmonella Anatum 1197 NCTC 5779 
 Serratia marcescens 464 Unknown 
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2.2.2 Introduction to impediometry 
Impediometry is based on the observation that microbial metabolism changes the 
conductivity of culture media. Impedance can be defined as the resistance to a flow of 
an alternating current as it passes through a conducting medium, and is a function of 
conductance, capacitance and the applied frequency (Eden & Eden 1984). In 
microbiological impediometry, the impedance change is measured using a pair of 
electrodes submerged in the test sample with inoculated bacteria. Upon bacterial 
growth, an increase in conductance and capacitance and a decrease in impedance are 
observed (Silley & Forsythe 1996). These changes are  caused by the conversion of 
neutral or weakly charged molecules of substrates to charged molecules of 
metabolism end-products (for example glucose to lactic acid), and the increase of 
particle mobility by cleavage of larger molecules to smaller molecules (for example 
conversion of lactate ion to a smaller more mobile bicarbonate ion) (Silley & Forsythe 
1996). At some stage during microbial growth, the amount of ions produced will 
reach the point when an increase in impedance can be detected. This time is called the 
“time to detection“ or TTD and occurs in the early stages of the exponential growth 
phase.  TTD is a function of the size of the initial population, the growth kinetics of 
the test organism and properties of the test medium (Eden & Eden 1984). The 
generation time td  of a particular organism in a defined medium is obtained by 
plotting the scattergram of logarithm (base2) of the bacterial concentration of the 
samples against the corresponding TTDs; applying a linear regression on the 
scattergram and using the formula td = log 2 / B, where B is the slope of the linear 
regression curve. For more details on the calculation see  Section ‎2.2.3. 
The measurement can be performed in two ways, using either direct or indirect 
technique. In direct technique, the bacteria are in direct contact with the electrodes 
and the changes in the conductance of the growth medium directly reflect the changes 
in the test medium. In indirect technique, the growth of the microorganism is detected 
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by the release of carbon dioxide, which is absorbed by KOH in the test tube causing a 
decrease in conductivity. The indirect technique is especially useful if bacteria do not 
metabolise the nutrients in the medium by fermentation and therefore do not produce 
enough ions that could be detected by the direct impedance method.   
 
 
2.2.3 Calculation of doubling time (td) – adapted from (Eden 
& Eden 1984) 
This section provides a justification for the use of the fomula td = log 2 / B for 
calculation of the doubling time td. 
 
If c0 is the initial bacterial concentration, TTD is time to detection, and tL is the 
duration of lag phase, it can be shown that the relationship between log c0 and (TTD – 
tL) is linear within a range of bacterial concentrations (as discussed below).  
 
If cB0 is the bacterial concentration at the beginning of the exponential phase, after n 
generations the bacterial concentration will be: 
n
BB cc 20            (1) 
 
Since the number of generations is n = t / td, and  
2
n
 = e 
n ln2
 , we obtain: 
dtt
BB ecc
/2ln
0          (2) 
 
As bacterial division is not occurring during the lag phase, the instantaneous bacterial 
concentration cB during the exponential phase becomes: 
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  dL tttBB ectc
/2ln)(
0
         (3) 
 
The equation (3) can be translated into the total concentration of ions generated by the 
microbial metabolism in the growth medium. If each microorganism generates KB 
ions per second, the total concentration of ions at any time is:  

t
BBS dttcKtc
0
)()(          (4) 
 
Where cS is the concentration of ions generated by microbial metabolism and KB is a 
‘bacterial activity‘ coefficient in min-1. 
 
Although during the lag phase bacteria do not multiply, they are metabolizing and 
increasing the ionic concentration. From the equation (4), the ionic concentration cS at 
the end of the exponential phase will be: 
tcKdtcKtc BB
t
BBS
L
0
0
0)(          (5) 
 
During the exponential phase the total ionic concentration is the sum of the ionic 
concentration at the end of the lag phase (5) and the concentration of ions generated 
during the bacterial multiplication (3). Using equations (3) and (5) we obtain: 
)(tcS
dL
L
dL
L
tttdBBd
LBB
t
t
ttt
BB
t
BB e
tcKt
tcKdtecKdtcK
/2ln)(0
0
/2ln)(
0
0
0
)
2ln
)
2ln
(
   (6) 
 
If  t >> tL, the first term in equation (5) becomes negligible. At some point in time, the 
concentration of ions generated by the bacteria cS reaches the magnitude of the initial 
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ionic concentration cSi and measurable increase in conductivity can be detected. This 
time is denoted as TTD. 
dL ttTTDdBB
sSi e
tcK
TTDcc
/2ln)(0 )
2ln
)(

       (7) 
 
 
The expected relationship can be derived from equation (7): 
 L
ddB
Si
B tTTD
ttK
c
c 
2ln2ln
lnln 0        (8) 
 
For convenence, this equation can be converted using decadic logarithm into: 
 L
ddB
Si
B tTTD
ttK
c
c 
2log2ln
loglog 0       (9) 
 
 
Now we can see that the relationship between decadic logarithm of initial bacterial 
concentration and time to detection TTD (9) describes a straight line with a negative 
slope B and intercept A, where  
dt
B
2log
   and   
dB
Si
tK
c
A
2ln
log     (10) 
 
Both constants depend on the particular properties of the organism and medium used. 
The simple equation td = log 2 / B derived from (10) is used for the determination of 
doubling time td from the slope B of the regression curve of the scattergram of the 
decadic logarithm of initial bacterial concentration and time to detection TTD as 
shown in Figure 3. 
 
46 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.Relationship between the decadic logarithm of initial bacterial concentration 
c0 and time to detection TTD. 
 
2.2.4 Direct impedance method 
Growth rates of all strains at 27, 37, 41 and 44
o
C were obtained using the RABIT 
system (Rapid Automated Bacterial Impedance Technique, Don Whitley Scientific 
Ltd., Figure 4). Bacterial strains were inoculated into 9 ml of TSA and incubated 
overnight at 37
o
C.  RABIT tubes were filled with 2 ml of infant formula, which was 
reconstituted aseptically according to the manufacturer’s instructions with sterile 
distilled water, and the tubes were inoculated with 100 µl of serial dilutions of the 
overnight cultures.  Four serial dilutions in duplicate (10
-2
 – 10-5) were recorded for 
each growth rate. The tubes were then incubated in the RABIT system at 27, 37, 41 or 
44
o
C using the direct impedance setting whilst the impedance changes were recorded 
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by the system. The time to detection (TTD) and impedance curves were recorded for 
each sample. Impedance threshold of 8 µS was used, which means that a TTD was 
called if a change of impedance equal or greater than 8 µS was reached in three 
subsequent readings. The readings were taken every 6 minutes. The samples that 
produced inferior curves or curves indicating contamination (as described in  2.2.6) 
were disregarded in the calculation. The generation times for each strain in a given 
medium and temperature were calculated as described in  2.2.3.  
 
 
Figure 4. RABIT system (Rapid Automated Bacterial Impedance Technique) 
 
Note that in preliminary experiments, seven different serial dilutions (10
-2
 – 10-8) were 
used for the calculation of the generation times, but after establishing that a good R
2
 
coefficient of the linear regression could be obtained using 3-4 first serial dilutions, 
we limited the samples analysed to four serial dilutions (10
-2
-10
-5
), which also limited 
the sampling error associated with using low bacterial concentrations. The 10
-1
 serial 
dilution was not used because for very high bacterial concentrations, the relationship 
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between bacterial concentration and TTD is not linear, but hyperbolic, and cannot be 
used for determination of doubling time (Eden & Eden 1984). 
 
2.2.5  Indirect impedance method 
Bacterial strains were inoculated into 9 ml of TSA and incubated overnight at 37
o
C. 
1% molten agar (w/v) was mixed with 1% (w/v) KOH and 0.75 ml of the mixture 
were pipetted into the bottom of the plastic RABIT impedance tubes, not allowing the 
mixture to set on the sides of the tube. Two millilitres of PIF aseptically reconstituted 
according to the manufacturer’s instructions were pipetted into sterile small glass 
tubes and 100 µl of a serial dilution of the overnight culture was added to the tube. 
Four serial dilutions in duplicate (10
-2
 – 10-5) were used for each experiment. The 
glass tubes were carefully lowered into the RABIT impedance tubes and sealed with 
rubber bungs. The tubes were placed in the RABIT system and incubated at 27, 37, 41 
or 44
o
C using the indirect impedance setting (impedance threshold -12 µS) whilst the 
impedance changes were recorded by the system. The results were processed in the 
same way as for the direct impedance method, although in this case, the impedance 
change was negative. 
 
2.2.6 Quality control of impedance curves and TTDs 
generated by the automated RABIT system  
Figure 5 illustrates a set of impedance curves for different dilutions of the same 
sample and TTDs used for the calculation of the doubling times. In some cases, it is 
possible that a TTD value is miscalled by the RABIT system. If a TTD value was 
miscalled due to the contamination of the test sample, the aberrant impedance curve 
could be easily identified by plotting the impedance curves of different dilutions of 
the same sample, as shown in Figure 5; the aberrant impedance curve would have a 
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different shape compared to the other curves of the same set. If the TTD value was 
miscalled due to an electrical spike or gas production, or when the threshold 
impedance change was reached before or after the actual exponential growth phase, it 
was possible to identify the TTD value from the table of impedance values available 
in the RABIT software package.   
  
 
 
 
 
 
 
 
 
 
Figure 5. Impedance curves of different serial dilutions of E.coli 605 at 37
o
C 
 
2.2.7 Determination of generation times and lag times by 
viable count 
The use of the RABIT impedance system is limited to the temperatures above ambient. 
For that reason, we were obliged to choose a different method to examine bacterial 
growth at 21
o
C. Two most common methods used to monitor bacterial growth are 
total viable count and optical density (OD) measurement over a time course.  As OD 
measurement cannot be used with turbid solutions such as reconstituted PIF, our 
experiments were based on the total viable count approach. Unlike the impedance 
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method, the viable count method allowed us to also determine lag time, a critical 
parameter for growth modelling. 
 A single colony from a fresh TSA plate was inoculated into 9 ml of TSB and 
incubated at 37
o
C overnight. Powdered infant formula products were aseptically 
reconstituted according to the manufacturer’s instructions in sterile distilled water. 
The tubes with 10 ml of the reconstituted formulae were inoculated with 100 µl of a 
10
-3
 dilution of an overnight TSA culture, which corresponded to a starting inoculum 
of approximately 10
5
 cfu/ml. The reconstituted formulae were incubated at 21
o
C over 
a 20 – 22 h period; samples for the viable count were taken at 1-1.5 h intervals for the 
first 5 hours of the experiment and then at 2 h intervals. Viable count was performed 
on TSA according to the Miles & Misra (1938) method after a 16 h incubation period 
at 37
o
C.  The data obtained were loaded into MicroFit 1.0 software 
(http://www.ifr.ac.uk/MicroFit/), which generated generation times and lag times for 
all datasets (Figure 6). The Microfit software tool uses the model proposed by Baranyi 
& Roberts (1994), which was designated as the model that provides the best fit for the 
majority of datasets and gives reasonably precise lag time estimates in a comparison 
of different models by  Baty & Delignette-Muller (2004). 
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Figure 6. Example of data analysis using Microfit software 
 
2.3. Results 
2.3.1 Laboratory determination of generation times 
We determined the generation times of 28 bacterial strains across 21 bacterial species 
in casein- and whey-dominant infant formulae at temperatures 21, 27, 37, 41 and 44
o
C.  
This temperature range was chosen because it reflects a wide spectrum of PIF 
reconstitution, cooling and storage practices (Figure 2).  The following sections 
present the results for Category A organisms (Cronobacter and Salmonella) and 
Category B organisms defined  by (FAO/WHO 2006). 
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Input data
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2.3.2 Growth of Category A organisms: Cronobacter spp. and 
Salmonella spp. 
Generation times were determined for 11 Cronobacter strains across 5 Cronobacter 
species (C. sakazakii, C. malonaticus, C. muytjensii, C. turicensis and C. dublinensis) 
at 21, 27, 37, 41 and 44
o
C. The results are presented in Table 2. 
Table 2. Generation times of Cronobacter strains grown at 21-44
o
C in casein- and 
whey-dominant formulae.  
Organism Strain PIF
Doubling time (min)
21 C 27 C 37 C 41 C 44 C
C. sakazakii 1 W 46 41 25 22 20
C 47 39 22 23 30
C. sakazakii 2 W 56 40 24 24 24
C 87 37 20 20 21
C. sakazakii 114 W 54 NG 33 31 39
C 55 NG 34 39 46
C. sakazakii 566 W 57 NG 21 20 23
C 60 46 23 19 24
C. sakazakii 658 W 86 35 20 22 28
C 94 42 22 21 22
C. sakazakii 767 W 36 38 19 20 21
C 54 41 21 20 23
C. malonaticus 1212 W 59 53 24 23 35
C 76 48 28 31 31
C. malonaticus 685 W 40 55 25 25 33
C 58 48 32 35 NG
C. muytjensii 3 W 73 36 22 24 23
C 73 34 20 20 21
C. turicensis 57 W 48 35 20 18 NG
C 54 39 23 21 NG
C. dublinensis 582 W 65 33 22 26 NG
C 68 41 25 28 NG
 
Footnotes: C = casein-dominant PIF, W = whey-dominant PIF.    NG = growth not detected. Blue font: 
the shortest doubling time of the strain.  
 
 
58 
60 
53 
 
The generation times varied both between the Cronobacter species and between 
strains of each species (Table 2). There were considerable differences in upper 
temperature range for growth within the Cronobacter genera. All C. sakazakii strains, 
C. muytjensii and C. malonaticus type strain (1212) were able to grow at 44
o
C, 
whereas C. turicensis and C. dublinensis were not detectable at this temperature. C. 
malonaticus 685 showed different growth behaviour in whey- and casein-dominant 
PIF; the organism was able to grow in whey-dominant PIF at 44
o
C, but its growth in 
casein-dominant PIF was not detected (Table 2). The generation times of Cronobacter 
strains were also dependent upon formula type. A statistically significant difference in 
generation times between the two types of formula was observed at 21, 37
 
and 41
o
C 
(p=0.037, p=0.018 and 0.016, Wilcoxon signed-rank test). At these temperatures, the 
bacteria grew faster in whey-dominant PIF, whereas no significant difference between 
the two formulae was noted for temperatures 27 and 44
o
C.  Interestingly, growth of C. 
sakazakii 566 was not detected in whey-dominant formula. 
The most striking observation was the relatively short generation times of some 
Cronobacter strains at elevated temperatures (41 and 44
o
C). All Cronobacter strains 
studied except C. dublinensis were able to grow the fastest at 41
o
C at least in one 
formula type and 6/11 strains were able to grow at 44
o
C at a rate comparable to 
growth at 37
o
C. 
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Figure 7. Distribution of generation times of Cronobacter (n=11) in whey-dominant 
and casein – dominant PIF at 21 – 41oC.   Blue (C) = casein-dominant PIF, red (W) = 
whey-dominant PIF.  
 
As we can see from the distribution of generation times of Cronobacter strains in 
Figure 7, the greatest variation in growth was observed at 21
o
C in both casein- and 
whey-dominant formula, there was less variation in growth rates at 27 and 44
o
C and, 
as expected, the least variation at 37 and 41
o
C.  Except growth at 21
o
C, there was less 
variation in generation times in casein-dominant PIF then in whey-dominant PIF. C. 
sakazakii strain 114 clearly showed different growth behaviour compared to other 
Cronobacter strains, as its growth was significantly slower. Figure 7 also shows that 
the generation times of Cronobacter strains at 37, 41 and 44
o
C were comparable and 
close to the optimal rate of growth. 
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Figure 8 shows the impedance curves of C. sakazakii strain 2 in whey- and casein-
dominant PIF. Surprisingly, the impedance curves of C. sakazakii pictured are 
different even though the two formulae have almost identical stated nutritional content. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 8. Impedance curves of C. sakazakii (strain 2) grown in casein- and whey-
dominant formulae. 
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All Salmonella strains grew at 21, 27, 37 and 41
o
C, but none of them grew at 44
o
C, 
except S. Senftenberg, which had a generation time of 60 min in whey-dominant PIF 
(Table 3). Similarly to Cronobacter strains, growth of Salmonella strains was faster in 
the whey-dominant PIF compared to casein-dominant PIF, although it was not 
possible to assess the significance of this difference statistically because of limited 
numbers of data (Table 3). 
 
Table 3. Generation times of Salmonella strains grown at 21-44
o
C in casein- and 
whey-dominant formulae. 
 
 
 
 
 
 
 
Footnotes: C = casein-dominant PIF, W = whey-dominant PIF.    NG = growth not detected. Blue font: 
the shortest doubling time of the strain.  
 
  
                 
2.3.3 Growth of Category B organisms: other 
Enterobacteriaceae 
Generation times were determined for 14 Enterobacteriaceae strains across 7 
Enterobacteriaceae species at 21, 27, 37, 41 and 44
o
C (Table 4). 
ND36193343W1197Salmonella Anatum
ND39234041C
ND25253952W358Salmonella Enteritidis
ND30304346C
6027203549W239Salmonella Senftenberg
ND32242947C
Organism Strain PIF
Doubling time (min)
21°C 27°C 37°C 41°C 44°C
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Table 4. Generation times of Enterobacteriaceae strains grown at 21-44
o
C in casein- 
and whey-dominant formulae.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Footnotes: C = casein-dominant PIF, W = whey-dominant PIF.    NG = growth not detected. Blue font: 
the shortest doubling time of the strain.  
 
The optimum growth temperature varied between the Enterobacteriaceae. For C. 
freundi, C. koseri, E. cancerogenus, E. cloacae, E. vulneris, Hafnia, Pantoea and 
Serratia it was close to 37
o
C, whereas for E. hormaechei, E. coli 605, 790 & 796, K. 
oxytoca and K. pneumoniae the optimum temperature was closer to 41
o
C (Table 4). 
NGNG273741W464Serratia marcescens
NGNG233443C
NGNG3328109W44Pantoea ananatis
NGNG334396C
NGNG383754W236Hafnia alvei
NGNGNG4155
C
NGNG2939101W52Escherichia vulneris
NGNG2836110C
2420214085W605Escherichia coli
2119213777C
1817183743W790Escherichia coli
2220213741C
2018202043W796Escherichia coli
2616151837C
NG20203336W790Enterobacter hormaechei
NG22223230C
NG29233841W806Enterobacter cancerogenus
NG24243743C
Organism Strain PIF
Doubling time (min)
21°C 27°C 37°C 41°C 44°C
Citrobacter freundii 153 W 52 36 25 39 NG
C 46 39 26 48 NG
Citrobacter koseri 598 W 46 40 23 29 NG
C 52 41 23 23 NG
Enterobacter cloacae 49 W 58 39 23 26 52
C 55 40 22 26 58
Klebsiella oxytoca 379 W 38 37 23 23 NG
C 36 40 23 23 NG
Klebsiella pneumoniae 273 W 48 40 21 21 33
C 52 41 22 24 42
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At lower temperatures (21
o
C, 27
o
C and 37
o
C), impedance response was detected for 
all strains except Hafnia in casein-dominant PIF, whereas Hafnia, Serratia, Pantoea 
and E. vulneris, did not grow at higher temperatures (41
o
C and 44
o
C, Table 4). Since 
lactose is the major sugar in both formulae and all these organisms are lactose non-
fermenters, we hypothesized that these organisms might have not produced enough 
ionic fermentation end products and their growth could have been missed by the direct 
impedance method.  The growth of these four species was re-determined using the 
indirect impedance method, whereby growth is detected by the liberation of carbon 
dioxide (Silley, Forsythe 1996). The indirect method confirmed the results obtained 
via the direct method and showed that these strains did not grow in PIF at elevated 
temperatures. Same values were obtained for H. alvei (generation time of 38 min in 
whey-dominant PIF and no detectable response in casein-dominant PIF) using both 
direct and indirect impedance methods.  At 44
o
C growth in both types of PIF was 
inhibited in most of the Enterobacteriaceae, the only organisms which were able to 
grow at this temperature were E. cloacae, all E. coli strains (605, 790 & 796 ) and K. 
pneumoniae (Table 4). 
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Figure 9. Distribution of generation times of Enterobacteriaceae (n=14) in casein- 
and whey-dominant PIF at 21 – 41oC. Blue (C) = casein-dominant PIF, red (W) = 
whey-dominant PIF.  
 
There was a greater variation in generation times between the Enterobacteriaceae 
strains  at 21 and 44
o
C, whereas the range of their generation times at 27 and 37
o
C 
were smaller (Figure 9). Some strains showed different growth behaviour compared to 
the majority of Enterobacteriaceae; these are shown as outliers in Figure 9. For 
example, E. coli 605 grew significantly slower in both types of formula at 21
o
C, A. 
baumanii grew significantly slower at 27 and 37
o
C in both formulae and C. freundii 
grew significantly slower at 44
o
C in casein-dominant PIF (Figure 9). It was also 
notable that E. coli 796 grew significantly faster in both formulae at 27
o
C and at 37
o
C 
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in casein-dominant PIF. Unlike for Cronobacter strains, no statistically significant 
difference between the casen- and whey-dominant formula was observed  in 
Entrobacteriaceae strains (Wilcoxon signed-rank test). 
Figure 10 shows that different bacterial species can have characteristic impedance 
curves. Besides the speed of the microbial metabolism and growth, the shape of the 
curves reflects the dynamics of the microbial metabolism including switching to 
different energy sources during fermentative metabolism. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Impedance curves of three Enterobacteriaceae species in casein-dominant 
formula 
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2.3.4 Bacterial lag phase and lag time  
In microbial kinetics, the lag phase is usually observed before bacterial multiplication 
as a delayed response to a change in environment, i.e. change of the culturing 
conditions, and can occur in both growth and inactivation processes (Swinnen et al. 
2004). It is defined as a transition period during which the specific growth rate 
increases to the maximum value characteristic for the culture environment. As the lag 
phase duration increases with decreasing temperatures (Buchanan & Klawitter 1991) 
its determination is especially important for growth modelling at sub-optimal 
temperatures.  Lag phase duration is influenced by a variety of factors such as changes 
of environmental conditions, the entity and the phenotype of the bacterium, the 
growth stage or physiological history of the cells and the inoculum size (Swinnen et al. 
2004). 
2.3.5 Laboratory determination of lag time 
We determined the lag times for category A (Cronobacter and Salmonella), and 
category B (other Enterobacteriaceae and Acinetobacter) organisms in casein- and 
whey-dominant PIF at 21
o
C, as the lag times at 21
o
C were expected to be the longest 
and would have the greatest impact on predictive growth modelling. For details on the 
method see  2.2.7. The lag times of both category A and B organism are presented in  
Table 5. 
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Table 5. Lag times (h) of category A (Cronobacter and Salmonella) and category B  
(Enterobacteriaceae and Acinetobacter) organisms at 21
o
C in whey- and casein-
dominant PIF.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
W  - Whey-dominant PIF    C  -  Casein-dominant PIF  *  -  lag times not accurately predicted 
by Microfit 
 
9.14.0415Acinetobacter baumanii
2.11.5379Klebsiella oxytoca
2.00.7273Klebsiella pneumoniae
5.43.244Pantoea ananatis
2.00.9236Hafnia alvei
3.31.352Escherichia vulneris
3.01.849Enterobacter cloacae
3.32.0806Enterobacter cancerogenus
2.81.3790Enterobacter hormaechei
3.42.3464Serratia marcescens
3673598Citrobacter koseri
1.61.0605Escherichia coli
2.11.51197Salmonella Anatum
1.51.8358Salmonella Enteritidis
2.72.0239Salmonella Senftenberg
3.61.3153Citrobacter freundii
Organism Strain Whey-based PIF Casein-based PIF
Cronobacter sakazakii 1 1.6 2.7
Cronobacter sakazakii 2 1.8 0.0*
Cronobacter sakazakii 114 2.7 4.6
Cronobacter sakazakii 658 0.6* 1.5*
Cronobacter sakazakii 767 2.7 1.9
Cronobacter malonaticus 1212 2.2 1.5
Cronobacter malonaticus 685 3.2 3.2
Cronobacter sakazakii 658 1.5* 0.6*
Cronobacter muytjensii 3 1.5 2.4
Cronobacter turicensis 57 1.9 1.8
Cronobacter dublinensis 582 1.8 3.4
Escherichia coli 780 2.7 3.6
Escherichia coli 796 2.4 3.3
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It seems apparent that organisms grown in casein-dominant PIF tend to have longer 
lag times compared to whey-dominant PIF. However, this difference was only 
statistically significant for category B organisms (Enterobacteriaceae and 
Acinetobacter) at the level of p=0.01 (Wilcoxon signed-rank test). There was no 
statistically significant difference in lag times between the casein and whey-dominant 
formula in category A organisms (Cronobacter and Salmonella). The mean lag time at 
21
o
C for category A organisms in casein-dominant PIF was 2.5 h and 2.1 h in whey-
dominant PIF; the mean lag time for category B organisms in casein-dominant PIF 
was 3.0 h and in whey-dominant PIF 1.7 h. Acinetobacter had remarkably long lag 
time in both formulae, 9.1 h in casein-dominant and 4.0 h in whey-dominant PIF.  
        
A.  B. 
    
Figure 11. Distribution of lag times of (A) Cronobacter (n=14) and (B) selected 
Enterobacteriaceae and Acinetobacter (n=15) in casein- and whey-dominant formulae 
at 21°C. Outlier 1 = Acinetobacter baumanii. 
 
L
ag
 t
im
e 
(h
) 
64 
 
2.3.6 Predictive modelling of bacterial growth & risk 
assessment  
The growth data obtained for the Category A and B organisms obtained in our study 
were used to model predicted temperature profiles of Cronobacter and other 
Enterobacteriaceae in casein- and whey-dominant PIF (Figure 12). In combination 
with the heat inactivation data obtained by Dr. Juncal Caubilla-Baron, the data were 
used to update the JEMRA Risk Model for Cronobacter spp. The modelling was done 
by Decisionalysis Risk Consultants, Inc. 
Bacterial growth and death rates in whey- and casein-dominant infant formulae for 
Cronobacter spp., Salmonella serovars, other Enterobacteriaceae, and Acinetobacter 
spp. were used with the JEMRA Cronobacter risk model for 7 scenarios with 
reconstitution temperatures between 10 and 70°C. The scenarios are listed in 
Appendix 1.  For all scenarios, reconstitution at 70°C predicted a 1-log decrease in 
bacterial numbers for Salm. Senftenberg and Salm. Enteritidis, and >10
4
 log decrease 
for C. sakazakii depending on the formula base.  The model also predicted overall 
decreases in bacterial numbers for all scenarios when the reconstitution temperature 
was 60°C, although this was less than 0.5 log  for some strains.   In contrast, at 50°C 
some strains had predicted increases depending upon the scenario and the formula 
base.  
In summary, using various scenarios, reconstitution of PIF with water at a 
temperature >60°C (and in particular >70°C) was predicted to reduce the overall 
number of Cronobacter spp., Salmonella, other Enterobacteriaceae and Acinetobacter 
sp. The extent of bacterial kill was dependent upon the bacterial strain, type of 
formula, and scenario. The full report is available at: 
http://www.foodbase.org.uk/results.php?f_report_id=395.  
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Figure 12. Predicted temperature profiles for the category A and B organisms (split 
into 3 sets) included in the data set.  Whey- and casein-dominant infant formulae are 
on the left and the right, respectively.  In each case the baseline model is included for 
comparison.   
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2.4. Discussion 
Cronobacter species are opportunistic pathogens that can cause life-threatening 
disease including necrotizing enterocolitis, septicaemia and meningitis, with 
premature neonates and infants at a particular risk. Neonates are a high risk 
population due to their immature immune system which can promote opportunistic 
infections, lower acidity of the stomach, and absence of an established gut microflora 
(FAO/WHO 2004). Unlike infant formula, human breast milk contains compounds 
with protective properties that limit bacterial growth. Processing technologies are 
unable to completely eliminate potentially pathogenic bacteria in breast milk 
substitutes without affecting their nutritional properties and it is known that 
Cronobacter occurs as one of the contaminating organisms in PIF (Muytjens et al. 
1988, Iversen & Forsythe 2004a, Chap et al. 2009, Jaradat et al. 2009). Moreover, the 
temperature abuse of reconstituted PIF was reported as a common risk factor in 
Cronobacter outbreaks in France (Coignard et al. 2006, Caubilla-Barron et al. 2007) 
associated with deaths of infants. For these reasons, stringent control measures 
including temperature control need to be put in place, which necessitates a robust risk 
model that accounts for the considerable phylogenetic diversity of the Cronobacter 
genus confirmed by the recent taxonomic reclassification of the organisms previously 
known as ‘E. sakazakii’.   
 
The initial 2006 JEMRA Risk Model for Cronobacter spp. used data supplied by 
NTU and Prof. Marcel Zwietering (Wageningen University) from FAO/WHO 2004 
and FAO/WHO 2006. The risk model was constructed prior to the taxonomic revision 
of Cronobacter (Iversen et al. 2008) and did not consider the Cronobacter species 
diversity. Moreover, it did not consider Salmonella serovars or other 
Enterobacteriaceae potentially present in breast milk substitutes. It is pertinent to note 
that recently there have been outbreaks of Salmonella infections in neonates linked to 
infant formula in Spain and France (Jourdan et al. 2008, Soler et al. 2008) and other 
Enterobacteriaceae examined in this study are frequent contaminants of infant 
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formula, and potential pathogens. It was also unknown whether their growth 
behaviour significantly varied between Cronobacter spp. or was dependent on 
formula type.  
This study for the first time presents growth data for five Cronobacter species: C. 
sakazakii, C. malonaticus, C. turicensis, C. muytjensii and C. dublinensis at a range of 
temperatures reflecting wide spectrum of PIF reconstitution, cooling and storage 
practices in two different types of formula, casein-and whey-dominant. In addition, it 
presents data for Salmonella, Enterobacter cloacae, Citrobacter koseri, Citrobacter 
freundii, Klebsiella oxytoca, Klebsiella pneumoniae, Pantoea agglomerans, 
Escherichia vulneris, Escherichia coli, Hafnia alvei, Serratia spp., Acinetobacter sp, 
Enterobacter hormachei and Enterobacter cancerogenus. Altogether, data were 
obtained for all Category A and Category B organisms as defined by (FAO/WHO 
2006).  
We determined the generation times of 28 bacterial strains across 21 bacterial species 
in casein- and whey-dominant infant formula at temperatures 21, 27, 37, 41 and 44
o
C, 
including 11 Cronobacter strains representing different Cronobacter species (C. 
sakazakii, C. malonaticus, C. muytjensii, C. turicensis and C. dublinensis) and three 
strains of Salmonella. Please note that the generation times at 21
o
C were obtained by 
viable count, whereas all other values were obtained using impediometry, and 
therefore these two sets of values were not determined with the same level of 
precision.  
There was considerable variation in doubling times among C. sakazakii strains and 
between different Cronobacter species at 21
o
C. At 37, 41 and 44
o
C, however, the 
range of generation times between all Cronobacter strains was quite narrow and the 
growths were comparable to the optimal rate of growth. This shows that Cronobacter 
is an organism well adapted for growth at a wide range of temperatures including 
44
o
C, which inhibits growth of most other Enterobacteriaceae.   
There were considerable differences in upper temperature range for growth within the 
Cronobacter genera. All C. sakazakii strains, C. muytjensii and C. malonaticus type 
strain (1212) were able to grow at 44
o
C, whereas C. turicensis and C. dublinensis 
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were not detectable at this temperature. C. sakazakii strain 114 had different growth 
characteristics compared to other Cronobacter strains; its growth was significantly 
slower at all temperatures except 21
o
C.  Unfortunately, strain 114 was one of the three 
strains in our collection with unknown origin, so we cannot make any hypotheses 
about the possible reasons. In an extensive study on growth rates of Cronobacter in 
PIF and breast milk, Lenati (2008) reported that the strain’s origin had a significant 
effect on growth rate. The average generation times of clinical isolates at 23 and 37
o
C 
were longer in breast milk than in fortified BM, compared to the environmental and 
food isiolates. The origin of strains had no effect on generation times in PIF, however. 
Generation times were also determined for 14 other Enterobacteriaceae strains across 
7 Enterobacteriaceae species. The optimum growth temperature C. freundi, C. koseri, 
E. cancerogenus, E. cloacae, E. vulneris, Hafnia, Pantoea and Serratia was 37
o
C, 
whereas for E. hormaechei, E. coli 605, 790 & 796, K. oxytoca and K. pneumoniae 
the optimum temperature was 41
o
C. Interestingly, Hafnia, Serratia, Pantoea and E. 
vulneris did not grow at higher temperatures (41
o
C and 44
o
C), which was confirmed 
by both direct and indirect impedance method. Whether the inhibition of growth is 
connected with the organisms lack of ability to ferment lactose or the organisms’ 
decreased thermotolerance is unknown.  
The variation in generation times between the Enterobacteriaceae strains at 21 and 
44
o
C was greater compared to the variation at 27 and 37
o
C. Considerable differences 
in growth behaviour compared to the other Enterobacteriaceae were observed in E. 
coli 605, which grew slower in both types of formula at 21
o
C, A. baumanii, which 
grew significantly slower at 27 and 37
o
C in both formulae and in C. freundii, which 
grew significantly slower at 44
o
C in casein-dominant PIF. It was notable that E. coli 
796 grew significantly faster in both formulae at 27
o
C and at 37
o
C in casein-dominant 
PIF.   
One of the most surprising results of this study is the upper growth temperature of 
Cronobacter strains. All Cronobacter strains except C. dublinensis and C. turicensis 
were able to grow the fastest at 41
o
C at least in one formula type and most 
Cronobacter strains were able to double every 22 min at 44
o
C, which is the rate of 
growth comparable to growth at 37
o
C. Considering that the reconstitution temperature 
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in some feeding practices is < 50
o
C, this has a very important implication for the 
safety of PIF products. Reconstitution temperature close to 50
o
C would not mean a 
significant reduction of the microbial load in the product, it could even support 
microbial growth during cooling and storage of reconstituted PIF.   The results from 
our study suggest that most Cronobacter species and some other Enterobacteriaceae 
are able to grow at a surprisingly fast rate even at elevated temperature of 44
o
C. The 
results highlight the need for new guidelines for reconstitution and storage of infant 
formula. 
None of the Salmonella strains tested  grew at 44
o
C, except S. Senftenberg, which had 
a generation time of 60 min in whey-dominant PIF and growth at 41
o
C was slower 
compared to Cronobacter strains. Similarly to Salmonella, growth at 44
o
C was 
inhibited in most of the Category B organisms; the only species which were able to 
grow at this temperature were E. cloacae, all E. coli strains (605, 790 & 796) and K. 
pneumoniae.   This suggests that Salmonella and other Enterobacteriaceae except E. 
coli are less heat tolerant and that the current reconstitution practices would reduce the 
contamination in reconstituted PIF and therefore the risk of infection by these 
organisms. However, the risk posed by Cronobacter and E. coli potentially present in 
PIF would not be adequately controlled using the current reconstitution practices, as 
reconstitution at temperatures close to 50
o
C would not stop bacterial multiplication in 
the products. In light of these findings, new guidelines for PIF reconstitution should 
be considered. 
Our results showed that generation times of Cronobacter strains were also depending 
upon the type of PIF used. The bacteria grew significantly faster in whey-dominant 
PIF at 21, 37
 
and 41
o
C,  whereas there was no significant difference between the two 
formulae at 27 and 44
o
C.  Similarly to Cronobacter strains, growth of Salmonella 
strains was faster in the whey-dominant PIF at 21, 37
 
and 41
o
C compared to casein-
dominant PIF. Both C. malonaticus 685 and Salmonella Senftenberg were able to 
grow in whey-dominant PIF at 44
o
C, but they did not grow in casein-dominant PIF. In 
general, we observed less variation in generation times in casein-dominant PIF than in 
whey-dominant PIF. This suggests that whey protein may have a certain thermo-
protective effect. 
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Enterobacteriaceae had significantly shorter lag times in whey-dominant PIF at 21
o
C. 
However, there was no significant difference between the lag times of Cronobacter 
between the two types of formula. 
In summary, notable differences in generation times and lag times have been observed 
between casein- and whey-dominant PIF, although these should have virtually 
identical nutritional content according to their product labelling. The impedance 
curves obtained for growth of Cronobacter and other Enterobacteriaceae confirm that 
the bacteria do indeed have different growth behaviour in the two formulae. In both 
types of formulae, the protein is derived from cow’s milk protein. In whey-dominant 
milks the protein is adjusted to a similar casein to whey ratio to human breast milk 
(40:60) and the formula may also have a lower mineral content, in particular sodium 
and potassium. In casein-dominant formulae the ratio of casein to whey is the same as 
in cows' milk (80:20). The different growth behaviour or Cronobacter and other 
Enterobacteriaceae might be attributed to different source of the key nutrients, 
presence of inhibitory substances in the particular formulations or a discrepancy 
between the product label and the product content. 
The risks associated with the growth of Cronobacter in breast milk substitutes were 
further highlighted by the recent study examining growth of pathogenic bacteria 
inside the enteral feeding tubes published by our team at NTU (Hurrell et al. 2009b). 
The studies identified the enteral feeding tubes, which are used in intensive neonatal 
care units (NICU) to provide nutrition to hospitalised infants, as loci for bacterial 
multiplication that can significantly increase the risk of infection by Cronobacter or 
other pathogenic bacteria. As it was demonstrated in another study (Hurrell et al. 
2009a), biofilm formation in the interior of the feeding tubes further contributes to the 
contamination of infant feed. It therefore seems essential to limit bacterial 
contamination in the original reconstituted formula before it reaches the enteral 
feeding tube and temperature control of the prepared feeds becomes a crucial hazard 
control point. However, it was shown in Hurrell et al. (2009b) that significant 
numbers of Enterobacteriaceae were recovered from the biofilms inside enteral 
feeding tubes in infants that were fed infant formula, but also breast milk and sterile 
ready-to-feed formula. This suggests that microbiological control should not be only 
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focussed on the intrinsic contamination of PIF, but also on general practices of 
preparation of feeds for enteral feeding. 
The growth data obtained in this study were, along with the thermal inactivation data 
and a reconstitution practices survey collected by Dr. Juncal Caubilla-Baron, provided 
to the Food Standards Agency in order to update the JEMRA Risk Model for 
Cronobacter spp., which will help the regulatory bodies and formula manufacturers 
evaluate the risks associated with contamination of PIF by Cronobacter and other 
potentially harmful bacteria. The results of this study and the derived risk model may 
also prompt the UK regulatory bodies to enforce the change of the formula 
preparation guidelines provided with their product in order to protect the most 
vulnerable part of our population, infants. 
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3. CRONOBACTER SPP. COMPARISON BY 
COMPARATIVE GENOMIC HYBRIDIZATION 
3.1. Introduction 
3.1.1 DNA microarray technology 
Microarray technologies are a popular tool to study interactions between complex 
biopolymers such as DNA, proteins or lipids. The term ‘microarray’ simply refers to 
the use of multiple arrays of spatially organized molecules miniaturized to a small 
format. DNA microarray technology is an automated, high-throughput technique 
developed on the basis of Southern blotting that facilitates simultaneous parallel 
analysis of potentially thousands of genes from a given biological species.  The 
technology is based on hybridization of chemically or enzymatically labelled sample 
DNA to reporter elements bound to a surface of a microarray slide. The probes are 
attached or directly synthetised on a microarray slide surface; and they can consist of 
genomic regions such as open reading frames (ORF), short oligonucleotide probes or 
‘tiled’ whole genomes. In a tiling array, probes (usually synthetic oligonucleotides) 
covering the whole genome of an organism are represented on the microarray, often 
with overlapping sequences. The material and spatial organization of microarray 
slides vary between different microarray formats, depending on the question that 
needs to be examined.  After the hybridization reaction, the unbound probes are 
washed away using different stringency buffers and the remaining fluorescent signal 
resulting from complementary binding between oligonucleotide probes on the array 
probes and sample DNA is measured using a confocal microarray scanner.  A 
reference sample is included in the experimental setup to compare the test sample 
results to a control condition or to a reference organism. In bacterial comparative 
genomic hybridisation (CGH), the reference sample is typically the same sequenced 
strain that was used to design the array probes, and its DNA should thus hybridize to 
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all probes on the microarray. The presence or absence of a DNA sequence in a test 
strain is determined by comparing the fluorescent intensities of the test strain element 
against the reference strain element.  
 
The most widely used application of DNA microarrays is expression analysis, which 
compares the expression patterns of samples subject to different culture conditions,   
carrying mutated genes or originating from different tissues, whereas the Comparative 
Genomic Hybridization (CGH) method has been developed to examine the variation 
between the genomic content of closely related organisms. The CGH methodology 
has been used extensively for DNA copy-number analysis in humans to identify 
chromosomal aberrations that can lead to cancer and other diseases.  In microbiology, 
CGH serves as a tool to examine presence and absence of particular genes or genomic 
regions, as well as to determine phylogenetic relationship between tested strains. CGH 
analysis can reveal the presence of various evolution events such as acquisition of 
genes by horizontal gene transfer and gene deletions on the whole-genome scale. 
Apart from expression analysis and CGH, microarrays can be also used for 
resequencing, microbial identification, single nucleotide polymorphism (SNP) 
analysis and drug discovery (Huyghe et al. 2009).    
There are two basic types of elements used for the microarray design: PCR products 
and oligonucleotide probes. The advantages of PCR product-based microarrays are 
their relative simplicity, relatively low cost, and reproducibility (Dorrell et al. 2005). 
On the other hand, oligonucleotide-based DNA microarrays are not dependent on 
PCR to amplify the gene targets, they offer a reduced cross-hybridisation and an 
increase in the differentiation of homologous regions; mutant alleles or even single 
nucleotide polymorphisms can be detected using such arrays (Dorrell et al. 2005). 
 
3.1.2 Virulence factors of Cronobacter 
There are a limited number of studies examining the molecular basis of the virulence 
factors of Cronobacter. To date, the metalloprotease Zpx (Kothary et al. 2007), the 
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outer membrane proteins OmpA (Mohan Nair & Venkitanarayanan 2006, 
Singamsetty et al. 2008, Mittal et al. 2009b, Kim et al. 2010) and ompX (Kim et al. 
2010), the O-antigen cluster (Mullane et al. 2008b, MacLean et al. 2009a, MacLean et 
al. 2009b, MacLean et al. 2009c, Czerwicka et al. 2010), biofilm formation (Iversen 
et al. 2004, Lehner et al. 2005, Kim et al. 2006, Kim et al. 2007a, Hurrell et al. 
2009a), and capsule (Hurrell et al. 2009a) have been studied. Since Cronobacter is a 
Gram-negative member of the Enterobacteriaceae, it is reasonable to expect other 
virulence determinants to be present, such as type IV and type VI secretion systems. 
The following section gives a short review on the virulence factors that were 
examined in this project. 
 
 
3.1.2.1 Lipopolysaccharide  and O-antigen 
 Exopolysaccharides (EPS) are components of the bacterial
 
cell envelope; they include  
the
 
serotype-specific lipopolysaccharide (LPS), capsular
 
K-antigen and other 
organism-specific compounds. Lipopolysaccharide (LPS), also known as bacterial 
endotoxin, is a major component of the outer membrane of Gram-negative bacteria. 
The LPS consists of three parts: lipid A, a conserved core oligosaccharide region, and 
finally O-antigen, which is a repetitive glycan polymer specific for each serogroup 
(Stenutz et al. 2006), consisting of oligosaccharide units that are repeated between 10 
and 30 times and have between 3 to 6 sugars (Trent et al. 2006). As a major structure 
that is exposed on the bacterial surface, the O-antigen is highly immunogenic, causing 
strong antibody responses (Comstock & Kasper 2006). The lipid A domain, also 
known as endotoxin, anchors the molecule in the outer membrane and is the bioactive 
component recognized by the immune system during human infection. The LPS 
structure is represented in Figure 13. 
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Figure 13. Schematic representation of a LPS unit. Source: (Soares et al. 2008). 
(NAG: N-acetyl-D-glucosamine; P: phosphatidyl group; KDO: 3-Deoxy-D-manno-
octulosonic Acid;HEP: heptose; GAL: D-galactose; GLC: D-glucose; L-ALA: L-
alanine; RHA: D-rhamnose; FUC: D-fucose; MAN: D-manose). Acyl lipid chains 
SN1,SN2 and SN3 are labeled (left). Atomistic model of the A-B+ LPS membrane of 
Pseudomonas aeruginosa (right). Membrane atoms are represented in“sticks”, Ca++ 
ions in filled yellow and water in transparent blue model.  
 
Due to their ability to mediate bacterial virulence and host response, LPS and O-
antigen are considered important virulence factors.   There is a strong link between 
invasiveness of Cronobacter and LPS presence in PIF. Townsend et al. (2007b) 
showed that PIF is frequently contaminated by high levels of LPS and suggested that 
LPS may enhance the translocation of Cronobacter from the blood to the CNS during 
Cronobacter-induced sepsis, but the mechanism of such enhancement was unclear. 
The variability of the O-antigen gene clusters in bacterial pathogens has been 
successfully used as the molecular basis for serotyping (Feng et al. 2005, Fitzgerald et 
al. 2006). As it is implicated in avoidance of host immune system and survival in 
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different environments, the O-antigen locus is subject to strong selective pressure 
(Reeves 1993). It is known that the variations in O-antigen biosynthesis loci can arise 
not only from substantial genetic differences, but also from a variation in a single 
gene and that even slight genetic variation in this locus can have a great impact on 
immune recognition (Comstock & Kasper 2006). 
The O-antigen gene locus usually contains three categories of genes: i) genes 
encoding enzymes involved in the synthesis of the O-subunit sugars, ii) genes 
encoding glycotransferases necessary for the assembly of sugars in the O subunit, and  
iii) genes encoding the transporter (wzx) and polymerase (wzy) proteins involved in 
the processing and assembly af the O-antigen from O subunits (Mullane et al. 2008b) . 
The O-antigen locus size depends on the sugar composition, as well as on the antigen 
structure (Schnaitman & Klena 1993). Mullane et al. (2008b) characterized the 
molecular structure of the O-antigen locus of two Cronobacter serotypes O:1 and O:2 
and identified nine additional  potential serotypes. The authors found that the genetic 
organization of the O-antigen locus in Cronobacter was similar to the corresponding 
locus in related Enterobacteriaceae. Each O-antigen cluster contained 11 unique 
ORFs.  
It has been shown that bacteria can switch between smooth and rough forms of LPS; 
these two different forms are a result of mutations in one or more genes involved in 
the synthesis and polymerization of the O-antigen chains (Coimbra et al. 2000). In E. 
coli, the O-antigen heterogeneity was a result of mutation in the gene encoding the 
Wzz protein (Franco et al. 1996). Switching between smooth and rough forms of LPS 
has also been documented in Cronobacter (Farmer 1980).  It was speculated that 
mutations in homologs of WxxB O-antigen chain determining protein may cause the 
differences in O-antigen chain lengths and therefore the existence of S and R forms. 
The O-antigen is one of the few structural features of Cronobacter that has been 
investigated and it is known that it varies across the Cronobacter spp. In C. sakazakii 
and C. malonaticus, the O-antigen is composed of various branched polymers, 
whereas they are unbranched in C. muytjensii. In C. sakazakii BAA-894 (MacLean et 
al. 2009a) (Figure 14A) it is a branched polymer of pentasaccharide units composed 
of 2-acetamido-2-deoxy-D-galactose, 3-(N-acetyl-L-alanylamido)-3-deoxy-D-qui
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novose, D-glucuronic acid, and D-glucose. C. sakazakii strain 767 is also a branched 
polymer but of a repeating heptasaccharide composed of 2-acetamido-2-deoxy-D-
glucose, and D-galacturonic acid, L-rhamnose, and D-glucose (Czerwicka et al. 2010) 
(Figure 14B). C. malonaticus LPS (MacLean et al. 2009c) (Figure 14D) is also a 
branched pentasaccharide unit of 2-amino-2-deoxy-D-glucose, 2-amino-2-deoxy-D-
galactose, 3-deoxy-D-manno-oct-2-ulosonic acid, D-galactose and D-glucose residues. 
C. sakazakii ATCC 29004 possesses a branched hexasaccharide O-unit with a 
randomly mono-O-acetylated terminal rhamnose residue in the side chain. This 
structure is the most similar to the O-antigen of C. sakazakii 767, which differs in the 
presence of an additional lateral alpha-d-Glcp residue on GlcNAc and the pattern of 
O-acetylation (Arbatsky et al. 2010). Whereas, C. muytjensii LPS (MacLean et al. 
2009b) (Figure 14C) is a linear unbranched pentasaccharide polymer of 2-acetamido-
2-deoxy-D-galactose, 2-acetamido-2-deoxy-D-glucose, 2-acetamido-3-deoxy-D-
quinovose, L-rhamnose and D-glucuronic acid.   
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Figure 14. Known O-antigen structures of Cronobacter. A. C. sakazakii BAA-894 
(MacLean et al. 2009a); B. C. sakazakii 767 (Czerwicka et al. 2010); C. C. muytjensii 
3270 (MacLean et al. 2009b); D. C. malonaticus (MacLean et al. 2009c).  
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3.1.2.2 Type VI secretion systems 
Bacterial secretion systems deliver proteins and toxins across the bacterial membrane 
into the environment, or onto an eukaryotic target.  There have been six secretion 
systems characterized to date (type I – VI), with type VI being the most newly 
identified. Type VI secretion systems (T6SS) have been found in almost 100 bacterial 
species, but have been characterized in only a few Gram-negative bacteria, including 
Salmonella enterica, Escherichia coli, Rhizobium leguminosarum, Vibrio cholerae, 
Pseudomonas aeruginosa, Francisella tularensis, and Burkholderia spp., as 
referenced in Filloux et al. (2008). T6SS are involved in adherence, cytotoxicity, host-
cell invasion, growth inside macrophages and survival within the host. 
Type VI secretion systems (T6SS) were originally described as systems of Gram-
negative bacteria that contain two components of another secretion system, type IV 
secretion system (T4SS), IcmF and DotU (Filloux et al. 2008). Although these 
proteins were encoded within a conserved gene cluster that did not share homology 
with other T4SS components, another cluster of conserved genes was being 
systematically found in the vicinity of these genes, initially known as IAHP (IcmF 
associated homologous proteins). In the plant symbiont Rhizobium leguminosarum, a 
homologue of dotU ImpK was identified as a component of a system encoding a 
secretion machine which could block colonization process in pea plants (Bladergroen 
et al. 2003). In Salmonella enterica, a complete genomic cluster sci (Salmonella 
enterica centisome 7 genomic island) was described as a cluster encoding many T6SS 
genes.  The deletion of the whole sci cluster caused a decreased ability of S. enterica 
to enter eukaryotic cells. However, the cluster also included genes involved in 
fimbrial assembly and invasion (Folkesson et al. 2002). 
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T6SS involve different genomic organisation of various combinations of genes, and 
the core genes of T6SS are therefore very hard to define (Cascales 2008). A lack of 
systematic nomenclature further complicates the study of T6SS, as homologous genes 
may have several names and unrelated genes can be called the same. No consensus in 
the model for the assembly of the T6SS has been defined yet (Cascales 2008) and 
T6SS gene clusters of different bacterial species vary in their organization (Filloux et 
al. 2008). The model for the T6SS system proposed by Cascales (2008) based on the 
reviewed literature is shown in Figure 15.  According to an extensive review by 
Filloux et al. (2008), T6SS gene clusters usually encode from 12 to 25 proteins, of 
which only DotU and IcmF-like proteins have homologues in T4SS and have 
transmembrane domains. The T6SS clusters do not necessarily encode these two 
proteins, which may be located outside the T6SS locus and most of the other T6SS 
genes encode unknown proteins. The locus frequently contains genes for ATPases, 
which provide energy for the transport process, with ClpB homologues (named ClpV) 
are found most often. It has been speculated, however, that the function of ClpV 
might be different from ClpB proteins which solubilise aggregated proteins, such as 
providing energy-dependent transport of polypeptides (Yeo & Waksman 2004) or 
folding/unfolding components of T6SS prior to their assembly or T6SS effectors 
before their secretion (Filloux et al. 2008). The T6SS gene clusters also frequently 
encode a putative outer membrane lipoprotein (VasD in V. cholerae) that may 
contribute to pore formation in the membrane (Filloux et al. 2008). The T6SS gene 
clusters in some bacteria also encode serine/threonine kinases and phosphatases 
(Mukhopadhyay et al. 1999, Mougous et al. 2007). It has been shown that in P. 
aeruginosa, both T6SS assembly and effector secretion require phosphorylation by 
Ser/Thr kinase PpkA, and are prevented from dephosphorylation by Ser/Thr 
phosphatase PppA (Mougous et al. 2007). In some cases, T6SS components 
contribute to virulence, but independently of other T6SS components. For example, 
expression of T6SS genes in Franciscella tularensis is required for growth and 
survival in macrophages, but expression of these genes does not require other T6SS 
genes (Barker et al. 2009). 
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A single organism can have multiple copies of complete or partially complete T6SS 
loci, often including different types of T6SS, but it is uncertain whether these loci 
cooperate with each other (Filloux et al. 2008) and very little is known about the 
protein interactions of the various components of the system.  The phylogenetic tree 
constructed by Boyer and colleagues reveals that these do not result from duplication 
events, and have been conserved throughout evolution, which suggests a mechanism 
that favours this trend (Boyer et al. 2009). The authors proposed that this might be 
explained by specialization of the systems for different purposes and different cellular 
targets. Many of the bacterial species with multiple T6SS clusters that are not 
paralogous, have multiple hosts or diverse environments (Jani & Cotter 2010). 
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Figure 15. A model for type VI secretion system assembly and function. Source: 
Cascales (2008). An inner membrane channel formed by the IcmF-like and IcmH-like 
proteins interacts at the cytoplasmic side of the IM with a complex composed of the 
probable cytosolic type VI secrection (T6S) subunits and the ClpV AAA
+
 ATPase. 
Recruitment of the ClpV multimer is induced by the regulation of forkhead-associated 
(FHA) phosphorylation through the activities of PpkA and PppA, and by the presence 
of the Hcp protein. A multimer of the putative lipoprotein in association with 
periplasmic subunits is shown at the outer membrane. Putative routes for substrate 
translocation are depicted through the cell envelope and the host-cell membrane (blue 
arrow) including a ‘one-step’ mechanism through a unique channel, and a ‘two-step’ 
mechanism, in which both steps are catalysed by T6S subunits with transient 
accumulation in the periplasm (P). This hypothetical model shows a trimeric VgrG 
inserted into the OM through the amino-terminal domain and puncturing the host cell 
through the needle-like structure formed by the central domains, releasing the activity 
domain into the host cytosol (for eukaryotic-like activities) or in the medium (for 
binding or adhesion activities). J, L, M and H (TssJ, TssL, TssM and TssH 
respectively) represent the T6S core components, following the nomenclature of 
(Shalom et al. 2007). Source:  Cascales (2008). 
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 Interestingly, there is a remarkable resemblance of some of the T6SS components 
(Hcp, VgrG, gp-like protein COG3501) to proteins of bacteriophage origin (Leiman et 
al. 2009). The VgrG protein domains share similarities with the proteins gp5 and gp7 
of the bacteriophage T4 spike. The bacteriophage uses dimers or trimers of these 
proteins to puncture the bacterial envelope and inject its DNA to the cell (Rossmann 
et al. 2004). Pukatzki et al. (2007) found that the VgrG proteins form homotrimeric or 
heterotrimeric complexes, and this type of assembly suggests that the putative phage 
spike-like complexes may be used as a puncturing device to penetrate the bacterial 
cell envelope or host cell membrane (Filloux et al. 2008). Pukatzki and colleagues 
also hypothesized that the T6SS Hcp proteins, which form a hexameric rings with a 
central channel (Mougous et al. 2007) might be forming a tube for the T6SS effectors  
surrounding the VgrG complex. 
Although many of the structural T6SS proteins have been described, there is a lack of 
identified effector proteins (Jani & Cotter 2010). Hcp and VgrG-like proteins were 
identified as potential secreted effector proteins, as they were found in culture 
supernatants of most bacteria with T6SS, but it was shown that their secretion is 
mutually dependant (Dudley et al. 2006, Pukatzki et al. 2007), suggesting that they 
may also act as structural components. The experimental study of T6SS is challenging, 
as T6SS genes are usually not induced in laboratory conditions. For example in R. 
leguminosarum, the T6SS secretion is temperature dependant, with optimum secretion 
at 24
o
C (Bladergroen et al. 2003) and in S. enterica, expression of genes from the 
T6SS cluster (including the SciS encoding the ImF-like protein) is induced inside 
macrophages (Parsons & Heffron 2005).  
 T6SS are considered important factors for virulence and survival within host cells 
(Cossart & Sansonetti 2004), although recent findings suggest that these systems are 
more versatile and that they can promote commensal or mutualistic relationships 
between bacteria (Jani & Cotter 2010). For example, it has been shown that T6SS can 
limit bacterial replication of virulence by changing the state of virulence to 
commensal or mutualistic relationship (Bladergroen et al. 2003, Parsons & Heffron 
2005, Chow & Mazmanian 2010). The two-component response regulator system 
SsrAB negatively controls the expression of a T6SS gene sciS and positively controls 
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the expression of genes on Salmonella pathogenicity island 2 (SPI-2) including T3SS 
genes that mediate macrophage cell death (Garmendia et al. 2003). It seems that in 
Salmonella, T6SS induction limits the bacterial load in host cells and intracellular 
replication, which leads to bacterial persistence rather than macrophage death and 
damage to the host (Parsons & Heffron 2005). 
 
3.1.2.3 Fimbriae  
Interestingly, fimbriae (or pili) were first discovered as receptors for bacteriophages 
(Anderson 1949). In 1950, proteinaceous non-flagellar appendages were discovered 
on the surface on E. coli by electron microscopy (Houwink & van Iterson 1950). It 
was shown that these structures mediate adherence of E. coli to eukaryotic cells 
(Duguid et al. 1955). These multi-subunit, filamentous surface structures are 
associated with adhesion to bacteria, host cells or environmental surfaces (Fronzes et 
al. 2008). Moreover, pili can have an important role in the pathogenesis of bacterial 
disease, as they are also involved in host-pathogen interactions, host colonization, 
biofilm formation and cell-to-cell signalling (Kline et al. 2009, Proft & Baker 2009,). 
The pathways involved in pilus assembly are established pathogenicity determinants, 
as well as potential targets for control of infectious diseases. Type I pili in UPEC 
contain the FimH adhesin that is necessary for UPEC pathogenesis. FimH also binds 
to the mannosylated receptors on the bladder epithelium, and mutation in the residues 
of FimH essential for mannose binding results in decreased virulence in a mouse 
urinary tract infection model. 
There are several types of pilus assembly systems. In Gram-negative bacteria, we 
distinguish the chaperone/usher (CU)-assembled pili, type IV pili, and curli, among 
which the chaperone-usher pathway is the best described and contains the most 
representatives (Nuccio & Baumler 2007, Kline et al. 2010). In uropathogenic E. coli 
(UPEC), the CU pili are represented by type 1 pilus and Pap (P) pilus. The 
components of these pilus sytems are encoded in a gene cluster that contains the genes 
for the pilin major and minor subunits, the adhesin and the corresponding chaperone 
and usher proteins (Kline et al. 2010). Bacterial genomes typically encode numerous 
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pilus operons, but these are often poorly expressed under standard laboratory 
conditions (Humphries et al. 2003). Figure 16 shows a model of type 1 pilus 
chaperone–usher pathway assembly. 
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Figure 16. Schematic model of type 1 pilus assembly by the chaperone–usher pathway. 
Source: (Nishiyama et al. 2005). The periplasmic chaperone FimC forms 
stoichiometric complexes with the newly translocated pilus subunits (FimA, FimG, 
FimF, FimH). In these complexes, FimC donates its G1 donor strand to the individual 
subunits, thereby completing the immunoglobulin-like fold of the subunits. FimC–
subunit complexes diffuse to the assembly platform (usher) FimD, which specifically 
recognizes FimC–subunit complexes via its periplasmic, N-terminal segment of 
residues 1–139. Subsequently, FimC is released to the periplasm, and the subunit is 
delivered to the translocation pore of FimD, where it is supposed to interact with the 
previously incorporated subunit via donor strand exchange. The pilus rod, composed 
of FimA subunits, assembles into its helical quaternary structure on the cell surface. 
IM, inner membrane; OM, outer membrane. Source: (Nishiyama et al. 2005). 
  
The pilin subunits are translocated across the cytoplasmic membrane to form 
complexes with the periplasmatic chaperone proteins that ensure their proper folding 
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(Jones 1993). Each chaperone-subunit complex is then targeted towards the outer 
membrane usher, which functions as an assembly site and a pore in the outer 
membrane that allows export of the growing pilus fiber to the cell surface (Thanassi et 
al. 1998), with the most distal protein being secreted the first (Nishiyama et al. 2005). 
The chaperone-pilin complex then dissociates and the subunit is added to the base of 
the growing pilus (Kline et al. 2010). The adhesin mediates attachment of the pilus to 
a specific receptor.   
  
3.1.2.4 Iron uptake  
Iron acts as an essential mineral for many cellular functions including electron 
transport, ATP production via oxidative phosphorylation, DNA metabolism, 
protection against oxidative stress and regulation of gene expression, but it is toxic 
and poorly soluble in its free ferric form (Crosa et al. 2004). A single bacterial cell 
requires from 10
5
 to 10
6
 ferric ions per generation to maintain the optimal 10
−6
 M 
internal concentration (Braun & Killmann 1999). In the presence of oxygen, the level 
of free iron is strictly decreased by formation of insoluble ferric hydroxides, and in 
mammalian hosts, its availability is further limited by host iron-binding proteins 
(Crosa et al. 2004). In human serum, the concentration of iron is regulated by 
transferrin to a concentration of ≈10−24 M (Aisen et al. 1978, Kretchmar et al. 1988). 
Pathogenic bacteria must be able to compete for this very limited supply of iron with 
their host organism in order to survive and propagate in the host.   Furthermore, the 
decreased iron availability in host organisms can serve as a stimulus triggering 
expression of virulence-related genes. It has been shown that increased iron 
availability correlates with increased virulence of Escherichia, Klebsiella, Listeria, 
Neisseria, Pasteurella, Shigella,  Salmonella, Vibrio, and Yersinia, as reviewed in 
(Raymond et al. 2003). The efficiency of iron assimilation via expression of iron 
uptake mechanisms is hence an important aspect of bacterial virulence.  
 
Bacteria have evolved several mechanisms to cope with iron scarcity and scavenge 
iron from the host environment:  use of proteases that cleave the iron-binding proteins 
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to obtain free iron, reducing Fe
3+
 to Fe
2+
 followed by the release of iron from a protein 
complex, and siderophore synthesis (Henderson & Payne 1994). Siderophore 
production is probably the best studied mechanism of iron acquisition in pathogenic 
bacteria. Siderophores are high-affinity iron-binding compounds produced by various 
bacterial species as a response to iron depletion. Their expression is regulated by Fur, 
a homodimer which binds to a consensus sequence Fur box. Firstly, the ferric 
siderophore complex binds to the receptor protein on the microbial cell surface, then 
the complex is translocated across the outer and inner membrane, and finally, iron is 
released for metabolism inside the cell (Crosa et al. 2004). Iron uptake via the 
catechol siderophore enterobactin (or entrochelin) is the best described among the 
siderophore-mediated iron uptake systems in prokaryotes. The biosynthesis of 
aerobactin requires the expression of the operon entABCDEF and the transport system 
for enterobactin is encoded by genes fepABCD and fepG. In addition, some 
Enterobacteriaceae are able to synthesize a hydroxamate siderophore aerobactin, 
which has also been linked to increased virulence in members of  Enterobacteriaceae 
(Lafont et al. 1987, Martinez et al. 1994). Aerobactin system was first described on 
the large E. coli plasmid pColIV-K30 by (Warner et al. 1981) and the products of the 
biosynthetic pathway were identified by (de Lorenzo et al. 1986). Aerobactin 
synthesis requires expression of four genes iucABCD. Aerobactin is then secreted into 
the extracellular environment, and iron-aerobactin complex binds to a specific outer 
membrane TonB-dependent receptor IutA. Interestingly, the aerobactin synthesis 
genes iucABCD and the outer membrane receptor gene iutA are located in the same 
operon, whereas the genes required for trans-membrane transport which encode the 
periplasmic binding protein FhuB and the inner membrane permease FhuCD form a 
different genetic cluster that is not related to aerobactin synthesis (Crosa et al. 2004). 
 
 
3.1.2.5 Prophages in bacterial chromosomes  
Bacterial genomes typically contain multiple prophages which can constitute a 
substantial proportion of the total bacterial DNA (Canchaya et al. 2003, Casjens 
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2003). In contrast, sequenced Archaea and most intracellular eubacterial pathogens do 
not contain prophages or their remnants (Canchaya et al. 2004). It has been 
documented that E.coli O157:H7 strain Sakai contained 18 prophages making 16% of 
its total DNA (Canchaya et al. 2003). More importantly, prophages can constitute a 
large part of strain-specific DNA in both pathogenic and non-pathogenic bacteria 
(Porwollik et al. 2002). In a comparison of Staphylococcus aureus strains, prophages 
were the major contributors to variability (Kuroda et al. 2001). In E. coli, half of the 
1-Mb DNA that is variable between E.coli 0157:H7 and K-12 consists of prophage 
DNA (Ohnishi et al. 2001). 
Phage DNA acts as a vector for horizontal gene transfer between bacteria. 
Interestingly, prophages often carry additional genes (termed cargo genes, morons, or 
lysogenic conversion genes) that are not required for the phage life cycle, but may 
change the phenotype or fitness of the phage (Brussow et al. 2004). These cargo 
genes include a variety of proven or putative virulence factors (Brussow et al. 2004, 
Wagner & Waldor 2002) and even regulatory factors that alter expression of virulence 
genes that are not encoded by the phage (Spanier & Cleary 1980). Phage genes can 
encode virulence properties such as bacterial adhesion, colonization, invasion, serum 
resistance and resistance to phagocytes, exotoxin production, sensitivity to antibiotics 
and transmissibility among humans.  
 
Table 6 provides a summary of virulence properties that may be altered by prophages. 
Some cases have been documented when phage tail genes had dual functions and 
served as adhesion proteins for the attachment of bacteria to its host, such as 
Streptococcus mitis pblAB genes (Bensing et al. 2001ab). Prophages can also mediate 
progression of many bacterial infectious diseases and influence expression of 
virulence factors (Breitbart & Rohwer 2005). In addition to this, prophages can 
contribute to the rearrangement of bacterial chromosomes by providing targets for 
homologous recombination between bacterial genomes that harbour related prophages 
(Brussow & Hendrix 2002, Nakagawa et al. 2003). In an extensive review on phages 
and evolution of bacterial pathogens by Brussow et al. (2004), the authors 
summarized that apart from introduction of new genes via lysogenic conversion or 
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transduction, phages can also modulate bacterial fitness by providing anchor points 
for genome rearrangements, by gene disruption, via protection of the bacterium from 
lytic infection, and by lysis of competing strains via prophage induction. 
 
Table 6. Bacterial virulence properties altered by bacteriophages. Reproduced from 
(Wagner & Waldor 2002). 
Organism                Mechanism Source 
 
 Colonization/adhesion  
Escherichia  coli The -encoded lom gene promotes adhesion to 
buccal epithelial cells. 
(Reeve & Shaw 1979, Barondess 
& Beckwith 1990) 
   
Streptococcus mitis The SM1-encoded PblA and PblB surface proteins 
promote adhesion to platelets. 
(Bensing et al. 2001b) 
Vibrio cholerae The toxin-coregulated pilus may be phage 
encoded. 
(Karaolis et al. 1999) 
   Invasion  
Salmonella enterica Phage SopE  transduces a type III secretion 
system effector that promotes entry into epithelial 
cells. 
(Mirold et al. 1999) 
 Phage Gifsy-1 encodes gipA, a gene that enhances 
survival in the Peyer's patch. 
(Stanley 2000) 
Streptococcus 
pyogenes 
Hyaluronidase is phage encoded. (Hynes & Ferretti 1989) 
Staphylococcus 
aureus 
Fibrinolysin is phage encoded. (Sako et al. 1983) 
  Resistance to serum/phagocytes  
Escherichia coli The -encoded bor gene confers a survival 
advantage in animal serum. 
(Barondess & Beckwith 1990) 
Pseudomonas 
aeruginosa 
Phages encode enzymes that alter the O antigen. (Holloway &  Cooper 1962) 
Salmonella enterica Phage Gifsy-2 encodes SodC, a superoxide 
dismutase. 
(Figueroa-Bossi & Bossi 1999) 
 Phages encode enzymes that alter the O antigen. (Robbins &  Uchida 1962, Wright 
1971) 
Shigella dysenteriae Phages encode enzymes that alter the O antigen. (Mavris et al. 1997, Guan et al. 
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1999) 
Staphylococcus 
aureus 
Phages encode CHIPS, a phagocytotoxin. Van Wamel et al.
a
 
 Phage PVL encodes the Panton-Valentine 
leukocidin. 
(Kaneko et al. 1997) 
Streptococcus 
pyogenes 
Lysogeny up-regulates the antiphagocytic M 
protein. 
(Spanier & Cleary 1980) 
 Exotoxin production  
Bordetella avium Pertussis toxin is phage encoded in B. avium. van Horne et al.
b
 
Clostridium botulinum Botulinum toxin is phage encoded. (Wagner & Waldor 2002) 
Corynebacterium 
diphtheriae 
Diphtheria toxin is phage encoded. (Holmes & Barksdale, 1969, 
Uchida et al. 1971) 
Escherichia coli The Shiga toxins are phage encoded. (Newland et al. 1985, Willshaw et 
al. 1985, Huang et al. 1986) 
Pseudomonas 
aeruginosa 
Pseudomonas cytotoxins are phage encoded. (Hardt et al. 1998) 
 Shigella dysenteriae The Shiga toxin genes are associated with phage 
sequences, probably a defective prophage. 
(McDonough, Butterton 1999) 
Staphylococcus 
aureus 
Staphylococcal enterotoxins are phage encoded.  
 
 
Staphylococcal exfoliative toxins are phage 
encoded.  
 
Toxic shock syndrome toxin is encoded by SapI, a 
mobile pathogenicity island transduced at high 
frequency by phage 80 . 
(Casman 1965, Betley & 
Mekalanos 1985, Coleman et al. 
1989) 
(Yamaguchi et al. 2000) 
 
 
(Lindsay et al. 1998) 
   
   
Streptococcus 
pyogenes 
Streptococcal pyrogenic (erythrogenic, scarlatinal) 
exotoxins are phage encoded. 
(Johnson & Schlievert 1984, 
Weeks & Ferretti 1984, Goshorn 
& Schlievert 1989) 
Vibrio cholerae Cholera toxin is phage encoded. (Waldor & Mekalanos 1996) 
  Susceptibility to antibiotics  
Staphylococcus 
aureus 
Generalized transduction contributes to horizontal 
transmission of Gram-positive antibiotic-
resistance genes. 
(Fujii et al. 1988, Fischetti et al. 
2000) 
   
 Transmission  
    V. cholerae Phage-encoded cholera toxin likely promotes 
transmission by stimulating copious amounts of 
watery diarrhea. 
(Waldor & Mekalanos 1996) 
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a
 Van Wamel et al., Abstr. 101st Gen. Meet. Am. Soc. Microbiol. 2001. 
b
 S. J. van Horne, D. Bjornsen, P. Carpentier, and L. M. Temple, Abstr. 101
st
 Gen. Meet. Am. Soc. 
Microbiol. 2001, abstr. B-109, p. 64-65, 2001. 
 
3.2. Targeted gene disruption using λ-red technique 
Creating gene disruptions via targeted gene deletion can be achieved using a variety 
of techniques. Generally, linear or plasmid DNA carrying an antibiotic resistance  
marker flanked by regions of homology to the target gene, or just outside of it, can be 
transformed into bacterial cells. Thereafter a recombination event between the 
homologous regions is induced. The cells are then screened for acquired antibiotic 
resistance and the gene disruption is verified in the cells with the correct phenotype by 
PCR and sequencing of the target region. 
There are a range of experimental techniques exploiting this strategy. The first 
protocols that used linear DNA for gene replacement (Jasin & Schimmel 1984, 
Winans et al. 1985) were limited to strains deficient in the RecBCD nuclease system, 
which would otherwise degrade the linear double stranded phage DNA (Murphy 
1998). Other methods used the integration of a plasmid into the bacterial chromosome 
and subsequent resolution of the integrated complex, which regenerated either the 
wild type locus or the desired gene replacement. One of the limitations of such 
protocols was that plasmids that do not replicate under the conditions used for 
selection of targeted mutants had to be used, such as temperature-sensitive plasmids 
or phagemid-based vectors, so that plasmids carrying the marker  were ultimately lost 
due to cell division. According to Murphy (1998), other disadvantages of this strategy 
included the low frequency of the resolution of the cointegrate, the necessity to clone 
the gene before the replacement and unintended gene replacements generated by the 
replacement allele. 
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The first gene replacement protocol that used bacteriophage λ recombination genes 
known as ”Red” or “λ-Red” was developed by Murphy (1998). The λ-Red system 
uses the activity of λ bacteriophage genes exo, bet and gam. Assisted by the host 
RecA protein, the (5′-3′) exonuclease Exo binds to dsDNA and generates single 
stranded DNA overhangs, and the Bet protein induces recombination between these 
overhangs and homologous regions of the chromosome. Gam inhibits the host 
RecBCD exonuclease that would cause digestion of phage DNA.  λ-Red 
recombination is stimulated by the presence of dsDNA ends, generated by a 
restriction endonuclease (Stahl et al. 1985). Datsenko and Wanner developed an 
improved λ-Red gene replacement method that is now widely used for generating 
targeted deletions in E. coli and in other bacteria (Datsenko, Wanner 2000). In this 
method, the desired chromosomal sequence is replaced by a PCR product with ~ 26-nt 
homology at each end to target sequences flanking the gene to be replaced. Gene 
replacement occurs via λ-Red recombination, mediated by the pKD46 plasmid 
expressing the λ-Red system under the control of an arabinose promoter. pKD46 has a 
temperature-sensitive replicon and it  can be subsequently eliminated by growth at 
37
o
C. However, external supervisor Dr. Jon Hobman (University of Nottingham) 
working in collaboration with the University of Birmingham reported limited success 
with the Datsenko and Wanner method in pathogenic E. coli strains; O157:H7 Sakai 
strain, CFT073 UPEC, O42 EAEC and ETEC strains (Lee et al. 2009). For that 
reason, the team developed an improved protocol for creating gene disruptions and for 
coupling of genes to epitope tags (Lee et al. 2009). The protocol was based on the 
“Gene gorging” method developed by Herring et al. (2003) which uses two plasmids. 
The recombineering plasmid pACBSR includes the λ-Red and I-SceI endonuclease 
genes which are controlled by an arabinose-inducible araBAD promoter. The donor 
plasmid (pDOC) carries an antibiotic resistance cassette, or epitope tag flanked by 
regions of homology to the target gene and the recognition site for the I-Sce-I 
endonuclease. In the presence of arabinose, the donor plasmid is cleaved by I-SceI 
and a linear dsDNA target for the lambda-Red system is generated.  Hobman and 
colleagues designed a set of donor plasmids which include a kanamycin resistance 
cassette and the sacB gene, pDOC-K (Figure 17). SacB encodes a levansucrase, which 
converts sucrose to levans and has been shown to be lethal in E. coli and other Gram-
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negative bacteria (Gay & Kado 1985). Plasmids expressing kanamycin resitance and 
sacB can be therefore used for the counterselection of true recombinants on media 
containing kanamycin and sucrose. An I-SceI recognition site was added to the 
recombineering plasmid to make pACBSCE. This means that this plasmid is cleaved 
after induction of expression of I-SceI and  the λ-Red genes, and hence the exposure 
of cells to the λ-Red proteins, which might lead to undesirable chromosomal 
rearrangements, is limited (Lee et al. 2009). This method was successfully used to 
generate deletion mutants in enterohaemorrhagic O157:H7 (EHEC), uropathogenic 
CFT073 (UPEC), enteroaggregative O42 (EAEC) and enterotoxigenic H10407 
(ETEC) E. coli strains as well as in K-12 laboratory strains. The gene doctoring 
method is outlined in Figure 18 reproduced from (Lee et al. 2009).  
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Figure 17. The pDOC donor plasmids. Taken from Lee et al. (2009). Circular 
representation of the pEX100T plasmid showing the location of the origins of 
replication, the sacB gene and the ampicillin resistance gene. Below is a linear 
representation of the pDOC plasmid inserts, showing the I-SceI restriction sites, 
cloning regions (CR, CR1 and CR2) and the Flp recognition sites flanking the 
kanamycin resistance cassette (Kan
R
). 
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Figure 18. Gene doctoring protocol. Taken from (Lee et al. 2009). The pDOC donor 
plasmid and the recombineering plasmid pACBSCE are co-transformed into the 
recipient strain. Arabinose induction promotes expression of the λ-Red gene products 
and I-SceI. I-SceI generates a linear DNA fragment from the donor plasmid that is a 
substrate for recombination with the chromosome mediated by the λ-Red system. In 
addition, I-SceI also cleaves the pACBSCE recombineering plasmid, resulting in loss 
of plasmid and loss of λ-Red expression. Recombination occurs between homologous 
regions on the linear DNA substrate and the chromosome, transferring the kanamycin 
cassette, onto the chromosome. Recombinants are selected by the ability to survive 
and grow on LB supplemented with kanamycin and sucrose. Only true recombinants, 
which have lost the sacB gene due to donor plasmid loss and have retained the 
kanamycin cassette due to recombination, are able to survive and grow on this 
medium. Confirmation that the correct chromosomal modification has been generated, 
is achieved by amplifying the target region by PCR using primers that anneal adjacent 
to this region and electrophoresing the products on a 0.7% agarose gel. Size 
differences in PCR product between the wild-type and modified strain confirm 
whether a chromosomal modification has been achieved.   
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3.3. Aims 
The taxonomic reclassification of Enterobacter sakazakii into six separate species 
accepted in 2008 (Iversen et al. 2008) confirmed the immense phenotypical diversity 
of the Cronobacter genus that was observed in many earlier studies. To date, only 
strains from C. sakazakii, C. malonaticus and C. turicensis have been associated with 
neonatal infections, which suggests that there are considerable differences between 
the virulence of Cronobacter species. Also, most of the studies published before 2008 
have been in fact done on “Enterobacter sakazakii” strains, without further assigning 
the Cronobacter species according to the new taxonomy.  It is probable that most of 
the strains studied before were in fact C. sakazakii, as it is the most commonly 
isolated Cronobacter species. Although earlier studies have considerabely widened 
our knowledge about Cronobacter pathogenicity, the mechanisms by which 
Cronobacter causes the disease are still largely unclear, and few virulence factors 
have been identified to date. Due to the severity of infant infection, a better 
understanding of the genomic variation between Cronobacter spp. is needed, and will 
be of interest to manufacturers of powdered infant formula, regulatory bodies, as well 
as those studying the evolution and diversity of pathogenicity. 
The sequencing of the first strain of Cronobacter, C. sakazakii BAA-894 and 
depositing of its sequence to GenBank by my external supervisor McClelland at 
Washington University in September 2007 marked a new era in the research of this 
opportunistic pathogen. For the first time, whole genome comparative approaches 
such as use of DNA microarrays and whole-genome alignments were possible. The 
aim of my study is to use the first complete genome sequence of C. sakazakii strain 
BAA-894 isolated from powdered formula associated with a NICU outbreak 
(Himelright et al. 2002) for comparative genomic hybridization (CGH) analysis of 
physiological and virulence related traits across the Cronobacter genus, via the first 
Cronobacter whole-genome microarray. The microarray will be designed and 
produced by NimbleGen and a comparative genome hybridization assay will be 
98 
 
performed with different Cronobacter strains with known history and virulence 
potential from our internal collection representing C. sakazakii strains, C. malonaticus, 
C. turicensis, C. dublinensis and C. muytjensii, against the sequenced genome strain C. 
sakazakii BAA-89. Strains will be chosen according to their association with 
virulence (ie. clinical source and previous tissue culture assays) and 16S rDNA cluster 
grouping.   The data obtained will be analysed to describe the regions of genes whose 
distribution is variable between the Cronobacter strains, describe the gene clusters 
with importance for Cronobacter’s pathogenesis, evaluate the distribution of the 
organism’s known virulence determinants, as well as to discover new virulence 
factors that have not been previously identified by combining the CGH data with the 
strains’ virulence data.  
99 
 
3.4. Materials and methods 
3.4.1 Cronobacter DNA microarray and comparative 
genomic hybridisation 
3.4.1.1 Bacterial strains 
Table 7. Cronobacter strains used in the microarray study.  
Strain Comment Source 
16S 
rDNA
11
 
References 
C. sakazakii  BAA-894 
Genome 
sequenced 
strain 
Powdered 
formula 
- 
(Himelright et al. 2002, 
Baldwin et al. 2009) 
C. sakazakii ATCC 29544
T
 
Species type 
strain 
Child's 
throat 
0.38 
(Iversen et al. 2008, 
Baldwin et al. 2009) 
C. sakazakii ATCC 12868  Unknown 0.57 (Baldwin et al. 2009) 
C. sakazakii strain 20  Clinical 0.57 (Baldwin et al. 2009) 
C. sakazakii strain 701 
Fatal NEC III 
case 
Peritoneal 
fluid 
0.47 
(Caubilla-Barron et al. 2007, 
Baldwin et al. 2009) 
C. sakazakii strain 767 
Fatal 
meningitis 
case 
Trachea 0.47 
(Caubilla-Barron et al. 2007, 
Baldwin et al. 2009) 
C. sakazakii strain 696 NEC II case Stools 0.57 
(Caubilla-Barron et al. 2007, 
Baldwin et al. 2009) 
C. malonaticus LMG 23826
T
 
Species type 
strain 
Breast 
abscess 
isolate 
0.57 (Iversen et al. 2008) 
C. turicensis LMG 23827
T
 
Species type 
strain. 
Meningitis 
case 
Blood 
isolate 
1.8 (Iversen et al. 2008) 
C. muytjensiii ATCC 51329
T
 
Species type 
strain 
Unknown 2.94 (Iversen et al. 2008) 
C. dublinensis LMG 23823
T
 
Species type 
strain 
Milk 
powder 
plant 
3.69 (Iversen et al. 2008) 
1 
 % 16S rDNA sequence difference from C. sakazakii BAA-894 
 
3.4.1.2 Genomic DNA extraction  
Total genomic DNA of 10 selected Cronobacter strains (Table 7) and the reference 
sequenced strain C. sakazakii BAA-894 (NC_009778) was isolated and purified. 
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Three different isolation protocols (SIGMA GenElute, SIGMA GenElute with 
additional purification and QIAGEN Genomic-tip 100/G) were tried. Finally, a 
modified QIAGEN Genomic-tip 100/G protocol was used to obtain the required DNA 
purity (A260/A280 ≥ 1.8 and A260/A230 ≥ 1.9). The QIAGEN protocol was modified 
to include an extended cell lysis (1h), extended deproteinization and an additional 
wash of the precipitated DNA (see protocol below).  
 
 A single colony of Cronobacter from a fresh TSA plate was inoculated into 9 
ml of LB broth and incubated overnight at 37
o
C. 
 3 ml of overnight culture were pelleted by centrifugation at 5000 g for 10 min 
and the supernatant was discarded. 
 The bacteria were resuspended in 3.5 ml of buffer B1 by thorough vortexing at 
top speed. 
 80 μl of lysozyme stock solution (100 mg/ml), and 100 μl of Proteinase K 
stock solution were added to the bacterial suspension and  incubated at 37°C 
for 1 h. 
 1.2 ml of Buffer B2 were added to the lysate and mixed by inverting the tube 
several times. The lysate was incubated at 50°C for 1 h. 
 The Genomic-tip was placed over a tube using a tip holder and equilibrated 
with 4 ml of Buffer QBT. 
 The bacterial lysate was vortexed for 10 s at maximum speed, applied  to the 
equilibrated Genomic-tip and allowed to empty by gravity flow. 
 The Genomic-tip was washed with 3 x 7.5 ml of Buffer QC, allowing the 
Buffer QC to move through the Genomic-tip by gravity flow.  
 The genomic DNA was eluted with 5 ml of Buffer QF prewarmed to 50oC, 
allowing the Genomic tip to drain by gravity flow. 
 The DNA was precipitated by adding 3.5 ml of isopropanol to the eluate.  The 
sample was mixed by inverting the tube 10 times and centrifuged immediately 
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at >5000 x g for 15 min. The supernatant was carefully discarded and the 
pellets air dried for 10 min. 
 The DNA was immediately transferred to a microcentrifuge tube containing 
0.2 ml of DNase free water and dissolved at 55°C for 1 – 2.5 h. The samples 
were checked every 30 min to ensure that the shortest possible resuspension 
time was used to avoid degradation of the DNA.  
 
The DNA samples were checked for fragmentation on 0.8% agarose gels 
electrophoresis ( 3.4.2.4) and checked for protein and RNA content by 
spectrophotometry at 280 and 230 nm, respectively, using NanoDrop (Fisher 
Scientific). The DNA concentration was determined by spectrophotometry at 260 nm. 
 
3.4.1.3 Plasmid DNA extraction 
The plasmid DNA was extracted according to the method described in Kado & Liu 
(1981). The composition of the solutions used and the extraction procedure is 
described below.  
 
E buffer (for 1l ) 
 4.85 g of Tris base (121.14 g.mol-1) were resuspended in 1 l of distilled water 
to obtain a 40 mM solution. 
  0.74 g of Na2EDTA (372.24 g.mol
-1
) were added to the Tris base solution to 
obtain 2mM Na2EDTA  
 The pH was adjusted to 7.9 with glacial acetic acid 
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Lysis buffer (for 100 ml) 
 0.61 g of Tris base (121.14 g.mol-1) were dissolved in 40 ml of distilled water 
and 30 ml of 10% SDS (w/v) were added to the solution. 
 8 g of NaOH (40 g.mol-1) were dissolved in 100 ml of distilled water to obtain 
2M NaOH solution using a 100 ml volumetric flask for accuracy. The solution 
could be stored for a maximum of 3 weeks. 
 To bring the SDS/Tris solution to pH 12.6, 3.2 ml of the 2M NaOH solution 
were added and the mixture was brought to 100 ml using a volumetric flask. 
This solution could only be used on the day of preparation. 
 
Plasmid DNA extraction protocol 
 One colony of a Cronobacter strain was inoculated into 5 ml of LB broth 
and incubated overnight at 37
o
C in a shaking incubator. 
 3 ml of the overnight culture were centrifuged for 3 min at 7,000 g in a 
conventional centrifuge and the resulting pellet was resuspended in 50 µl 
of E buffer.  
 100 µl of the lysis buffer were added and the tube was gently mixed to 
observe lysis. 
 The sample was heated at 55 oC for 60 min in a heatblock.  
 150 µl of phenol/chloroform were added to the sample and gently mixed. 
 The sample was centrifuged for 30 min at 12,000 g to separate phases 
 45 µl of the top phase containing plasmid DNA were analysed by gel 
electrophoresis ( 3.4.2.4), which was run in 0.7% E buffer gel at 90 V for 
1.5 h. 
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For samples where no bands of plasmid DNA were visible on the gel, the plasmid 
DNA extraction was repeated with the QIAfilter Plasmid Midi Kit, using the protocol 
available at http://www.qiagen.com. 
 
 
3.4.1.4 C. sakazakii ATCC BAA-894 microarray design 
A 384,030 probe oligonucleotide tiling DNA microarray which comprised the 
complete genomic sequence of C. sakazakii ATCC BAA-894 was designed for us by 
Fred Long and Michael McClelland (based at the Vaccine Research Institute of San 
Diego, San Diego, California, US).  Probes were designed at an average of less than 
12 base spacing on alternating strands, leading to an average of over 100 50-mer 
oligonucleotide probes per annotated gene. Probes were designed using the protocol 
below (provided by Prof. McClelland).  
Every possible 50-base probe from both strands of the C. sakazakii genome and two 
plasmids pESA2 and pESA3 was tested for the ability to be manufactured by 
NimbleGen. Those that required too many NimbleGen cycles were shortened. 
Resulting candidate probes that were less than 35 bases long were omitted.   The 
remaining 9,061,350 potential probes had an average melting temperature (Tm) of 
74
o
C. Probes that had Tm above the average were shortened to a minimum of 35 
bases. The probes were selected from the pool of 9,061,350 potential probes by 
selecting the best probe at 11.375-base increments, alternating between strands each 
time. The resulting 386,802 candidate probe sequences were analyzed to remove any 
probes that covered the same region as another probe due to duplications in the 
genome and the resulting 384,030 unique sequences were chosen for the array. 
Mappings between the unique probe sequences and their genome/plasmid/gene 
positions were stored in a separate file. 
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3.4.1.5 Comparative Genomic Hybridization (CGH) 
Comparative hybridisation (CGH) was performed by Roche NimbleGen Inc. 
(http://www.nimblegen.com/) according to the method described at 
http://www.nimblegen.com/products/lit/cgh_userguide_v6p0.pdf. Briefly, total 
genomic DNA of the reference strain C. sakazakii BAA-894 and the test strains 
isolated as described in  3.4.1.2 was sheared into shorter fragments. Equal quantities of 
DNA fragments of each strain were labelled with a fluorescent dye; the reference 
DNA was labelled with Cy5 and the test sample DNA was labelled with Cy3. After 
the hybridization reaction using probes designed as described in  3.4.1.4 the two colour 
arrays were scanned using the MS 200 Microarray Scanner and the MS 200 Data 
Collection Software; the fluorescent intensities from both channels were calculated 
using the NimbleScan software.  
   
3.4.1.6 Data normalization 
Data normalization was performed by Roche NimbleGen Inc. 
(http://www.nimblegen.com/) according to the method described at 
http://www.nimblegen.com/products/lit/cgh_userguide_v6p0.pdf.  
DNA from the sequenced strain, C. sakazakii BAA-894, was used as the internal array 
control to minimize any background effects. For within-array normalization, a 
LOWESS method (Cleveland 1979) was used as spatial correction and QSPline 
(Workman et al. 2002) was used to correct for dye bias. The raw data was deposited 
in GenBank GEO (accession number GSE19308). 
 
3.4.1.7 Examples of data  
Hybridization and design data were delivered in form of i) Design file; ii) Positioning 
file; and iii) Intensity files. 
i) Design file (.ndf) is a tab-delimited text file that describes the placement of the 
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probes on the microarray slide in a format similar to a probe file. The unique identifier 
of the probes is PROBE_ID, except quality control probes, which have non-unique 
PROBE_ID (Figure 19). 
 
 
Figure 19. Example of a Design (ndf.) file 
 
ii) The positions (.pos) file is a tab-delimited text file that maps each probe to its 
position in the reference genome. Positions are keyed on PROBE_ID (Figure 20). 
 
 
Figure 20. Example of a Positioning file 
 
iii) A pair report (.pair) provides sequence, probe, and signal intensity information for 
one data channel. Two pair reports were supplied for each hybridization experiment, 
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one for the test (Cy3) channel and one for the reference (Cy5) channel. Column ‘PM’ 
shows the normalised fluorescent intensity values  from each hybridization 
experiment (Figure 21). 
 
 
Figure 21. Example of Intensity (.pair) file 
 
After a series of problems with data delivery from NimbleGen,  normalized data were 
analyzed using the NimbleGen software NimbleScan and SignalMap. These did not 
contain suitable tools for bacterial CGH data analysis, however. The delivered data 
were also missing a correct annotation file crucial for data analysis. Prof. McClelland 
(external advisor and author of Cronobacter sequencing project) supplied the missing 
annotation file.   
 
3.4.1.8 Calculation of median log2 intensities and data visualization 
by  WebArrayDB 
 For the following steps of CGH data analysis, the data were transformed into log2 
(test channel intensity / reference channel intensity). The probes corresponding to the 
intergenic regions of the reference genome were filtered out and the intensity files and 
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the positioning files from NimbleGen were transformed to the file formats suitable for 
WebArrayDB (http://www.webarraydb.org/webarray/index.html) using SPSS 
software. Median log2 intensity ratios for each C. sakazakii BAA-894 gene based on 
the log2 ratios of separate probes were calculated by the new CGH tool available on 
WebArrayDB.  
 
3.4.1.9 Dynamic cut-off determination by GACK and gene category 
assignment  
The GACK algorithm developed by Charles Kim (Kim et al. 2002) sets a floating set 
of thresholds (cut-offs) for each hybridization set based on computational analysis of 
the log2 ratio data distribution. Briefly, the GACK algorithm finds the location and 
height of the main peak of the log2 ratio distribution and determines the coordinates of 
the two “side points”, which are points at half of the peaks maximum height (Figure 
22). Then GACK calculates the normal probability density function, which is an 
estimate of the data distribution if all the genes analysed were present, and which is a 
function of the height of the main peak and the coordinates of the two side points. 
Finally, the ‘Estimated Probability of Presence’ (EPP) function is calculated, which is 
simply the normal probability density function divided by the real log2 ratio 
distribution. Note that only the left portion of the EPP curve is considered for the cut-
off determination (Figure 22). 
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Figure 22. GACK analysis. Hybridization data for Cronobacter sakazakii type strain  
ATCC 29544. Red: histogram of log2 ratio intensity medians for 4,381 Cronobacter  
sakazakii genes;  green: estimated present genes; blue:  Estimated Probability of 
Presence (EPP) as determined by GACK.  
 
The median log2 ratio data calculated by WebArrayDB CGH plotter were transformed 
to the data format supported by GACK (Figure 23).   
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Figure 23. Input data for GACK analysis 
 
Each Cronobacter gene was classified according to the most stringent settings of the 
trinary output of GACK as present (1), intermediate (0) or absent (-1). Genes 
classified as ‘present’ had a log2 intensity ratio (test/reference) greater than the cut-off 
value corresponding to the 100% estimated probability of presence (EPP) as 
calculated by GACK. The ‘absent’ genes had a log2 ratio equal or inferior to the cut-
off value corresponding to 0% EPP. This category includes genes that are absent from 
the test strain, but can also include genes with a degree of sequence divergence. The 
‘intermediate’ category includes genes whose status could not be assigned with 
certainty and can include genes with some degree of sequence divergence. The EPP 
function and cut-offs were determined separately for hybridization data for each strain. 
 
 
3.4.1.10 Whole genome clustering 
Clustering analysis was performed using Cluster (Eisen et al. 1998). Hierarchical 
clustering was performed using the average linkage method on the trinary matrix 
based on the CGH analysis (1 for present, 0 for uncertain and −1 for absent/divergent 
gene). The tree was visualised using the Treeview software (Eisen et al. 1998). 
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3.4.1.11 Prophage Identification 
ACLAME was used for prophage identification (Lima-Mendez et al. 2008). This was 
accessed at http://aclame.ulb.ac.be/Tools/Prophinder/. The Prophinder algorithm uses 
BLASTP to identify coding sequences (CDS) that are similar to phage proteins stored 
in the ACLAME database (http://aclame.ulb.ac.be/). Prophinder then identifies 
regions with a significantly high density of phage-like proteins and compares the 
number of the matching CDS in these regions to the number of CDS that could be 
expected by chance only. Using the ACLAME annotations and biological information 
that is integrated in the database, Prophinder selects the phage-like regions best 
matching potential prophages.  
 
3.4.1.12 Identification of genomic islands 
Genomic islands in C. sakazakii BAA-894 were identified  by IslandViewer (Langille 
& Brinkman 2009). This software tool combines several methods for gene island 
prediction: IslandPick (Langille et al. 2008), SIGI-HMM (Waack et al. 2006) and 
IslandPath (Hsiao et al. 2003). 
 
3.4.2 Construction of Cronobacter mutants‎ via‎ “Gene‎
Doctoring”‎recombineering‎method 
 
3.4.2.1 Plasmids used in this method 
Plasmids pDOC, pDOC-K, pACBSR and pACBSRSceI (Table 8) were kindly 
provided by Dr. Jon Hobman (University of Nottingham, UK). 
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Table 8. Plasmids used in the gene doctoring method. 
Name Size (kb) Genes carried Resistance marker 
pDOC 5.8 sacB AmpR
1
 
pDOC-K 5.8 sacB AmpR, KanR
2
 
pACBSR 7.3 λ- Red system: exo, bet, gam CmR3 
pACBSRSceIV 7.3 λ- Red system: exo, bet, gam, Sce-I site CmR3 
 
1
 ampicillin marker for selection on media containing 200 µg/ml ampicillin 
2
  kanamycin marker for selection on media containing 50 µg/ml kanamycin 
3
 chloramphenicol marker for selection on media containing 35 µg/ml 
chloramphenicol 
 
3.4.2.2 Plasmid extraction 
Extraction of plasmid DNA was performed using the QIAprep Spin Miniprep Kit 
(Qiagen). Note that the standard manufacturer’s protocol recommends incubation of 
cultures for 16 h at 37°C and using 5 ml of the culture. However, the yield of plasmid 
DNA was greatly increased when incubation for just 5 h at 37°C and 1.5 ml of culture 
was used. All solutions listed below were provided with the kit. 
 
 A single Cronobacter colony from a fresh TSA plate was inoculated into 1.5 
ml of LB with the appropriate selective antibiotic and incubated for 5 h at 
37°C in a shaking incubator (2000 rpm). 
 The bacterial cells were harvested by centrifugation at > 8000 rpm (6800 x g) 
in table-top microcentrifuge for 3 min at room temperature and the supernatant 
was discarded. 
 The pelleted bacterial cells were resuspended in 250 μl Buffer P1 with added 
RNAse and LyseBlue reagent, and transferred to a microcentrifuge tube. The 
bacteria were resuspended completely by vortexing until no cell clumps 
remained. 
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 250 μl of Buffer P2 were added and the suspension was mixed thoroughly by 
inverting the tube until a homogeneously coloured suspension was achieved. 
The lysis reaction was not allowed to proceed for more than 5 min. 
 350 μl of Buffer N3 were added and the solution was mixed thoroughly by 
inverting the tube. The suspension was mixed until all trace of blue had gone 
and the suspension was colourless.  
 The suspension was centrifuged for 10 min at 13,000 rpm (~17,900 x g) in a 
microcentrifuge. 
 The supernatant was applied to a QIAprep spin column by decanting and 
centrifuged for 30–60 s at 13,000 rpm (~17,900 x g). The flow-through was 
discarded. 
 The QIAprep spin column was washed by adding 0.5 ml Buffer PB and 
centrifuged for 30–60 s at 13,000 rpm (~17,900 x g). The flow-through was 
discarded. 
 The QIAprep spin column was washed by adding 0.75 ml Buffer PE and 
centrifuged for 30–60 s at 13,000 rpm (~17,900 x g). The flow-through was 
discarded and the column was centrifuged for an additional 1 min to remove 
residual wash buffer.  
 The  QIAprep column was placed  in a clean 1.5 ml microcentrifuge tube. To 
elute DNA, 50 μl of Buffer EB were added to the center of each QIAprep spin 
column, let stand for 1 min, and centrifuged for 1 min. 
 
3.4.2.3 PCR amplification of  kanamycin cassette  
To amplify the kanamycin cassette from pDOC-K, primers containing regions 
annealing to the extremities of the kanamycin cassette and to the DNA flanking the 
gene of interest were designed (Table 9). The forward primers were designed to 
contain 32 bp of the DNA immediately upstream of the start of the gene of interest, 
followed by an 18-bp sequence, which anneals to the 5’ end of the kanamycin casette 
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on pDOC-K. The reverse primers were designed to contain 32 bp of the reverse 
complement of the DNA immediately downstream to the 3’end of the gene and a 17-
bp sequence that anneals to the 3’end of the kanamycin cassette. 
 
Table 9. List of primers used for the PCR amplification of the 1.4-kb kanamycin 
cassette from pDOC-K.  
Name Sequence
1
             
cusA_F TGTAAATATGCATTCAGGGCACTGAGGAGACGACGAATTGGCTGGAGCTGCTTC 
cusA_R GAAGGACACCCACAGGGGGTGCCCTTTCAGGTTCTCCTTAGTTCCTATTCC 
cusB_F ATGCCAGGTGTTTTGATTTTTTAGCGGAAAATTGTAATTGGCTGGAGCTGCTTC 
cusB_R GATGCCGGACTGTTGCTGTGACTCATGCAGAACTCCTTAGTTCCTATTCC 
cusC_F AACCATTTACCAGGTCTGCCTGGACGAGAAGCGTTAATTGGCTGGAGCTGCTTC 
cusC_R GAGAGTTATCTGAAGTGAATCAAGATAACGCTGCTCCTTAGTTCCTATTCC 
1
 The sequences annealing to the kanamycin casette are marked in bold. 
 
High-fidelity Phusion
®
 (Finnzymes) polymerase was used to generate blunt-ended 
PCR products suitable for cloning into pDOC. Each PCR reaction contained the 
following reagents:  
Phusion polymerase buffer 5x 5 µl 
Magnesium chloride (50mM) 5.5 µl 
dNTP mix (10mM each dNTP) 1.0 µl 
Forward primer (10µM) 1.25 µl 
Reverse primer (10 µM) 1.25 µl 
DMSO (100%) 0.8 µl 
Phusion polymerase (0.02 U/ µl) 0.25 µl 
Nuclease free water To a final volume of 25 µl 
 
The tube was gently mixed by tapping and 2 µl of the pDOC-K template (15-30 ng) 
were added.  The manufacturer of Phusion
®
 HotStart DNA polymerase recommends 
using the 2-step protocol with primers that are longer than 20 nt and have Tm values 
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above 69
o
C. All the primers used for the amplification of kanamycin cassette satisfied 
this condition and a 2-step protocol with the following settings was run. 
 
Initial denaturation 98
o
C 30 s 
Denaturation 98
o
C 10 s 
Annealing + extension 72
o
C 26 s 
30 cycles   
Final extension 72
o
C 10 min 
 
To confirm the results of the PCR, a 5 µl aliquot of the reaction mixture was analysed 
by agarose gel electrophoresis ( 3.4.2.4). Subsequently, the PCR products were 
purified using the Qiaquick PCR purification kit ( 3.4.2.5) and their concentration was 
measured by spectrophotometry at 260 nm using NanoDrop. 
 
3.4.2.4 Agarose gel electrophoresis 
To prepare 1% agarose gel, 0.5 g of agarose were mixed with 50 ml of TAE buffer 
and 7 µl of SYBRSafe. The agarose solution was microwaved until dissolved and 
poured into the electrophoresis casting tray to settle. Aliquots (5 µl) of PCR samples 
were mixed with 1 µl of gel loading dye and loaded onto the gel, alongside 5 µl 1-kb 
DNA ladder. The gel was run in TAE buffer at 100 V for 40 min (5 V/cm). 
 
3.4.2.5 Purification of PCR products 
The PCR products were purified using the QIAquick PCR Purification Kit (Qiagen). 
The protocol is detailed below. 
 200 µl of Buffer PB with added indicator was added to 40 µl of the PCR 
sample and mixed.   
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 A QIAquick spin column was placed in a provided 2 ml collection tube. To 
bind DNA, the sample was applied to the QIAquick column and centrifuged 
for 60 s at 17,900 x g (13,000 rpm) in a microcentrifuge. The flow-through 
was discarded and the QIAquick column was placed back into the same tube. 
 0.75 ml of Buffer PE was added to the QIAquick column and centrifuged for 
60 s. The flow-through was discarded and the QIAquick column placed back 
in the same tube. 
 The column was centrifuged for an additional 1 min at 17,900 x g (13,000 
rpm). 
 The QIAquick column was placed in a clean 1.5 ml microcentrifuge tube and 
30 μl of Buffer EB were added to the center of the QIAquick membrane and 
centrifuged the column for 1 min at 17,900 x g (13,000 rpm). To increase the 
concentration of the purified PCR product, this step was repeated. 
 
3.4.2.6 Restriction of pDOC by EcoRV 
To open the pDOC vector by EcoRV, the following reagents were mixed in a 1.5 ml 
tube: 
EcoRV (10,000 units/ml) 1 µl 
10X NE buffer 5 µl 
pDOC template  up to 100ng 
nuclease-free water add to final volume of 50 µl 
 
EcoRV was the last reagent added and all the components were mixed prior to adding 
the enzyme. The reaction mixture was incubated at 37
o
C for 1 hour. As the presence 
of the enzyme could interfere with further processing of the sample, the enzyme was 
heat inactivated by incubating the reaction mixture at 80
o
C for 20 min. 
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3.4.2.7 Cloning of the kanamycin cassette into pDOC 
For cloning of the kanamycin cassette flanked by regions homologous to the DNA 
adjacent to the genes to be deleted into pDOC, the ratio of vector : insert was 
determined according to the following equation: 
3 x ng (vector) x kb (insert) / kb (vector) = ng insert 
For a 1.4 kb insert and a 4 kb vector, the ratio of  insert : vector  was 1 : 1 (ng). 
To increase the efficiency of the cloning reaction, a higher ration insert : vector was 
used (1.5 : 1.0). 
 
The following reagents were added to a 0.5 ml PCR tube and mixed: 
Vector DNA 50 ng 
Insert DNA 75 ng 
Ligase 10 x buffer 1.5 µl 
Nuclease-free water to the final volume of 15 µl 
T4 DNA ligase (10 U/ µl) 1 µl 
The sample was then incubated at 10
o
C overnight.  
 
3.4.2.8 PCR to check the success of cloning of the kanamycin cassette 
into pDOC 
To confirm that the cloning of the kanamycin cassette into the pDOC plasmid was 
successful, PCR using the primers annealing to the DNA flanking the multicloning 
site in pDOC (Table 10) were used. 
 
  
117 
 
 
 
 
Table 10. Primers used to check the success of cloning of the kanamycin cassette into 
pDOC. 
Name Sequence %GC
1
 Tm
1
 
pDEXF TATGCTTCCGGCTCG 60 50 
pDEXR GGATGTGCTGCAAGG 60 50 
    
 1
...%GC and Tm were calculated using the biomath Tm calculator available at: 
http://www.promega.com/biomath/calc11.htm  
 
Each PCR reaction contained the following reagents:  
Phusion polymerase buffer 10x 5 µl 
Magnesium chloride (50mM) 5.5 µl 
dNTP mix (10mM each dNTP) 0.5 µl 
Forward primer (10µM) 1.25 µl 
Reverse primer (10 µM) 1.25 µl 
DMSO  0.8 µl 
Phusion
®
 polymerase (0.02 U/ µl) 0.25 µl 
Nuclease-free water To the volume of 50 µl 
 
The contents of the PCR tube was gently mixed by tapping, and 2 µl of the reaction 
mixture from the ligation step ( 3.4.2.7) were added.  The manufacturer of Phusion® 
HotStart DNA polymerase recommends using the 3-step protocol when Tm values are 
below 72
o
C for primers shorter than 20 nt (pDEXF and pDEXR). Extension of 15 
s/kb product for plasmid DNA is recommended.   A 3-step PCR protocol with the 
temperature cycling conditions detailed below was run. The empty vector would give 
product of ca 200 bp, whereas the vector with the insert would give a product of 1.6 
kbp. 
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Initial denaturation 98
o
C 30 s 
Denaturation 98
o
C 10 s 
Annealing  56
o
C 30 s 
Extension 72
o
C 26 s 
30 cycles   
Final extension 72
o
C 10 min 
To visualise the results of the PCR, a 5 µl aliquot of the reaction mixture was 
analysed by agarose gel electrophoresis ( 3.4.2.4). 
  
 
3.4.2.9 Transformation of OneShot® Top10 chemically competent E. 
coli cells  
The protocol for the transformation of chemically competent One Shot® Top10 E. 
coli cells (Invitrogen) with the plasmid DNA is outlined below. The SOC medium 
was provided with the kit. 
 A water bath was equilibrated to 42oC, SOC and LB media were warmed to 
room temperature. 
 LB plates containing 50 µg/ml kanamycin were warmed at 37oC for 30 min 
 The Top10 cells were thawed on ice. 
 1-5 µl of the plasmid DNA were added to Top 10 vial, mixed gently and 
incubated on ice for 30 min. 
 The cells were heat shocked at 42oC without shaking for 30 s. 
 250 µl of SOC medium were added to each vial and the cells were incubated 
at 37
o
C for 1 h in a shaking incubator (225 rpm). 
 20-200 µl from each transformation were spread on a selective plate and 
incubated overnight at 37
o
C. 
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Note: Positive (pUC19) and negative (Top10 cells without added plasmid) controls 
were included in the assay. 
 
3.4.2.10 Preparation of electrocompetent Cronobacter cells  
 A single Cronobacter colony from a fresh LB plate was inoculated into a flask 
containing 50 ml of LB and the culture was incubated overnight at 37
o
C with 
vigorous shaking (250 rpm). 
 Two flasks with 500 ml of prewarmed LB medium were inoculated with 25 ml 
of the overnight bacterial culture and the flasks were incubated at 37
o
C with 
aeration (200 rpm). 
 The OD600 of the cultures was measured every 20 min. 
 When the OD600 of the cultures reached 0.4, the flasks were rapidly transferred 
to an ice-cold water bath for 30 min.  
 The cultures were transferred to ice-cold centrifuge bottles and the cells were 
harvested by centrifugation at 3000 rpm for 15 minutes at 4
o
C. The 
supernatant was decanted and the pellet resuspended in 500 ml of ice-cold 
water. 
 The cells were centrifuged at 3000 rpm for 20 minutes at 4oC. The supernatant 
was carefully decanted and the pellet resuspended in 250 ml ice-cold 10 % 
glycerol. 
 The cells were centrifuged at 3500 rpm for 20 min at 4oC. The supernatant was 
carefully decanted and the pellet resuspended in 10 ml ice-cold 10 % glycerol. 
 The cells were centrifuged at 3500 rpm for 20 min for 20 min at 4oC. The 
supernatant was carefully decanted and the pellet resuspended in 1 ml of ice-
cold GYT medium.  
 80 µl aliquots of the cell suspension were stored at -80oC until required 
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3.4.2.11 Electroporation of plasmid DNA into electrocompetent 
Cronobacter cells 
 Electrocompetent Cronobacter cells were thawed on ice and 80 µl aliquots 
were pipetted into ice-cold sterile microcentrifuge tubes placed on ice. 
 1.5 µl of the plasmid DNA preparation (8-16 ng/µl) were added to each tube 
with electrocompetent cells and incubated on ice for 30-60 s. Using larger 
volumes than 1.5 µl was avoided, as it resulted in arcing during the electrical 
impulse. 
 The DNA/cell mixture was pipetted into an ice-cold electroporation cuvette, 
the outside of the cuvette was wiped dry and the cuvette was placed in the 
electroporation device (MXcell, BIO-RAD). The electroporation apparatus 
was set to deliver an electrical pulse of 25 µF capacitance, 2.5 kV and 200 
ohm resistance.  
 The cuvette was removed as quickly as possible from the apparatus and 1 ml 
of LB medium (at room temperature) was added. 
 The contents of the cuvette were transferred to a microcentrifuge tube and the 
cultures were incubated for 1 h at 37
o
C in a shaking incubator (200 rpm). 
 Different volumes (50 and 150 µl) of the cultures were plated on LB plates 
supplemented with the appropriate antibiotic (35 µg/ml chloramphenicol for 
pACBSR or pACBSRSceI and 200µg/ml ampicillin with 35 µg/ml 
chloramphenicol for the pDOC construct). 
 The plates were incubated overnight at 37oC. 
 
3.4.2.12 Arabinose induction and selection of mutants 
 Cronobacter colonies were patched on plates containing 10 % sucrose or 200 
µg/ml ampicillin. 
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 A single fresh sucrose sensitive and ampicillin resistant colony was inoculated 
into 1 ml of LB supplemented with 200 µg/ml ampicillin, 35 µg/ml 
chloramphenicol, 50 µg/ml kanamycin and 0.5 % glucose (w/v). The cultures 
were incubated at 37°C for 2 hours in a shaking incubator (200 rpm). Usually 
four parallel tubes were processed for each experiment. 
 Cells were harvested by centrifugation and re-suspended in 1 ml LB 
containing 0.5 % arabinose (w/v). Note that antibiotics were omitted from the 
growth medium at this stage. The culture was incubated at 37°C for 4-5 hours 
in a shaking incubator (200 rpm). 
  Dilutions of the culture were plated on to LB agar plates containing 50 μg/ml 
kanamycin and 10 % (w/v) sucrose and incubated overnight at 30°C. 
  Kanamycin resistant, sucrose insensitive recombinants were checked for 
donor plasmid loss by patching onto LB agar plates containing 200 μg/ml 
ampicillin and pACBSR or pACBSRSceI plasmid loss by patching onto LB 
agar plates containing 35 μg/ml chloramphenicol. 
 
3.4.2.13 Verification of gene deletion of cusA, cusB and cusC by 
PCR  
The samples of bacterial cultures for PCR screening were prepared as follows. A 
single Cronobacter colony was resuspended in 10 µl of PBS and the suspension was 
heated in the PCR thermocycler at 99
o
C for 10 min. Two microliters of the heated 
solution were used in each PCR reaction 
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To verify that the recombination event occurred at the desired loci, PCR primers 
annealing to the sites adjacent to the regions used for generating the kanamycin 
cassette PCR insert ( 3.4.2.3) were designed (Table 11). Size differences in PCR 
product between the wild-type and modified strain confirm whether a chromosomal 
modification has been achieved.  The predicted PCR products for cusA were 3.2 kb 
for wild-type strain and 1.4 kb for deletion mutant. In case of primers for the cusB and 
cusC mutants, the PCR products generated from the wild-type strain would have a 
very similar size to the PCR product amplified from the deletion mutant; the reverse 
primers cusB_CTRL_R  and cusC_CTRL_R were moved into the cusC gene. The 
wild type PCR products would in these cases be 1.2 kb, whereas no products would be 
generated from deletion mutants.   
 
Table 11. List of primers used in the PCR verification of gene deletion.  
Name Sequence %GC Tm 
cusA_CTRL_F AGGGCACTGAGGAGACGACGA 62 62 
cusA_CTRL_R CCCACAGGGGGTGCCCTTTC 70 62 
cusB_CTRL_F CCAGGTGTTTTGATTTTTTAGCGG 42 56 
cusB_CTRL_R ATGCCGGACTGTTGCTGTGACT 55 61 
cusC_CTRL_F GGTCTGCCTGGACGAGAAGCG 67 62 
cusC_CTRL_R CTGAAGTGAATCAAGATAACGC 41 54 
 
Each PCR reaction contained  the following reagents:  
GoTaq
®  
Flexi buffer 5x 3.0 µl 
Magnesium chloride (50mM) 1.5 µl 
dNTP mix (10mM each dNTP) 0.3 µl 
Forward primer (10 µM) 0.7 µl 
Reverse primer (10 µM) 0.7 µl 
GoTaq
®  
 Hot Start Polymerase (5U/ µl) 0.1 µl 
Nuclease free water To a final volume of 15 µl 
 
123 
 
The tube was gently mixed by tapping and 2 µl of the template were added.  The tubes 
were placed in a PCR thermocycler and a 3-step protocol with the following 
temperature cycling parameters was run. The 2 min denaturation step at 95
o
C is 
necessary to activate the GoTaq
®  
 Hot Start polymerase. 
Initial denaturation 95
o
C 2 min 
Denaturation 95
o
C 30 s 
Annealing 62
o
C
1
 30 s 
Extension 72
o
C
2
 1 min/kb of product 
30 cycles   
Final extension 72
o
C 5 min 
 
1
 gradient PCR was performed to optimize the annealing temperature for the PCR 
protocol. Expected products (3.2 k for cusA and 1.2 kb for cusB and cusC) were 
amplified in the whole range of annealing temperatures (57-66
o
C) with no visible 
difference in PCR product quantity 
2
 3.2 min for cusA, 1.2 min for cusB and cusC 
 
To visualise the results of the PCR, a 10 µl aliquot of the reaction mixture was 
analysed by agarose gel electrophoresis ( 3.4.2.4).  
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3.5. Results 
3.5.1 Cronobacter DNA microarray and comparative 
genomic hybridisation 
3.5.1.1 Development of new CGH data analysis tool 
WebArrayDB available at (http://webarraydb.org/webarray) is a database system and 
online cross-platform analysis suite for analysis of microarray data, developed by Prof. 
McClelland and his team, which allows storage of data in the repository and their 
online analysis. Prior to this study, the site only included tools for microarray 
expression data analysis, but Prof. McClelland agreed to design a CGH tool that could 
be used with data from NimbleGen arrays. The tool was developed by Xiao-Qin Xia 
and tested and optimised by myself. The new utility includes a CGH plotter which can 
plot the log2 ratio data against genomic location in an window of adjustable size with 
the possibility to colour code ranges of log2 ratio values (Figure 26) and a calculator 
of log2 ratio medians for each gene from log2 ratios of separate probes. The tool is 
now accessible on WebArrayDB upon request. 
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Figure 24. Example  of  a CGH plot in WebArrayDB. Two-channel microarray hybridization data for Cronobacter sakazakii ATCC 12868 (top 
chart) and Cronobacter muytjensii ATCC 51329
T
 (bottom chart) hybridized against the reference strain Cronobacter sakazakii BAA-894 is 
plotted against the genome location of oligonucleotide probes.  Green: gain of signal, Log2(Ratio)>1; red: loss of signal, Log2(Ratio)<-1. 
Log2(Ratio) = log2(test channel intensity/reference channel intensity). 
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3.5.1.2 Hybridization data distributions and gene category 
assignment 
Figure 25 shows the distribution of median log2 ratio intensity data for all strains 
examined by CGH. The microarray data distribution confirmed the taxonomic 
revision of Cronobacter spp. (formerly Enterobacter sakazakii) which separated the 
organisms into five different species (and one genomospecies). The log2 ratio 
histograms of C. sakazakii strains hybridised against the reference strain C. sakazakii 
BAA-894 (in red) have narrow main peaks, whereas the wider peaks of the log2 ratio 
distributions of the more distantly related species C. muytjensii, C. dublinensis, C. 
turicensis and C. malonaticus against C. sakazakii BAA-984 (in blue) reflect a greater 
sequence divergence of the test strains relative to the reference strain. The tailings on 
the left side of the distributions correspond to the genes that had a low test channel 
intensity value and therefore would be classified or absent/divergent.  Figure 25 
shows that the proportion of these genes is greater in the other members of the 
Cronobacter genera (in blue) compared to the C. sakazakii strains (in red). C 
muyjensii appears to be the most divergent compared to the reference C. sakazakii 
BAA-894. 
127 
 
 
 
log2 (Csak1/Csak658)
2.500.00-2.50-5.00-7.50
F
re
q
u
e
n
c
y
1,200
1,000
800
600
400
200
0
Mean =-0.43

Std. Dev. =1.979

N =4,382
log2 (Csak2/Csak658)
2.000.00-2.00-4.00-6.00-8.00
F
re
q
u
e
n
c
y
1,200
1,000
800
600
400
200
0
Mean =-0.13

Std. Dev. =1.795

N =4,382
log2 (Csak20/Csak658)
2.000.00-2.00-4.00-6.00-8.00
F
re
q
u
e
n
c
y
1,200
1,000
800
600
400
200
0
Mean =-0.47

Std. Dev. =1.795

N =4,382
log2 (Csak20/Csak658)
2.000.00-2.00-4.00-6.00-8.00
F
re
q
u
e
n
c
y
1,200
1,000
800
600
400
200
0
log2 (Csak767/Csak767)
2.000.00-2.00-4.00-6.00-8.00
F
r
e
q
u
e
n
c
y
1,200
1,000
800
600
400
200
0
log2 (Csak696/Csak658)
2.000.00-2.00-4.00-6.00-8.00
F
r
e
q
u
e
n
c
y
1,000
800
600
400
200
0
log2 (Cmuy3/Csak658)
2.500.00-2.50-5.00-7.50
F
re
q
u
e
n
c
y
500
400
300
200
100
0
log2 (Cdub1210/Csak658)
2.500.00-2.50-5.00-7.50
F
r
e
q
u
e
n
c
y
500
400
300
200
100
0
log2 (Ctur1211/Csak658)
2.500.00-2.50-5.00-7.50
F
r
e
q
u
e
n
c
y
400
300
200
100
0
log2 (Cmal1212/Csak658)
2.500.00-2.50-5.00-7.50
F
re
q
u
e
n
c
y
500
400
300
200
100
0
Figure 25. Histograms of the hybridization 
experiments. The distribution of the median 
Log2(Ratio)  is displayed for all strains used in the 
microarray study. In red: hybridization of C. sakazakii 
strain against C. sakazakii BAA-894. In blue: 
hybridization of  C. muytjensii, C. dublinensis, C. 
turicensis or C. malonaticus against C. sakazakii 
BAA-894. Log2(Ratio) = log2(test channel 
intensity/reference channel intensity).  
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The cut-off values used to classify each of the 4,382 genes represented on the 
microarray as i) present, ii) intermediate or iii) absent, were determined as described 
in  3.4.1.9 and are listed in Table 12.  
 
Table 12. Cut-off values of hybridiation ratios (test intensity / reference intensity) 
used for the assignment of absent, intermediate or present gene status.  
Strain 
Absent / 
intermediate 
Intermediate / 
present 
C. sakazakii ATCC 29544
T
 0.51 0.93 
C. sakazakii ATCC 12868 0.54 1.03 
C. sakazakii strain 20 0.45 0.85 
C. sakazakii strain 701 0.62 1.01 
C. sakazakii strain 767 0.66 1.05 
C. sakazakii strain 696 0.46 0.89 
C. malonaticus LMG 23826
T
 0.16 0.57 
C. turicensis LMG 23827
T
 0.11 0.43 
C. muytjensiii ATCC 51329
T
 0.10 0.31 
C. dublinensis LMG 23823
T
 0.11 0.32 
 
3.5.1.3 Core genome  
Of the 4,382 unique annotated gene sequences represented on the microarray, 54.9% 
(2,404) were classified as present in all C. sakazakii strains and 43.3% (1,899) were 
present in all ten Cronobacter strains representing five Cronobacter species. The vast 
majority of these shared genes are predicted to encode cellular essential functions 
such as energy metabolism, biosynthesis, DNA, RNA and protein synthesis, cell 
division and membrane transport. It should be noted that this core gene set was 
defined according to the most stringent trinary classification of genes by GACK and 
does not include the genes classified as intermediate. When intermediate genes are 
included, the core gene set for C. sakazakii species constitutes 80.9% (3,547) genes 
and core gene for Cronobacter genus includes 75.3% (3301) genes. The proportion of 
genes absent from test strains compared with C. sakazakii BAA-894 ranged from 
10.3% (453) in C. sakazakii strain 20 to 17.1% (751) in C. muytjensii. The trinary 
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classification of genes in 10 Cronobacter strains analysed by CGH is summarised in 
Table 13. 
 
Table 13. Number of absent, intermediate and present genes in Cronobacter strains 
when compared to the sequenced C. sakazakii BAA-894.  
Strain 
Absent 
genes (%)
1
 
Intermediate 
genes (%)
1
 
Present 
genes
1
 
C. sakazakii ATCC 29544
T
 582 (13.3) 449 (10.2) 3351 (76.5) 
C. sakazakii ATCC 12868 461 (10.5) 314 (7.2) 3607 (82.3) 
C. sakazakii strain 20 453 (10.3) 580 (13.2) 3349 (76.4) 
C. sakazakii strain 701 521 (11.9) 569 (13.0) 3292 (75.1) 
C. sakazakii strain 767 546 (12.5) 649 (14.8) 3187 (72.7) 
C. sakazakii strain 696 497 (11.3) 593 (13.5) 3292 (75.1) 
C. malonaticus LMG 23826
T
 522 (11.9) 608 (13.9) 3252 (74.2) 
C. turicensis LMG 23827
T
 495 (11.3) 591 (13.5) 3296 (75.2) 
C. muytjensii ATCC 51329
T
 751 (17.1) 522 (11.9) 3109 (70.9) 
C. dublinensis LMG 23823
T
 682 (15.6) 549 (12.5) 3151 (71.9) 
Absent in at least one C. sakazakii 835 (19.1)   
Absent in at least one Cronobacter  1081 (24.7)   
1
... Percentage out of 4,382 C. sakazakii BAA-894 genes represented on the 
microarray. For definition of “absent”, “intermediate” and “present” gene refer 
to  3.4.1.9.  
 
  
3.5.1.4 C. sakazakii plasmids 
The sequenced strain C. sakazakii BAA-894 contains two plasmids; pESA2 (31 kb) 
and pESA3 (131 kb). Thirty-eight genes were annotated on pESA2 and 127 genes on 
pESA3. The copy number of the plasmids was estimated from the median 
hybridization signals of oligonucleotides representing the plasmid compared to the 
sequenced genome. The ratio was (1:1.1:8.6) for the chromosome versus pESA2 
versus pESA3. Thus, pESA2 exists as low copy, and pESA3 appears to be a moderate 
copy number plasmid. The genes on pESA2 were absent in all other strains tested 
except C. turicensis, which had 19 (61.3%) genes present, and C. sakazakii 696, 
which had 4 (12.9%) genes present. Note that it is possible that some or all of the 
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detected present genes are located on the chromosome in other strains.The results for 
genes on pESA3 are summarized in Table 14. 
 
Table 14. pESA3 genes present in Cronobacter strains when compared to the 
sequenced strain of C. sakazakii BAA-894. 
Strain Present genes (%)
1
 Plasmid profile
2
 
C. sakazakii ATCC 12868 103 (88.8) + 
C. sakazakii strain 696 81 (69.8) + 
C. sakazakii strains 767 77 (66.4) + 
C. sakazakii strain 20 73 (62.9) + 
C. sakazakii strain 701 61 (52.6) + 
C. malonaticus LMG 23826
T
 57 (49.1) +(
3
) 
C. sakazakii ATCC 29544
T
 51 (44.0) +(
3
) 
C. turicensis LMG 23827
T
 35 (30.2) - 
C. dublinensis LMG 23823
T
 19 (16.4) - 
C. muytjensii ATCC 51329
T
 0 (0.0) - 
1
 Of the 127 annotated genes on pESA3, 116 were analyzed by comparative genomic 
hybridization. The other genes did not have sufficient number of probes that passed 
the filters for manufacture of the array. 
2
 Plasmid of a size similar to pESA3 (131 kb) was detected by gel electrophoresis of 
plasmid isolations. 
3
 The detected plasmid was smaller in size than pESA3 (110 kb).  
 
Plasmid profiling was performed on the Cronobacter strains analyzed by comparative 
hybridization. A plasmid of a size similar to pESA2 (31 kb) was detected in C. 
sakazakii 696 and in C. turicensis, which is in accordance with our CGH results. A 
large plasmid similar in size to pESA3 (131 kb) was visible in C. sakazakii strains 
ATCC 29544
T
, ATCC 2868, 20, 696, 701, 767 and C. malonaticus (Table 14). 
Note that genes on a multicopy or medium copy plasmid may require a different 
degree of divergence to be identified as absent or divergent by comparative 
hybridizations and it is therefore difficult to establish the accuracy of the CGH results 
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for plasmid genes. However, our CGH data correlated well with the experimental data,  
plasmids of similar size as pESA3 was detected in strains with 53-89 % present 
pESA3 genes as determined by CGH,  smaller plasmids (110 kb) were detected in 
strains with 51 and 57 % present pESA3 genes and no plasmid was detected in strains 
with 0-35 % pESA genes.  
 
3.5.1.5 Genome cluster analysis 
 Whole-genome clustering based on the gene category assignment by GACK ( 3.4.1.9) 
revealed that Cronobacter strains formed two distinct phylogenetic clusters (Figure 
26). All C. sakazakii strains formed one cluster, whereas C. malonaticus, C. turicensis, 
C. dublinensis and C. malonaticus formed a second, separate cluster. Within C. 
sakazakii, strains 701 and 767 were the most closely related and clustered together 
with strain 20. The remaining Cronobacter species formed sub-clusters: C. 
malonaticus clustered with C. turicensis and C. dublinensis grouped with C. 
muytjensii. The tree remained identical when adjacent genes were collapsed into a 
single phylogenetic character if they had the same pattern of presence and absence. 
The regions GR1- GR15 annotated Figure 26 will be described in the next section 
( 3.5.1.6). Note that the clustering was based on the presence of the genes of the 
reference C. sakazakii BAA-894 in other Cronobacter strains, and therefore genes 
that were present in other Cronobacter strains and missing in the reference strain were 
not involved in the analysis. 
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Figure 26. Whole genome clustering analysis showing the relatedness of 10 
Cronobacter isolates with respect to the genes of the reference strain C. 
sakazakii BAA-894. Genomic regions GR1–GR15 are marked. Clustering 
analysis was performed using Gene Cluster (EisenSoftware). Hierarchical 
clustering was performed using the average linkage method on the trinary 
matrix based on the CGH analysis: 1 for presence, 0 for intermediate status 
and −1 for absence/divergence of a gene. Green indicates present genes, 
orange uncertain genes and red absent genes. For description of strains refer to 
Table 7. 
 
GR2
GR3
GR4
GR6
GR10
GR12
GR14
GR15
GR12 
GR13
GR10 
GR11 
GR9
GR8
GR7
GR6
GR5
GR4
GR3 
GR2
GR1
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3.5.1.6 Genomic regions absent in some strains of Cronobacter 
Genes that were absent in more than half of Cronobacter strains relative to the 
sequenced strain C. sakazakii BAA-894 were selected for further analysis. These 
genes form 15 clusters of contiguous genes (based on the annotation of the reference 
genome). These are shown on Figure 27, where the number of strains in which a 
particular gene was classified as absent is plotted against the gene locus. The clusters 
were designated as regions GR1–GR15. 
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Figure 27. Distribution of the 15 variable regions across the C. sakazakii 
BAA-894 genome. Each column represents a gene classified as absent by 
CGH analysis in at least one strain. The height of the columns indicate the 
number of strains (out of 10) in which the gene was found to be absent. The 
major variable regions (blue) and prophages (red) are indicated in order of 
their appearance in the genome of C. sakazakii BAA-894. 
 
3.5.1.6.1 Prophages 
Of the 15 clusters, three putative prophage genomes and one prophage fragment were 
identified by Prophinder (Lima-Mendez et al. 2008) and three additional regions are 
probable prophage fragments based on the presence of phage protein homologues 
identified by BLASTP.  The genome organisation of the putative prophages is 
represented on Figure 28. 
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The average GC content of the sequenced C. sakazakii BAA-894 genome is 56%, the 
GC content of prophages 1, 2 and 3 was 53, 49 and 51%, respectively. In the three 
prophage gene clusters (prophages 1, 2 and 3), genes encoding close homologues of 
known phage genes involved in integration, lysis and termination as well as head and 
tail structure were identified, based on the annotation in IMG-JGI 
(http://img.jgi.doe.gov/cgi-bin/pub/main.cgi). Where necessary, the genes were re-
annotated based on amino acid identity searches in IMG-JGI.  The complete list of re-
annotated putative prophage genes is available in Appendix 2.  In addition, Figure 29 
shows the status of all putative prophage genes in the 10 Cronobacter strains. 
Prophage 1 (GR4; ESA_00990–ESA_01052). In the 46-kb putative prophage 1 
(Figure 28A), 30/63 (48%) hypothetical proteins were similar to known phage 
proteins. Homologues of phage genes involved in integration, lysis, head 
morphogenesis, tail assembly and phage regulation were identified. Prophage 1 also 
contains a gene (ESA_00997) encoding a protein homologous to the Eae-like 
adhesion protein associated with the attaching and effacing phenotype. However, the 
aligment on the Eae protein is only partial (50%). The eae gene is carried by some 
other bacteriophages of enteric pathogens: Salmonella phage epsilon34, E. coli 
O157:H7 bacteriophage PhiV10, enterobacterial phage P22 and enterobacterial phage 
epsilon15.  
Prophage 2 (GR6; ESA_01608–ESA_01644). Putative prophage 2 (Figure 28B) 
contains 37 genes, out of which 25 (68%) were homologous to known phage proteins. 
Prophage 2 contains several lambdoid phage genes encoding the following proteins: 
repressor CII (ESA_01613), replication proteins O and P (ESA_01614 and 
ESA_01615), the antitermination protein Q (ESA_01622), small and large subunits of 
the phage terminase (ESA_01632 and ESA_01633) as well as head and tail 
morphogenesis proteins. Head morphogenesis genes (ESA_01635–ESA_01637) were 
similar to head proteins of bacteriophage HK97 from the family of lambda phages. 
Two gene clusters in the prophage have very low average GC content; 33% 
(ESA_01616–ESA_01620) and 44% (ESA_01627–ESA_01631). Both these clusters 
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contain hypothetical proteins that showed no similarity with known proteins or 
functions.  
Prophage 3 (GR12; ESA_03025–ESA_03102) was the largest (47-kb) putative 
prophage identified (Figure 28C). Thirty-four genes (39%) genes had homology to 
known phage proteins or functions. The rest of the annotated genes are conserved 
proteins of unknown functions or hypothetical proteins. Similarly to prophage 2, 
several regulatory genes characteristic for lambdoid phages were identified: repressor 
proteins CI, CII and CIII, early gene regulator protein, replication proteins O and P as 
well as N independence proteins NinBFGZ. A cluster of three O-antigen conversion 
genes (ESA_03026–ESA_03028) was found in putative prophage 3 between phage 
integrase and tail morphogenesis genes (Figure 28). The putative colicin uptake 
protein TolA (ESA_03048) may be involved in the internalization of the 
bacteriophage, as the Tol pathway can be also used for the translocation of phages 
into the bacterial cell (Lazdunski 1988).
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 Figure 28. Gene maps of putative prophages. A. Gene map of putative prophage 1. B. Gene map of putative prophage 2. C. Gene map of putative prophage 
3. Annotation of the putative prophage genes is available in Appendix 2.
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Prophage fragment 1 (GR3; ESA_00604–ESA_00630). Eight of 19 genes in this 
region encode proteins associated with phages: plasmid and phage DNA primase 
(ESA_00620), a protein from Ash phage family (ESA_00624), the phage 
transcriptional regulator AlpA (ESA_00625), a putative phage capsid protein 
(ESA_00626), the phage transcriptional activator Ogr/Delta (ESA_00627) and phage 
integrase (ESA_00630). ESA_00618 was homologous to ea59 of lambda 
bacteriophage and ESA_00622 was homologous to a P4 phage protein. This cluster is 
most probably a phage remnant and may not encode a functional phage due to the 
absence of homologues of known structural tail proteins. The phage cluster was 
absent in all Cronobacter strains except a short region, ESA_00609–ESA_00617, that 
was present in C. sakazakii strains 701 and 767.  
Prophage fragment 2 (GR10; ESA_02304–ESA_02339). This cluster is likely to 
represent another prophage remnant. The region mostly contains hypothetical proteins 
with unknown functions. However, eight genes showed some degree of homology to 
proteins of phage origin. The cluster is flanked by a gene homologous to phage 
methyltransferase (ESA_02304) and a gene containing a site-specific recombinase 
domain that is found in putative integrases/recombinases of mobile genetic elements 
of diverse bacteria and phages (ESA_02339). It also includes genes homologous to 
phage lysozyme (ESA_02309), a phage tail component (ESA_02311), a putative 
phage tape measure protein (ESA_02313), another unspecified phage protein 
(ESA_02316), a major capsid protein (ESA_02319) and a phage portal protein 
(ESA_02320). GR10 might be another remnant of a prophage that has previously 
integrated into C. sakazakii BAA-894 genome. The presence of putative integrase 
flanking the cluster suggests introduction of this cluster into the genome by horizontal 
gene transfer. This cluster was absent in all Cronobacter strains except the genes 
encoding phage lysozyme (ESA_02309) and a hypothetical protein (ESA_02310), 
present in C. sakazakii strains ATCC 12868 and 20, probably as a part of different 
prophages. 
Prophage fragment 3 (GR11; ESA_02740–ESA_02755). The gene cluster of the 8-
kb putative prophage fragment 3 comprises 16 hypothetical proteins, 10 of which 
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(63%) may be associated with phage functions. As it lacks genes for head and tail 
morphogenesis as well as phage regulatory genes, it is likely to be a non-functional 
phage remnant. 
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Figure 29. Absence/presence status of prophage genes in Cronobacter strains. Red indicates absence/divergence of a particular gene, orange 
indicates uncertain status and green indicates presence of a gene. For gene status determination see   3.4.1.9. Csak1 =  C. sakazakii ATCC 29544T; 
Csak2 = C. sakazakii ATCC 12868, Cmal = C. malonaticus ; Cdub = C. dublinensis; Cmuy = C. muytjensii; Ctur = C. turicensis.
Prophage 1 
Prophage 2
Prophage 3
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3.5.1.6.2 Non-phage regions that differ among the strains 
There were nine genomic regions  not associated with phage genes that were absent in 
more than half of the Cronobacter strains relative to the sequenced strain C. sakazakii 
BAA-894; these regions are described below. The complete list of genes belonging to 
the variable non-phage regions and their presence in tested strains is available in 
Appendix 2. Where necessary, the genes were re-annotated based on homology 
searches in IMG-JGI (http://img.jgi.doe.gov/cgi-bin/pub/main.cgi). 
GR1 (ESA_00140–ESA_00145) is a small cluster of T6SS genes which will be 
described in more detail in Section  3.5.1.13. ESA_00145, a secretion lipoprotein from 
a VC _A0113 family was present in C. sakazakii strains 701 and 767 associated with 
fatal outbreaks. The rest of GR1 was absent in all tested strains except C. sakazakii 
696.  
GR2 (ESA_00292–ESA_00310) mostly contains uncharacterized conserved proteins 
and was absent from all Cronobacter strains.  
GR5 (ESA_01179–ESA_01189) contains a cluster of proteins involved in cell wall 
biogenesis and nucleotide sugar metabolism. It corresponds to the C. sakazakii O-
antigen gene locus used to distinguish the two Cronobacter serotypes O:1 and O:2 
(Mullane et al. 2008b). DNA microarray analysis revealed that GR5 is highly 
divergent; its genes were not sufficiently similar to be detected by microarray 
hybridization in any other Cronobacter strains. For more details on this region 
see  3.5.1.14. 
GR7 (ESA_01775–ESA_01804). Most genes in GR7 were predicted to be involved in 
tellurite resistance. It contains homologues of tellurite resistance proteins TerA, TerC, 
TerD, TerY and TerZ. This region was absent from all Cronobacter strains tested by 
CGH.  
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GR8 (ESA_01970–ESA_01976) contains seven genes encoding pilus assembly 
proteins. This cluster of genes was absent in all Cronobacter strains except C. 
sakazakii strain 20. For more details on fimbriae see  3.5.1.11. 
GR9 (ESA_02032–ESA_02041) contains genes encoding hypothetical proteins and 
four proteins involved in T6SS (ESA_02037–ESA_02040). These four genes were 
present in C. sakazakii strains 1 and 20 and absent in all other strains. For more details 
on type VI secretion systems see  3.5.1.13. 
GR13 (ESA_03887–ESA_03912) is a cluster of 16 hypothetical proteins, mostly 
without homology to known proteins or functions. At least two genes encode 
homologues of T6SS components (ESA_03899 and ESA_03905). This region partly 
overlaps with the T6SS cluster described in  3.5.1.13. This cluster was absent in all 
other Cronobacter strains tested by CGH.  
GR14 (ESA_04248–ESA_04255) encodes the putative cop operon involved in copper 
resistance. ESA_04248 encodes a protein identical to the copper resistance protein 
PcoE of E. cloacae (100% sequence identity, but only 60% homolog coverage), 
ESA_04249 encodes a putative copper-resistance protein CopA, ESA_04250 encodes 
a homolog of E. coli copper resistance protein CopB, ESA_04251 encodes a  homolog 
of Cu resistance protein CopC and ESA_04252 encodes a  putative copper export 
protein CopD. Along with CopA, CopB and CopC, CopD mediates copper resistance 
by sequestration of copper in the periplasm (Cha, Cooksey 1991). ESA_04253 
encodes a heavy metal response regulator PcoR (CusR) and ESA_04254 encodes a 
putative heavy metal sensor kinase CusS. This cluster was found in C. sakazakii 
strains ATCC 29544
T
 and 696, as well as C. turicensis and C. malonaticus. 
GR15 (ESA_pESA3p05493–ESA_pESA3p05505) contains genes located on C. 
sakazakii plasmid pESA3 and includes components of T4SS and T6SS pathways. 
GR15 was absent from all strains except C. sakazakii strains ATCC 29544
T
 and 696.  
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3.5.1.6.3 The differences in genome content of C. sakazakii and other 
Cronobacter species 
A list of genes that were classified as present or intermediate in all C. sakazakii strains 
but absent in one of the other Cronobacter species was compiled. There were 56 
genes absent in C. malonaticus, 91 genes absent in C. turicensis, 152 genes absent in 
C. dublinensis and 174 genes absent in C. muytjensii.  Among these genes, clusters of 
contiguous genes were identified and denoted as “specific regions” SR1-SR13. The 
presence of these regions in the different Cronobacter species is summarized in Table 
14 and the regions are described below. 
 
SR1 (ESA_00258 and ESA_00257) encodes a putative toxin/antitoxin pair RelE/RelB. 
RelE acts like a translational repressor, probably through binding ribosomes (Galvani, 
et al. 2001, Pedersen et al. 2002). RelB stably binds RelE, presumably deactivating it. 
The toxin/antitoxin pairs encoded on plasmids may act like addiction modules that 
help to maintain a plasmid in a bacterial population. When encoded on a chromosome, 
however, the toxin/antitoxin system probably represents selfish DNA (Pedersen et al. 
2002).  In the reference C. sakazakii BAA-894, these genes were encoded on a 
chromosome. The microarray data do not provide the information about the location 
of these genes in other tested strains, however. This region was missing in all other 
Cronobacter species except C. sakazakii.  
 
SR2 (ESA_01116 – ESA_01119) is a cluster of genes encoding a complete ABC-type 
multidrug efflux system. ESA_01116 encodes a multidrug efflux pump. ESA_01117 
encodes outer membrane efflux protein from a family including TolC. ESA_01118 is 
the permease component of the ABC-type system and ESA_01119 encodes the 
ATPase component of the efflux system. This region is missing in all other 
Cronobacter species except C. sakazakii. 
 
SR3 (ESA_01448 - ESA_01450) encodes three proteins from the family of fatty acid 
desaturases. Members of this family are involved in cholesterol biosynthesis and 
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biosynthesis of a plant cuticular wax, but may be implicated  in other biosynthetic 
pathways (Arthington et al. 1991, Aarts et al. 1995). The exact function of this cluster 
of genes is therefore unknown. This cluster was missing in C. malonaticus, but 
present in all other Cronobacter species. 
 
SR4 (ESA_02125 - ESA_02129) encodes a diverse group of proteins where no 
common assignment to a pathway or mechanism could be found. ESA_02125 and 
ESA_02128 encode acetyltransferases. ESA_02125 was present or intermediate in all 
species except C. turicensis, whereas ESA_02128 was only present in C. sakazakii 
strains and intermediate in C. malonaticus. ESA_02126 encodes a transcriptional 
regulator from the LysR family, this gene was present or intermediate in all species 
except C. turicensis.  ESA_02127 is a gene encoding a putative esterase / lipase, 
which was present in all species except C. muytjensii and C. dublinensis. ESA_02129 
encodes serine protease inhibitor ecotin. The gene for ecotin was intermediate in C. 
sakazakii strains and in C. malonaticus, but absent in C. muytjensii, C. dublinensis 
and C. turicensis.  
 
SR5 (ESA_02538 – ESA_02542) is a cluster of fimbrial genes. See section  3.5.1.11 
for details. 
 
SR6 (ESA_02544 – ESA_02547). The genes from this cluster are involved in the 
metabolism of β-glucosides.  ESA_02544 is a transcriptional antiterminator from the 
BglG family, which is involved
 
in positive control of the utilization of different sugars 
by
 
transcription antitermination (Bardowski et al. 1994). ESA_02545 encodes a 
kinase that converts β-glucosides to 6-phospho-β-glucosides   and ESA_02546 
encodes a 6-phospho- β-glucosidase (EC 3.2.1.86). According to the annotation in 
IMG-JGI (http://img.jgi.doe.gov/cgi-bin/pub/main.cgi), ESA_02546 is specific to 
arbutin-6 phosphate and salicilin-6-phosphate, transforming them into β-D-glucose-6-
phosphate, whereas ESA_02545 has a wider specificity to β-glucosides. It remains to 
be determined whether the pathway described is specific to arbutin/salicin or may 
convert a wider range of β-glucosides. ESA_02547 also encodes 6-phospho-β-
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glucosidase (EC 3.2.1.86) which may have the same or similar function as 
ESA_02546. This cluster of genes was present in all strains except C. turicensis. 
 
SR7 (ESA_02549 – ESA_02553) may encode a complete ABC multidrug transport 
system. ESA_02549 encodes a transcriptional regulator from the TetR family of 
proteins, which may function as a repressor that controls the level of susceptibility to 
hydrophobic antibiotics and detergents (Pan & Spratt 1994, Hillen & Berens 1994). 
ESA_02550 encodes a multidrug resistance efflux pump, ESA_02551 encodes the 
ATPase component and genes ESA_02552 and ESA_02553 encode the permease 
components. This cluster of genes was present in all Cronobacter strains except C. 
muytjensii.  
 
SR8 (ESA_02616 – ESA_02618) contains genes related to mannose metabolism. 
ESA_02616 is an alpha-mannosidase, ESA_02617 is a gene taking part in  mannosyl-
D-glycerate uptake via the phosphotransferase system and ESA_02618 is  mannosyl-
D-glycerate transport/metabolism system repressor. This cluster was present in all 
species except C. turicensis. 
 
SR9 (ESA_02795 – ESA_02799) is a fimbrial cluster. For more details see  3.5.1.11. 
 
SR10 (ESA_03301 – ESA_03305). This region encodes proteins involved in the 
metabolism of fructose and mannose via the PTS and a putative porin KdgM.  
ESA_03301 encodes a isomerizing glucosamine--fructose-6-phosphate 
aminotransferase. The SIS domain of ESA_03301 is found in phosphosugar 
isomerases, phosphosugar binding proteins, and also in proteins that regulate the 
expression of genes involved in synthesis of phosphosugars (Teplyakov et al. 1998). 
ESA_03302, located on the opposite strand to the rest of the genes in this cluster, 
encodes an oligogalacturonate-specific porin protein (KdgM). ESA_03303 encodes a  
fructose-specific II component of the PTS system FruA, which  converts fructose to 
fructose-1-phosphate. ESA_03304 encodes alpha-mannosidase involved in mannose 
degradation. ESA_03305 encodes a phosphomannose isomerase, which converts D-
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mannose to β-D-glucose-6-phosphate. This cluster of genes was only present in C. 
sakazakii strains and absent in other Cronobacter species. 
 
SR11 (ESA_03609 – ESA_03613) is a cluster of genes also involved in mannose  
metabolism. ESA_03609 encodes a putative β-galactosidase. Genes ESA_03610 and 
ESA_03612 encode genes involved in the N-acetylneuraminate and N-
acetylmannosamine degradation pathway.  ESA_03610 encodes a N-
acetylmannosamine kinase and ESA_03611 encodes a N-acetylneuraminate lyase. 
Gene ESA_03612 encodes a transcriptional regulator from the GntR family. This 
cluster of genes was only present in C. sakazakii strains and absent in all other 
Cronobacter species. 
 
SR 12 (ESA_04067 – ESA_04073) is a cluster of fimbrial genes. For more details 
see  3.5.1.11. 
 
SR13 (ESA_04101 – ESA_04106) encodes genes that may be involved in the O-PS 
biogenesis. ESA_04102 encodes a glycosyltransferase involved in cell wall 
biogenesis, ESA_04103 encodes a putative O-antigen ligase and related enzymes. 
Genes ESA_04104 and ESA_04105 encode  glycosyltransferases  and ESA_04105 
encodes a putative lipopolysaccharide heptosyltransferase III. This cluster of genes 
was present in all Cronobacter strains, but absent in C. malonaticus. ESA_04103 was 
only present in C. sakazakii strains. Note that this is not the O-antigen locus described 
by Mullane et al. (2008b). 
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Table 14. Genomic regions that differed between Cronobacter species.  
ID Gene loci Description 
Csak 
(n=7) 
Cmal Ctur Cmuy 
SR1 ESA_00257 - ESA_00258 
Toxin/antitoxin 
RelE/RelB YES NO NO NO 
SR2 ESA_01116 - ESA_01119 
ABC-type multidrug 
efflux YES NO NO NO 
SR3 ESA_01448  - ESA_01450  
Fatty acid 
desaturases YES NO YES YES 
SR4 ESA_02125 - ESA_02129 Ecotin (ESA_02129) YES YES NO NO 
SR5 ESA_02538 - ESA_02542  Fimbriae YES NO NO NO 
SR6 ESA_02544 - ESA_02547  
β -glucosides 
metabolism YES YES NO YES 
SR7 ESA_02549 - ESA_02553  
Multidrug efflux 
system YES YES YES NO 
SR8 ESA_02616 - ESA_02618  
Mannosyl-D-
glycerate uptake YES YES NO YES 
SR9 ESA_02795 - ESA_02799 Fimbriae YES NO NO NO 
SR10 ESA_03301 - ESA_03320  
Mannose 
metabolism YES NO NO NO 
SR11 ESA_03609 - ESA_03613  
Mannose 
metabolism YES NO NO NO 
SR12 ESA_04067 - ESA_04073  Fimbriae YES NO NO NO 
SR13 ESA_04101 - ESA_04106 Cell wall biogenesis YES NO  YES
1
 YES
1
 
1 
See main text for details about absence/presence of particular genes from this cluster 
Csak =  C. sakazakii; Cmal = C. malonaticus ; Cdub = C. dublinensis; Cmuy = C. muytjensii; 
Ctur = C. turicensis 
 
3.5.1.7 Comparison of C. sakazakii BAA-894 to other Enterobacterial 
genera 
The C. sakazakii BAA-894 genome sequence was compared to the genomes of 
Citrobacter koseri BAA-895, Klebsiella oxytoca VJSK009, E. coli K12 MG1655 and 
Salmonella enterica Typhimurium strain LT2, representing some of the most closely 
related genera to Cronobacter. This was done by Fred Long (Vaccine Research 
Institute of San Diego, USA). Using a threshold of identity of >85% in a 100 base 
window, 334 genes were present in all Cronobacter strains but absent or diverged in 
the four members of other genera. These genes included a cluster of T6SS genes 
(ESA_03943 - ESA_03948) which might be involved in virulence, and a putative 
palatinose operon (ESA_02709 - ESA_02715). Alpha-glucosidase activity, which has 
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been linked to palatinose metabolism, is considered as one of the major biochemical 
traits that distinguish Cronobacter from other related Enterobacteriaceae. The gene 
cluster ESA_02709 - ESA_02715 is identical to the C. sakazakii putative palatinose 
operon described in (Lehner et al. 2006). Genes ESA_02714 and ESA_02713 encode 
palatinose-binding proteins PalE and PalF. ESA_02712 encodes a palatinose ABC 
transporter membrane protein PalG, ESA_02711 encodes a palatinose ABC 
transporter ATP-binding protein palK, genes ESA_02710 and ESA_02709 encode an 
alpha-glycosidase PalQ and PalZ.  
 
3.5.1.8 Genomic islands  
Genomic islands in C. sakazakii BAA-894 were identified  by IslandViewer (Langille, 
Brinkman 2009). Most of the mobile genetic elements identified in the genome of 
corresponded to the variable genomic regions discovered using our microarray data 
(Section  3.5.1.6). The regions that do not correspond to the variable regions encode 
hypothetical proteins or conserved uncharacterized proteins. The putative genomic 
islands are listed in Table 15, along with the corresponding variable genomic regions 
and their description. Note that the loci of the genomic islands may include additional 
genes or include less genes compared to the variable genomic regions. 
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Table 15.  Putative genomic islands in C. sakazakii BAA-894 
Genomic island location 
Genomic 
region
1
 
Specific 
region
2
 
Description 
ESA_00293 - ESA_00305 GR2  Uncharacterised proteins 
ESA_00604 - ESA_00612 GR3  Putative prophage fragment 1 
ESA_00622 - ESA_00634 GR3  Putative prophage fragment 1 
ESA_00988 - ESA_00996 GR4  Putative prophage 1 
ESA_01116 - ESA_01120  SR2 Toxin/antitoxin pair RelE/RelB 
ESA_01179 - ESA_01188 GR5  O-antigen gene locus 
ESA_01261 - ESA_01276   Hypothetical proteins 
ESA_01610 - ESA_01623 GR6  Putative prophage 2 
ESA_01625 - ESA_01645 GR6  Putative prophage 2 
ESA_01177 - ESA_01804 GR7  Tellurite resistance cluster 
ESA_02028 - ESA_02034   Hypothetical proteins 
ESA_02303 - ESA_02341 GR10  Putative prophage fragment 2 
ESA_02741 - ESA_02754 GR11  Putative prophage fragment 3 
ESA_03009 - ESA_03106 GR12  Putative prophage 3 
ESA_03428 - ESA_03434   Hypothetical proteins 
ESA_04081 - ESA_04088   Hypothetical proteins 
ESA_04243 - ESA_04250 GR14  Copper resistance cluster 
ESA_04395 - ESA_04404   Hypothetical proteins 
1
 Variable genomic regions defined in  3.5.1.6.1 and  3.5.1.6.2 . 
2
 Species specific genomic regions defined in  3.5.1.6.3. 
 
3.5.1.9 Invasion of brain microvascular endothelial cells  
Because Cronobacter may cause fatal cases of neonatal meningitis, the status of genes 
identified in other organisms as associated with invasion of brain microvascular 
endothelial cells (BMEC) (ibeA, ibeB, yijP and ompA) in the sequenced strain was of 
particular interest (Prasadarao et al. 1996, Huang et al. 1999, Wang et al. 1999, 
Huang et al. 2001). The gene encoding OmpA was present in all Cronobacter strains. 
This protein is associated with the invasive ability of neonatal meningitic E. coli 
(Wang & Kim 2002) and Cronobacter (Nair et al. 2009, Kim et al. 2010). While 
genes ibeA and yijP produced no match in the reference strain C. sakazakii BAA-894, 
a match to ibeB was found. BLASTP analysis showed that this IbeB protein was 
homologous to the CusC protein from the copper and silver resistance cation efflux 
system cusCFBA which allows bacteria to invade BMEC (Franke et al. 2003).  
Microarray data revealed that the complete cation efflux system cusA (ESA_04242), 
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cusB (ESA_04241), cusC (ESA_04239), cusF (ESA_04240) and its regulatory genes 
cusR (ESA_04238) and cusS (ESA_04237) were present in strains associated with 
neonatal infections (C. sakazakii ATCC 29544
T
, 701, 767, 696, C. turicensis and C. 
malonaticus), and absent in the other tested strains. 
 
 
3.5.1.10 Comparison of C. sakazakii neonatal intensive care unit 
(NICU) outbreak strains with C. sakazakii type strain ATCC 
29544
T 
The genes that were shared by the three strains associated with C. sakazakii outbreaks 
in NICUs (BAA-894, 701 & 767) were compared to the C. sakazakii species type 
strain ATCC 29544
T
; the later showed decreased virulence properties compared to 
strains 701 and 767 in earlier tissue culture studies (Townsend et al. 2008a). One 
hundred and forty-four genes present in the three NICU strains were absent in the type 
strain, 66 (46%) of them were in clusters of consecutive genes based on the annotation 
of BAA-894. In most of these clusters, genes encoding proteins associated with 
resistance to antibiotics and different forms of stress were identified, including 
multidrug efflux systems, genes involved in resistance to oxidative stress, and those 
with a putative function in resistance to metals. The complete list of genes present in 
NICU outbreak strains C. sakazakii BAA-894, 707 and 767 and absent in the C. 
sakazakii type strain ATCC 29544
T
 is provided in Appendix 3, genes of interest are 
collated below into four categories. The presence of these genes in Cronobacter 
strains tested by CGH is summarised in Table 19 in Section  3.5.1.15. 
 
Category I. Genes encoding proteins associated with resistance to different forms of 
antibiotics: (i) a transcriptional regulator (ESA_01938) from the TetR family of 
protein repressors that control the level of susceptibility to hydrophobic antibiotics 
and detergents; (ii) a homologue of the CpmG protein involved in carbapenem 
resistance (ESA_pESA3p05435); (iii) a protein conferring resistance to antimicrobial 
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peptides Mig-14 (ESA_pESA3p05439); and (iv) a transcriptional regulator 
(ESA_pESA3p05448) involved in tetracycline resistance. 
 Category II.  Genes encoding components of multidrug efflux systems: (i) a cationic 
drug transporter (ESA_01940) from the family of proteins that confer resistance to a 
wide range of toxic compounds; (ii) a complete bacterial ABC-transport system 
involved in active transport across the cytoplasmic membrane (ESA_01944–
ESA_01946); and (iii) a variety of multidrug efflux components located on the 
plasmid pESA3 in BAA-894. 
Category III. Genes involved in resistance to oxidative stress and genes with a 
putative function in resistance to metals: (i), a redox-sensitive transcriptional activator 
SoxR (ESA_00115); (ii) a glutathione S-transferase (ESA_00116); (iii) ADP-ribose 
pyrophosphatase involved in oxidative stress protection (ESA_pESA3p05446); (iv) an 
arsenate reductase (ESA_pESA3p05485); and (v) a predicted transcriptional regulator 
involved in mercurium resistance ESA_pESA3p05463. 
Category IV. Other genes of interest include: (i) putative adhesins which are 
recognized as virulence factors in enteric bacteria (Campellone & Leong 2003) 
(ESA_00983–ESA_00986); (ii), the universal stress protein UspA (ESA_01955) 
which can enhance the rate of cell survival during prolonged exposure to stress 
conditions (Nystrom & Neidhardt 1994); (iii) a gene encoding a Type VI secretion 
lysozyme-related protein (ESA_02735); (iv) a gene encoding a predicted virulence 
SciE-type protein (ESA_02736) which affects the ability of bacteria to enter 
eukaryotic cells (Folkesson et al. 2002); and (v) genes involved in pilus assembly 
(ESA_03515 and ESA_03516). 
  
3.5.1.11 Fimbriae  
As the route of Cronobacter infection is probably through attachment and invasion of 
the intestinal cells, genes encoding surface appendages such as fimbriae are of interest. 
Four putative fimbriae clusters were identified in the genome of C. sakazakii BAA-
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894, some of which were mentioned previously in (Healy, Huynh et al. 2009). These 
are Cluster 1 (ESA_01970 - ESA_01976), cluster 2 (ESA_02538 – ESA_02542), 
cluster 3 (ESA_02795 – ESA_02799) and cluster 4 (ESA_04067 – ESA_04073) 
(Table 16). Analysis of the  CGH data showed that three of the four putative fimbrial 
clusters (Clusters 2, 3 and 4) were C. sakazakii specific, i.e. were classified as present 
or intermediate  in all five strains of C. sakazakii, but were absent in C. muytjensii, C. 
dublinensis, C. turicensis, and C. malonaticus. Cluster 1 was present only in the 
reference strain and in C. sakazakii strain 2, which suggests that it is strain specific 
(Table 16). According to the BLASTP analysis, the genetic content of all fimbriae 
clusters was most similar to the type I chaperone/usher-assembled pilus system as 
defined in Kline et al. (2010). Genes encoding pilin FimA, chaperone FimC and usher 
FimD have been found in all four putative fimbriae clusters. Some degree of 
homology to the remaining components necessary for type-I pilus assembly (the 
minor tip fibrillum FimG and fimbrial adhesin FimH) was found among the remaining 
genes in the fimbrial clusters; these clusters may encode complete and functional pili. 
However, there was not enough evidence for a robust annotation of genes that may 
encode FimA, FimG and FimH, as these shared at least 30% amino acid identity with 
each other and with the corresponding proteins in the model organism for the type-I 
pili, E. coli. The presence of the putative fimbriae clusters in Cronobacter species 
according to the CGH data is summarised in Table 16.
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Table 16. C. sakazakii BAA-894 fimbrial clusters and their presence in other Cronobacter strains 
Cluster  Locus tag Gene Product Csak1 Csak2 Csak20 Csak701 Csak767 Csak696 Cmal Ctur Cmuy Cdub 
 ESA_01970 Pilin FimA -1 1 -1 -1 -1 -1 -1 -1 -1 -1 
 ESA_01971 Pilin FimA -1 1 -1 -1 -1 -1 -1 -1 -1 -1 
1 ESA_01972 Pilin FimA -1 1 -1 -1 -1 -1 -1 -1 -1 -1 
 ESA_01973 Pilin FimA -1 1 -1 -1 -1 -1 -1 -1 -1 -1 
 ESA_01974 Usher FimD -1 1 -1 -1 -1 -1 -1 -1 -1 -1 
 ESA_01975 Chaperone FimC -1 0 -1 -1 -1 -1 -1 -1 -1 -1 
 ESA_01976  Pilin FimA -1 1 -1 -1 -1 -1 -1 -1 -1 -1 
 ESA_02538 Pilin FimA 1 1 1 1 1 1 -1 -1 -1 -1 
 ESA_02539 Chaperone FimC 0 1 1 0 0 1 -1 -1 -1 -1 
 ESA_02540 Usher FimD 1 1 1 1 1 1 -1 -1 -1 -1 
2 ESA_02541 Pilin FimA (FimH) 1 1 1 1 1 1 -1 -1 -1 -1 
 ESA_02542 Putative minor component FimG 1 1 1 1 1 1 -1 -1 -1 -1 
 ESA_02795 Fimbrial protein  1 1 1 1 1 1 -1 -1 -1 -1 
 ESA_02796 Pilin FimA 1 1 1 1 1 1 -1 -1 -1 -1 
3 ESA_02797 Usher FimD 1 1 1 1 1 1 -1 -1 -1 -1 
 ESA_02798 Chaperone FimC 1 1 1 1 1 1 -1 -1 -1 -1 
 ESA_02799 Putative fimbrial protein 1 1 0 0 0 0 0 -1 -1 -1 
 ESA_04067 Putative fimbrial protein 0 1 1 1 0 1 -1 -1 -1 -1 
 ESA_04068 Fimbrial protein -1 1 0 -1 -1 0 -1 -1 -1 -1 
4 ESA_04069 Fimbrial protein 0 1 1 1 1 1 -1 -1 -1 -1 
 ESA_04070 Fimbrial protein 0 1 1 1 1 1 -1 -1 -1 -1 
 ESA_04071 Usher FimD 1 1 1 1 1 1 -1 -1 -1 -1 
 ESA_04072 Chaperone FimC 1 1 1 1 1 1 0 0 -1 -1 
 ESA_04073 Fimbrial protein 0 1 1 1 1 1 -1 -1 -1 -1 
1 for presence , 0 for intermediate status and −1 for absence/divergence of a gene. Csak1 =  C. sakazakii ATCC 29544T; Csak2 = C. sakazakii ATCC 12868, Cmal = C. 
malonaticus ; Cdub = C. dublinensis; Cmuy = C. muytjensii; Ctur = C. turicensis.
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3.5.1.12 Iron uptake mechanisms  
A list of known iron assimilation mechanisms was compiled from the published 
literature and their presence  in Cronobacter strains was evaluated based on the 
available CGH data (Table 17).  
All Cronobacter strains examined by CGH possess complete operons for enterobactin 
synthesis (entABCDEFS) and enterobactin receptor and transport (fepABCDEG), 
except C. dublinensis, in which fepE is absent. All Cronobacter species except C. 
muytjensii also possess a complete operon for aerobactin synthesis iucABCD and its 
receptor iutA.  The operon for salmochelin synthesis was not present in the reference 
strain C. sakazakii BAA-894 used for the CGH and hence it was not possible to assess 
its presence in other Cronobacter strains (Table 17).  The presence of the iron uptake 
genes in the newly sequenced C. turicensis was verified by BLASTP and corresponded 
to the results obtained by CGH.  
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Table 17. Iron uptake systems and their presence in Cronobacter strains 
Gene Homolog in C. sakazakii  BAA-894 (BLASTN)Locus Tag Csak1 Csak2 Csak20 Csak701 Csak767 Csak696 Cmuy Cdub Ctur Cmal
Enterobactin synthesis - non ribosomal peptide synthesis pathway
entA 2,3-dihydroxybenzoate-2,3-dehydrogenase ESA_00799 1 1 1 1 1 1 0 1 1 1
entB hypothetical protein ESA_00798 ESA_00798 1 1 1 1 1 1 1 1 1 1
entC hypothetical protein ESA_00796 ESA_00797 0 1 0 0 0 0 1 1 1 1
entD hypothetical protein ESA_02731 ESA_02731 1 1 1 1 1 0 0 0 1 0
entE enterobactin synthase subunit E ESA_02729 0 1 0 0 1 1 0 1 1 0
entF enterobactin synthase subunit F ESA_02727 1 1 0 0 1 0 0 1 1 1
entS enterobactin exporter EntS ESA_00794 1 1 1 1 1 1 1 1 1 1
Enterobactin receptor & transporters
fepA outer membrane receptor FepA ESA_02730 1 1 1 1 1 1 1 1 1 1
fepB iron-enterobactin transporter ESA_00796 1 1 1 1 1 0 1 1 1 1
fepC hypothetical protein ESA_00791 ESA_00791 1 1 1 1 1 0 1 1 1 1
fepD iron-enterobactin transporter ESA_00793 1 1 0 0 1 0 1 1 1 1
fepE ferric enterobactin transport protein FepE ESA_00459 1 1 1 1 1 1 0 -1 0 0
fepG iron-enterobactin transporter permease ESA_00792 1 1 0 1 1 0 1 1 1 1
Salmochelin synthesis
iroB salmochelin siderophore system No match NA NA NA NA NA NA NA NA NA NA
iroC salmochelin siderophore system No match NA NA NA NA NA NA NA NA NA NA
iroD enterobactin/ferric enterobactin esterase No match NA NA NA NA NA NA NA NA NA NA
iroE IroE protein No match NA NA NA NA NA NA NA NA NA NA
iroN outer membrane receptor FepA ESA_01552 1 1 1 1 1 1 1 1 0 0
Aerobactin synthesis & receptor
iucA hypothetical protein ESA_pESA3p05547 ESA_pESA3p05547 1 1 0 0 1 1 -1 1 1 1
iucB hypothetical protein ESA_pESA3p05548 ESA_pESA3p05548 1 1 0 0 0 0 -1 1 1 1
iucC hypothetical protein ESA_pESA3p05549 ESA_pESA3p05549 0 0 0 0 0 0 -1 0 1 1
iucD hypothetical protein ESA_pESA3p05550 ESA_pESA3p05550 1 1 0 0 1 1 -1 1 1 1
iutA hypothetical protein ESA_pESA3p05551 ESA_pESA3p05551 1 1 1 1 1 1 -1 0 0 1
Other iron uptake genes
feS enterobactin/ferric enterobactin esterase No match NA NA NA NA NA NA NA NA NA NA
fhuA ferrichrome outer membrane transporter ESA_03190 1 1 1 1 1 -1 -1 1 0 1
fhuB iron-hydroxamate transporter permease ESA_03187 1 1 1 1 1 0 1 1 1 1
fhuD iron-hydroxamate transporter ESA_03188 1 1 1 1 1 1 1 1 1 1
fpvA ferrichrome outer membrane transporter No match NA NA NA NA NA NA NA NA NA NA
fur ferric uptake regulator No match NA NA NA NA NA NA NA NA NA NA
ibpA heat shock protein IbpA ESA_03960 1 1 1 1 0 1 1 1 1 1
ibpB heat shock chaperone IbpB ESA_03959 1 1 1 1 1 1 1 1 1 1  
1 for presence , 0 for intermediate status and −1 for absence/divergence of a gene. No match indicaes 
absence in the reference strain C. sakazakii BAA-894. NA = not appropriate. Csak1 =  C. sakazakii 
ATCC 29544
T
; Csak2 = C. sakazakii ATCC 12868, Cmal = C. malonaticus ; Cdub = C. dublinensis; 
Cmuy = C. muytjensii; Ctur = C. turicensis.
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3.5.1.13 Type VI secretion systems 
 
Five putative T6SS were identified in the genome of C. sakazakii BAA-894. The 
presence of the putative T6SS genes in other Cronobacter strains is summarised in 
Table 18. 
Cluster 1 (ESA_00140 – ESA_00145, GR1 as defined in  3.5.1.6.2) encodes most of 
the proteins that are conserved across different T6SS clusters (encoding a DotU 
homolog ESA_00141, Vgr homolog ESA_00142 and a putative lipoprotein from the 
VC_A0113 family ESA_00145). However, most T6SS clusters typically encode from 
12 to 25 proteins (Filloux et al. 2008) and also encode a ClpV ATPase, which was not 
found in this cluster. In some instances, the genes encoding Vgr and DotU proteins 
are located outside the main T6SS locus, and their products might cooperate with 
proteins encoded in other loci. Intrestingly, the lipoprotein ESA_00145 was detected 
in the most virulent strains C. sakazakii 701, 767 and 696, whilst the other genes from 
Cluster 1 were absent from all other Cronobacter strains. 
Cluster 2 (ESA_02035 – ESA_02041, GR9 as defined in  3.5.1.6.2) includes genes 
encoding a homolog of a Vgr-type protein (ESA_02035), lipoprotein from the 
VC_A0113 family ESA_02038 and other genes homologous to T6SS proteins.  
Cluster 3 (ESA_02735 – ESA_0240) contains genes encoding SciE-type protein 
(ESA_02736), Vgr-type protein (ESA_02739) and a protein homologous to phage gp7 
protein (ESA_02740), all of which are frequently found in T6SS clusters. However, 
this cluster is adjacent to a prophage fragment described in  3.5.1.6.1 and due to the 
sequence similarities between T6SS and prophages it is difficult to conclude whether 
this cluster is a part of a T6SS.   
Cluster 4 (ESA_03899 – ESA_03948, GR15 as defined in  3.5.1.6.2) is the longest 
and the most complete cluster of T6SS genes. Its 48 genes include all the components 
of T6SS typically conserved among different T6SS systems, such as genes encoding 
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Vgr-type proteins (ESA_03905 and ESA_03917), IcmF-type protein (ESA_03945), 
DotU-type protein (ESA_03946), ClpV ATPase (ESA_03921), SciE-type protein 
(ESA_03925), Ser/Thr protein phosphatase (ESA_03927) and Ser/Thr protein kinase 
(ESA_03920). This cluster may encode a complete and functional T6SS.   
Cluster 5 (ESA_pESA3p05491 - ESA_pESA3p05506) located on the plasmid 
pESA3 in C. sakazakii BAA-894 encodes another putative T6SS cluster encoding 
some of the conserved T6SS proteins. ESA_pESA3p05494 encodes DotU-like protein, 
ESA_pESA3p05495 encoded a protein with a C-terminal extension with similarity to 
OmpA, a protein strongly associated with virulence properties of Cronobacter (Kim 
et al. 2010, Mittal et al. 2009b, Nair et al. 2009). ESA_pESA3p05497 encodes a 
ClpV ATPase and ESA_pESA3p05500 encodes a Vgr-like protein.  
The Clusters 1 – 5 described here are putative T6SS clusters. It remains to be 
determined whether they encode functional T6SS or functional components of these. 
 
.  
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Table 18. Type VI secretion system genes and their presence in Cronobacter species. 
Locus Tag Gene Product in C. sakazakii BAA-894  Csak1  Csak2 Csak20 Csak701 Csak767 Csak696 Cmuy Cdub Ctur Cmal 
ESA_00141 DotU-like protein -1 -1 -1 -1 -1 1 -1 -1 -1 -1 
ESA_00142 type VI secretion system Vgr family protein -1 -1 -1 -1 -1 1 -1 -1 -1 -1 
ESA_00143 type VI secretion protein, VC_A0110 family -1 -1 -1 -1 -1 1 -1 -1 -1 -1 
ESA_00144 type VI secretion protein, VC_A0111 family -1 -1 -1 0 0 1 -1 -1 -1 -1 
ESA_00145 type VI secretion lipoprotein, VC_A0113 family -1 -1 -1 1 1 1 -1 -1 -1 -1 
ESA_02035 Vgr-like protein -1 -1 0 -1 -1 -1 -1 0 0 0 
ESA_02036 hypothetical protein -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 
ESA_02037 type VI secretion system Vgr family protein 0 -1 -1 -1 -1 -1 -1 0 0 -1 
ESA_02038 type VI secretion lipoprotein, VC_A0113 family 1 1 -1 -1 -1 -1 -1 0 0 -1 
ESA_02039 type VI secretion protein, VC_A0111 family 1 1 -1 -1 -1 -1 -1 0 0 -1 
ESA_02040 type VI secretion protein, VC_A0110 family 1 1 -1 -1 -1 -1 -1 0 0 -1 
ESA_02041 IcmF-related protein 1 1 -1 -1 -1 -1 -1 0 0 -1 
ESA_02735 type VI secretion system lysozyme-related protein -1 1 1 1 1 1 -1 0 0 0 
ESA_02736 type VI secretion system protein, SciE, ImpE  -1 1 1 1 1 1 -1 0 0 -1 
ESA_02737 hypothetical protein -1 1 1 1 1 1 -1 -1 0 -1 
ESA_02738 hypothetical protein, Rhs family protein -1 1 1 1 1 1 -1 0 0 -1 
ESA_02739 type VI secretion system Vgr family protein -1 1 1 -1 -1 1 -1 0 0 -1 
ESA_02740 hypothetical protein, phage gp7 homolog -1 -1 0 0 -1 -1 -1 -1 1 -1 
ESA_03899 Rhs family protein -1 -1 1 0 0 -1 1 1 1 1 
ESA_03900 hypothetical protein -1 -1 -1 -1 -1 -1 0 0 0 -1 
ESA_03902 hypothetical protein -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 
ESA_03903 Rhs family protein 0 1 1 1 1 1 1 1 1 1 
ESA_03904 hypothetical protein 1 1 1 1 1 1 1 1 1 0 
ESA_03905 type VI secretion system Vgr family protein 1 1 1 1 1 1 1 1 1 1 
ESA_03906 hypothetical protein 1 1 1 1 1 1 0 0 1 1 
ESA_03907 hypothetical protein 1 1 1 1 1 1 1 1 1 1 
ESA_03908 hypothetical protein 0 0 0 0 -1 0 -1 -1 1 1 
ESA_03909 hypothetical protein 0 0 0 -1 -1 0 -1 -1 0 1 
ESA_03910 hypothetical protein 0 1 1 0 0 -1 -1 -1 1 -1 
ESA_03911 Rhs family protein -1 1 -1 -1 -1 -1 1 1 1 -1 
ESA_03912 hypothetical protein -1 0 -1 -1 -1 -1 -1 1 -1 -1 
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Locus Tag Gene Product in C. sakazakii BAA-894  Csak1  Csak2 Csak20 Csak701 Csak767 Csak696 Cmuy Cdub Ctur Cmal 
ESA_03913 Rhs family protein 0 1 0 0 0 -1 1 1 1 -1 
ESA_03914 Ankyrin repeat 1 1 1 1 1 -1 1 0 0 -1 
ESA_03915 hypothetical protein 1 1 1 1 1 -1 1 1 1 -1 
ESA_03916 Uncharacterized protein conserved in bacteria 1 1 1 1 1 -1 1 1 1 -1 
ESA_03917 type VI secretion system Vgr family protein 1 1 1 1 1 1 1 1 1 1 
ESA_03918 Ankyrin repeat 1 1 1 1 1 1 0 0 0 0 
ESA_03919 hypothetical protein 1 1 1 1 1 1 1 1 1 0 
ESA_03920 Serine/threonine protein kinase 1 1 1 1 1 1 1 1 1 1 
ESA_03921 type VI secretion ATPase, ClpV1 family 1 1 1 1 1 1 1 1 1 1 
ESA_03922 type VI secretion protein, VC_A0111 family 1 1 1 1 1 0 1 1 1 1 
ESA_03923 type VI secretion protein, VC_A0110 family 1 1 0 1 1 0 1 1 1 1 
ESA_03924 type VI secretion system lysozyme-related protein 1 1 0 0 0 1 1 1 1 1 
ESA_03925 SciE-like type VI secretion system protein ImpE  0 1 1 1 1 1 1 1 1 1 
ESA_03926 hypothetical protein 1 1 1 1 1 1 1 1 1 1 
ESA_03927 Serine/threonine protein phosphatase 1 1 1 1 1 1 1 1 1 1 
ESA_03928 type VI secretion system FHA domain protein 1 1 1 0 1 1 1 1 1 1 
ESA_03929 hypothetical protein -1 0 1 1 1 -1 -1 -1 -1 -1 
ESA_03930 hypothetical protein -1 0 1 1 1 -1 -1 -1 -1 -1 
ESA_03932 hypothetical protein -1 0 1 0 1 -1 -1 -1 0 -1 
ESA_03933 hypothetical protein 0 -1 1 1 0 0 0 -1 1 1 
ESA_03934 type VI secretion system effector, Hcp1 family 0 1 1 1 1 1 1 1 1 1 
ESA_03935 hypothetical protein -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 
ESA_03936 hypothetical protein -1 -1 -1 -1 -1 -1 0 0 -1 -1 
ESA_03937 hypothetical protein -1 -1 -1 -1 -1 -1 0 0 0 -1 
ESA_03939 hypothetical protein 0 -1 -1 -1 -1 1 1 1 1 -1 
ESA_03940 hypothetical protein 1 1 1 1 1 1 1 1 1 1 
ESA_03941 
type VI secretion protein, EvpB/VC_A0108 
family 0 1 0 0 0 1 1 1 1 1 
ESA_03943 type VI secretion-associated protein, ImpA family 1 1 1 1 1 1 1 1 1 1 
ESA_03944 
type VI secretion-associated protein, 
BMA_A0400 family 1 1 1 1 1 1 1 1 1 1 
ESA_03945 type VI secretion protein IcmF 1 1 1 1 1 1 1 1 1 1 
ESA_03946 type VI secretion system protein, DotU family 1 1 1 1 1 1 1 1 1 1 
ESA_03947 type VI secretion protein, VC_A0114 family 1 1 1 1 1 1 1 1 1 1 
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Locus Tag Gene Product in C. sakazakii BAA-894  Csak1  Csak2 Csak20 Csak701 Csak767 Csak696 Cmuy Cdub Ctur Cmal 
ESA_03948 type VI secretion lipoprotein, VC_A0113 family 1 1 1 1 1 1 1 1 1 1 
pESA3p05491 type VI secretion protein, VC_A0107 family 0 1 1 1 1 1 -1 0 0 0 
pESA3p05492 
type VI secretion protein, EvpB/VC_A0108 
family 1 1 1 1 1 1 -1 1 1 1 
pESA3p05493 type VI secretion protein, VC_A0114 family -1 1 -1 -1 -1 1 -1 0 -1 -1 
pESA3p05494 type VI secretion system protein, DotU family -1 1 -1 -1 -1 1 -1 0 -1 -1 
pESA3p05495 
Outer membrane protein, peptidoglycan-
associated -1 1 -1 -1 -1 1 -1 -1 -1 -1 
pESA3p05496 type VI secretion system effector, Hcp1 family 1 1 -1 -1 -1 1 -1 1 1 -1 
pESA3p05497 type VI secretion ATPase, ClpV1 family -1 1 -1 -1 -1 1 -1 0 0 -1 
pESA3p05498 hypothetical protein -1 1 -1 -1 -1 0 -1 -1 -1 -1 
pESA3p05499 hypothetical protein -1 1 -1 -1 -1 1 -1 -1 -1 -1 
pESA3p05500 type VI secretion system Vgr family protein -1 1 -1 -1 -1 1 -1 -1 -1 -1 
pESA3p05503 hypothetical protein, putative lipoprotein 1 1 -1 -1 -1 1 -1 -1 -1 -1 
pESA3p05504 Uncharacterized conserved protein 1 1 -1 -1 -1 1 -1 -1 -1 -1 
pESA3p05505 hypothetical protein 1 1 -1 -1 -1 1 -1 -1 -1 -1 
pESA3p05506 type VI secretion lipoprotein, VC_A0113 family 1 1 1 1 1 1 -1 0 0 -1 
1 for presence , 0 for intermediate status and −1 for absence/divergence of a gene. Csak1 =  C. sakazakii ATCC 29544T; Csak2 = C. sakazakii ATCC 12868, Cmal = C. 
malonaticus ; Cdub = C. dublinensis; Cmuy = C. muytjensii; Ctur = C. turicensis
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3.5.1.14 Lipopolysaccharide (LPS) and O-antigen locus 
 The chemical structure of the lipo-polysaccharide in three Cronobacter species has 
been determined and shown to be compositionally and structurally different 
(MacLean et al. 2009abc, Czerwicka et al. 2010). It is therefore predictable that the 
biosynthetic pathways will vary across the genus and this has been confirmed by CGH. 
The gene cluster corresponding to the O-antigen cluster described by Mullane et al. 
(2008b) (ESA_01177–ESA_01189) was examined. The genetic architecture of the O-
antigen cluster in the sequenced C. sakazakii BAA-894 corresponds to the serotype 
O:1 as defined by Mullane and colleagues. According to our CGH data, two of the 
genes in this region, galF (ESA_01177) and rfbB (ESA_01178) are conserved among 
all Cronobacter strains tested except C. sakazakii 696, whereas the rest of the genes 
from the O-antigen locus are highly divergent; its genes were not sufficiently similar 
to be detected by microarray hybridization in any other Cronobacter strains. This 
correlates with the findings of Mullane et al. (2008b) who showed that both serotypes 
O:1 and O:2 had the two genes galF and rfbB in common, whereas the rest of the 
gene cluster content differed between the two serotypes.   
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3.5.1.15 Other virulence determinants 
In order to find other Cronobacter genes related to virulence, the UniProtKB/Swiss-
Prot (http://www.ebi.ac.uk/uniprot/database) was searched for virulence factors in the 
sequenced genomes of C. sakazakii BAA-894 and C. turicensis z3032 using the 
keyword ‘virulence’ and ‘adhesion’. The resulting hits were searched in IMG-JGI 
(http://img.jgi.doe.gov/cgi-bin/pub/main.cgi) to obtain their annotation or to identify 
their homologs in C. sakazakii BAA-894. The presence/absence of the putative 
virulence factors in other Cronobacter species and other C. sakazakii strains was 
assessed based on the CGH microarray data. The results are summarized in Table 19. 
Among the virulence-related genes, proteins involved in the T6SS, fimbriae assembly 
and belonging to the LPS and O-antigen cluster were found. These systems were 
examined in more detail earlier. The remaining virulence factors are described below.  
 
 
 
 
 
Figure 30 shows the gene map of the sequenced C. sakazakii BAA-894 with 
annotated selection of variable regions, virulence determinants and MLST loci. 
 
 ESA_02934 encodes an outer membrane autotransporter barrel domain 
involved in the type V autotransporter  pathway  implicated in virulence of 
Gram-negative bacteria (Henderson & Nataro, 2001).  
 ESA_03365 encodes a membrane protein that affects hemolysin expression 
under anaerobic conditions (Cox et al. 2000). Hemolysin expression is a 
recognised virulence factor in some pathogens, as bacteria producing 
hemolysins can inactivate immune system by lysing white blood cells.  
 ESA_02516 encodes a  haemagglutinin family N-terminal domain found in a  
variety of haemagglutinins and haemolysins.  
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 ESA_02576 encodes a pectin methylesterase which catalyses the de-
esterification of a major component of a plant cell wall, pectin, into pectate 
and methanol. It has been suggested that pathogenic bacteria may use similar 
mechanisms to invade eukaryotic cells to plant tissue invasion. 
 ESA_03608 encodes an outer membrane autotransporter barrel domain 
involved in type V secretion pathway, homologous to bacterial adhesin AidA, 
which mediates bacterial attachment to a broad spectrum of human and other 
mammalian cells in some diarrheagenic E. coli strains and other Gram-
negative bacteria. The expression of AidA was also found to dramatically 
enhance biofilm formation by E. coli on abiotic surfaces (Sherlock et al. 2004). 
 ESA_01908 encodes a putative virulence factor SrfB of unknown function 
conserved in bacteria. In Salmonella enterica, SrfB  is activated by the two-
component regulatory system SsrAB  encoded  on the Salmonella 
pathogenicity island SPI-2 (Worley et al. 2000). 
 ESA_02278 encodes an integral membrane protein MviN. In Salmonella 
enterica, deletion of mviN reduces virulence properties of the bacterium in a 
mouse model of typhoid disease and MviN is therefore considered a virulence 
factor. However, MviN is also an essential protein in many non-pathogenic 
bacteria (Carsiotis et al. 1989). 
 ESA_02216 encodes a response regulator phoP from the two-component 
signal transduction system phoP-phoQ.  The adjacent gene ESA_02217 
encodes the cognate signal transduction histidine kinase phoQ. 
 ESA_00878 encodes a surface lipoprotein VacJ. In Shigella flexneri, VacJ is 
required for the intercellular spreading of the pathogen (Suzuki et al. 1994). 
  ESA_03350 encodes a protein involved in polysaccharide export. The 
homolog of this protein was found in the E. coli K-12 gene cluster responsible 
for production of the extracellular polysaccharide colanic acid which may be 
implicated in virulence (Stevenson et al. 1996). 
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 ESA_00102 encodes a putative hemolysin activation/secretion protein HlyA 
that is secreted across both the cytoplasmic and outer membranes of Gram-
negative bacteria. 
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Table 19. Putative virulence factors in C. sakazakii BAA-894 and their presence in other Cronobacter strains 
Locus tag Gene Product Csak1 Csak2 Csak20 Csak701 Csak767 Csak696 Cmuy Cdub Ctur Cmal 
ESA_00102  Putative hemolysin activation/secretion protein HlyA 1 1 1 1 1 1 0 0 0 0 
ESA_00115 Redox-sensitive transcriptional activator SoxR  -1 1 1 1 1 1 1 1 1 1 
ESA_00116 Glutathione S-transferase  -1 1 1 1 1 1 0 1 1 0 
ESA_00614–17  Restriction endonucleases   -1 -1 -1 1 1 -1 -1 -1 -1 -1 
ESA_00878  VacJ,  intercellular spreading of Shigella flexneri 1 1 1 1 1 1 1 1 1 1 
ESA_00983–86 Putative adhesins -1 -1 1 1 1 1 -1 -1 -1 -1 
ESA_00997  eae-like adhesion protein, attaching and effacing -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 
ESA_01116 –19 ABC-type multidrug efflux system 0 0 1 0 1 1 -1 -1 -1 -1 
ESA_01908  Putative virulence factor SrfB  1 1 1 1 1 1 1 1 1 1 
ESA_01938 TetR family, hydrophobic antibiotics and detergents -1 1 1 1 1 1 0 0 1 1 
ESA_01940 Cationic drug transporter  -1 1 1 1 0 1 0 0 0 1 
ESA_01944–46 ABC-transport system  -1 1 1 1 1 1 1 1 1 1 
ESA_01955 Universal stress protein UspA  -1 1 1 1 1 1 -1 -1 -1 -1 
ESA_02129  Ecotin 0 0 0 0 0 1 1 1 1 1 
ESA_02216  Regulator  phoP 1 0 1 0 0 1 1 1 1 0 
ESA_02217  Signal transduction histidine kinase phoQ 1 1 1 1 1 1 1 1 1 1 
ESA_02278  Integral membrane protein MviN 1 1 1 1 1 1 -1 -1 0 -1 
ESA_02516  Haemagglutinin family N-terminal domain 1 1 1 1 1 1 -1 1 1 1 
ESA_02549 – 53 ABC multidrug transport system 1 1 1 0 0 1 1 1 1 1 
ESA_02576  Pectin methylesterase 0 1 0 1 1 1 -1 0 0 0 
ESA_02934  Outer membrane autotransporter barrel domain  1 1 1 1 1 1 0 1 0 0 
ESA_03350  Protein involved in polysaccharide export 1 1 1 1 1 1 0 1 0 1 
ESA_03365  Membrane protein affecting hemolysin expression  1 1 1 1 1 1 1 1 1 1 
ESA_03608  Outer membrane autotransporter barrel domain  1 1 1 1 1 1 0 0 0 0 
ESA_04238 - 42 Copper uptake CusABCFR 1 -1 -1 1 1 1 -1 -1 1 1 
ESA_04248–55 Copper resistance 1 -1 -1 -1 -1 1 -1 -1 1 1 
ESA_pESA3p05435 CpmG protein involved in carbapenem resistance -1 1 1 1 1 0 -1 0 0 1 
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Locus tag Gene Product Csak1 Csak2 Csak20 Csak701 Csak767 Csak696 Cmuy Cdub Ctur Cmal 
ESA_pESA3p05439 Mig-14 (resistance to antimicrobials) -1 1 1 1 1 0 -1 -1 0 -1 
ESA_pESA3p05446 
ADP-ribose pyrophosphatase ,  oxidative stress 
protection  -1 1 1 1 1 0 -1 -1 0 0 
ESA_pESA3p05448 Transcriptional regulator, tetracycline resistance -1 1 1 1 1 1 -1 0 1 1 
ESA_pESA3p05463 
Predicted transcriptional regulator involved in 
mercurium resistance  -1 1 1 1 1 1 -1 0 1 0 
ESA_pESA3p05485 Arsenate reductase  -1 1 1 1 1 1 -1 -1 1 0 
1 for presence , 0 for intermediate status and −1 for absence/divergence of a gene. Csak1 =  C. sakazakii ATCC 29544T; Csak2 = C. sakazakii ATCC 12868, Cmal = C. 
malonaticus ; Cdub = C. dublinensis; Cmuy = C. muytjensii; Ctur = C.turicensis. 
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Figure 30. Gene atlas of C. sakazakii 
BAA-894 with selected annotated 
regions (prophages, T6SS, fimbrial 
clusters, LPS locus, MLST loci, 
other virulence determinants). The 
gene atlas was obtained at 
(http://rast.nmpdr.org/rast.cgi). 
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3.5.2 Construction of Cronobacter mutants‎ via‎ “Gene‎
Doctoring”‎recombineering‎method 
3.5.2.1 Choice of strains and genes 
In a study examining the genes involved in bacterial meningitis, ibeB was identified 
as a gene required for E. coli K1 invasion of the blood-brain barrier (Huang et al. 
1999). It was shown that the ibeB deletion mutant had <1% of  the invasive ability of 
the wild-type in vitro and also showed significantly decreased invasivity in the in vivo 
model of E. coli meningitis compared to the wild-type strain. The cloning of ibeB 
back into the deletion mutant completely restored the invasive ability of the strain. 
BLASTP analysis showed that the protein IbeB was homologous (72% sequence 
identity, 99% query coverage) to the CusC protein from the copper and silver 
resistance cation efflux system in C. sakazakii BAA-894. Microarray data showed that 
the complete copper efflux system cusCFBA (ESA_04239 – ESA_04242) and its 
regulatory genes cusR (ESA_04238) and cusS (ESA_04237) were present in strains 
associated with neonatal infections (C. sakazakii ATCC 29544
T
, 701, 767, 696, C. 
turicensis and C. malonaticus), and absent in all other tested strains, which had no 
association with clinical cases of Cronobacter-induced illness. These findings make 
the genes belonging to the copper resistance operon strong candidates for virulence 
determinants contributing to the invasiveness of Cronobacter, but this hypothesis 
needs to be verified.  
To investigate whether cusC and other genes from the copper resistance operon have 
an effect on human brain microvascular endothelial cells invasion by Cronobacter, 
targeted gene deletion via the lambda-Red method described in  3.4.2 was attempted.  
Genes cusA, cusB and cusC were chosen for the first round of the gene deletions. 
CusA (3.2 kb) encodes an integral membrane proton-driven transporter, which forms a 
two-channel pump for the export of metal ions and concurrent import of protons 
(Munson et al. 2000), cusB (1.3 kb) encodes a membrane fusion protein (Saier et al. 
1994) and cusC (1.4 kb) encodes an outer membrane factor (Dinh et al. 1994).   
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3.5.2.2 Construction of cusA, cusB and cusC deletion mutants via the 
“gene‎doctoring”‎method  
 
The sequenced strain C. sakazakii BAA-894 and one of the most virulent strains of 
our collection associated with a fatal meningitis case, C. sakazakii 767 (Caubilla-
Barron et al. 2007), were chosen as target organisms for the gene deletions. These 
strains were tested for antibiotic sensitivity by plating on LB plates containing 35 
µg/ml chloramphenicol, 50 µg/ml kanamycin or 200 µg/ml ampicillin. Both strains 
were susceptible to all three antibiotics at this concentration. The same Cronobacter 
strains were tested for growth on LB plates containing 5 and 10 % (w/v) sucrose. All 
Cronobacter strains were able to grow at these concentrations of sucrose.  The 
kanamycin cassette was amplified by PCR from pDOC-K ( 3.4.2.3) using primers 
containing regions homologous to the extremities of the kanamycin cassette and the 
DNA flanking the genes cusA, cusB and cusC. The PCR yielded the expected 1.4 kb 
products (Figure 31), which were then purified as described in  3.4.2.5. 
 
 
Figure 31. PCR amplification of the 1.4-kb kanamycin cassette from pDOC-K using 
primers specified in  3.4.2.3.  
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The linearization of pDOC was verified by gel electrophoresis ( 3.4.2.4). The 
linearized plasmid travelled more slowly in the gel than the supercoiled closed 
circular complex (CCC) uncut plasmid and appeared to have a greater size, as shown 
on Figure 32. Note that a supercoiled marker was not used and the 1-kb DNA ladder 
was used to illustrate the difference in the conformation of the plasmid.  
 
 
Figure 32. Digestion of pDOC  with EcoRV.  
 
The kanamycin cassette flanked by regions homologous to the DNA adjacent to the 
genes of interest was cloned into pDOC linearized by EcoRV as described in  3.4.2.7 
and the success of the cloning was verified by PCR using the primers annealing to the 
DNA flanking the multicloning site in pDOC as detailed in  3.4.2.8. The empty vector 
would give product of ca 200 bp, whereas the vector with the insert would give a 
product of 1.6 kb (Figure 33). The first cloning attempts were unsuccessful, with 
ampicillin and kanamycin resistant transformants yielding no PCR products when 
screened using primers pDEXF and pDEXR. It was concluded that one of the possible 
problems might be degradation of ATP in the ligase buffer.  When the ligase buffer 
6.5 kb 
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was replaced by buffer with added ATP, faint bands were visible for all cloned 
products. The manufacturer of T4 DNA ligase (Promega) recommends ligation at 15-
20
o
C for 4-18 hours for blunt end products. However, incubation at 10
o
C significantly 
improved the yield of the ligation reaction. Using this modified protocol, higher 
quantities of the cloned products were obtained (Figure 33). 
 
Figure 33.  PCR verification of cloning of kanamycin cassette into pDOC. 
 
 To amplify the required quantity of the plasmid constructs, chemically competent 
One Shot Top 10 E. coli cells were transformed with the pDOC plasmid carrying the 
kanamycin cassette flanked by the short DNA sequences homologous to regions 
upstream and downstream of the genes to be knocked out, as described in  3.4.2.9. 
Plasmid DNA was isolated from the transformed cell cultures ( 3.4.2.2). 
Electrocompetent Cronobacter cells prepared according to ( 3.4.2.10) were 
transformed with the recombineering plasmid, pACBSRSceIV, and subsequently, the 
Cronobacter cells carrying pACBSRSceIV were made electrocompetent using the 
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same protocol and transformed with the pDOC donor construct created in  3.4.2.7, 
carrying regions of homology flanking genes cusA, cusB and cusC.  
Cronobacter colonies carrying the recombineering plasmid pACBSRSceIV and the 
donor plasmid were checked for sucrose sensitivity and ampicillin resistance; all 
colonies were sensitive to sucrose and ampicillin resistant. Those selected isolates 
were grown in the presence of arabinose ( 3.4.2.12) to induce homologous 
recombination. 
After arabinose induction, the mutants were plated on kanamycin and ampicillin LB 
agar plates. True mutants should acquire kanamycin resistance by homologous 
recombination with the donor plasmid at the desired loci, and become ampicillin 
sensitive due to loss of the donor plasmid pDOC. However, virtually all screened 
mutants retained ampicillin resistance, indicating that no donor plasmid loss occurred. 
In order to screen Cronobacter colonies for recombination events at the desired loci, 
PCR primers annealing to the sites adjacent to the regions used for generating the 
kanamycin cassette PCR construct were used ( 3.4.2.13). A PCR reaction with such 
primers will amplify a product corresponding to the wild-type gene, whereas PCR on 
a mutant with a deletion in a particular gene will amplify a product corresponding to 
the replacement of the gene with the kanamycin cassette. However, the control PCR 
yielded only the products expected in wild-type strains (3.2 kb for cusA, 1.2 kb for 
cusB and cusC).  
Similar problems were encountered by the team of external supervisor Dr. Hobman 
using this strategy. Dr. Hobman recommended using the pACBSR plasmid used by 
(Herring et al. 2003) which does not carry the I-Sce recognition site and is therefore 
not self-cleaving, instead of the pACBSRSceIV plasmid. The protocol was repeated 
using the plasmid pACBSR. Electrocompetent Cronobacter cells were transformed 
with pACBSR and subsequently with the pDOC donor construct created in  3.4.2.7. 
Prior to arabinose induction, colonies were checked for sucrose sensitivity and 
ampicillin resistance; all colonies were sensitive to sucrose and ampicillin resistant. 
After arabinose induction, the transformants were plated on to kanamycin and 
ampicillin LB agar plates. The vast majority of the transformants were again both 
ampicillin and kanamycin resistant, indicating that the donor plasmid had not been 
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lost, and kanamycin resistance probably originated from the kanamycin cassette on 
the donor plasmid. Some of the transformant colonies were screened by the PCR as 
described in  3.4.2.13. Typically, 50 colonies for each gene deletion were screened in 
each round of experiment, but the results were negative. The arabinose induction was 
repeated, but with the same negative results.  
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4. DISCUSSION 
4.1. Comparative genomic hybridisation method 
Whole-genome sequencing information is usually only available for a relatively 
limited number of bacteria and to date (Oct 2010), 1344 bacterial genomes have been 
sequenced. Comparative genomic hybridization (CGH) is a useful alternative to 
sequencing that can be used to study sequence variation at the strain and species level. 
With respect to Cronobacter, only Cronobacter sakazakii BAA-894 had been 
sequenced when this project was designed; another sequence of C. turicensis z3032 
became available after the completion of this project, in September 2009. In fact, the 
Cronobacter CGH microarray was designed only shortly after the taxonomic 
reclassification of “Enterobacter sakazakii” in 2008. Not only does our study present 
the first whole-genome analysis of all five known Cronobacter species; it is also one 
of the first steps towards studying virulence associated traits of this opportunistic 
pathogen in the context of whole genomes of diverse Cronobacter species.  
The analysis of microarray CGH data is not a straightforward matter and is further 
complicated by the total lack of a standardised method for analysis of such data. The 
literature is dominated by methods designed for microarray expression analysis, and 
so are the software tools available. The most widely used application of CGH is copy-
number variation analysis in eukaryotic cells, which is conceptually different from 
bacterial CGH analysis, and most CGH software tools are therefore inappropriate for 
microbial genome comparisons. It is not uncommon that research groups develop 
their own statistical tools for CGH data analysis to overcome this problem. The three 
main stumbling blocks of CGH analysis are: i) choice of software that would 
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conveniently manage large data for hundreds of thousands of probes and facilitate 
conversion between different data formats, ii) choice of software that would 
summarize probe intensity data for each gene, and iii) choice of method and software 
to determine “cut-off” values that would separate absent or highly divergent genes 
from present genes. It is now widely accepted that the empirically determined 
“constant” or “naive” cut-offs used in the early days of bacterial CGH are not 
appropriate, especially if less phylogenetically related strains are used.  
As it is difficult to infer the relationship between sequence identity and hybridisation 
signal, the accuracy of classification of genes into present/absent categories will 
always depend on the choice of the cut-off determination method. It is inevitable that 
a dataset of several thousand genes will contain a number of false-positive and false-
negative results. The dynamic cut-off determination method GACK (Genomotyping 
Analysis by Charles Kim, Kim et al. 2002) chosen for our CGH data analysis 
overcomes the problem of constant cut-offs by assigning two cut-off values for each 
individual hybridisation, based on statistical parameters of the hybridisation 
distribution. These cut-offs mark the transition from the absent to intermediate and 
from intermediate to present categories. Our interpretation of the trinary system is that 
genes classified as absent or present are classified with high accuracy, whereas genes 
in the intermediate category are genes with a degree of sequence divergence that 
could not be assigned a status with high accuracy. By opting for GACK and the 
trinary classification which includes an “intermediate” gene category, we attempted to 
minimise the number of falsely assigned genes. The GACK method was criticised by 
some authors for introducing complacency by creating a third category of genes with 
not enough evidence to decide (Carter et al. 2008). We believe, however, that this 
method was extremely useful for our CGH experiment involving a diverse bacterial 
population that included  five different Cronobacter species.   
Excluding our study, there has not been published any whole-genome comparative 
study examining Cronobacter spp. using the microarray technology. However, 
microarray-based comparative genome indexing (CGI) with an array covering 10%  
of the C. sakazakii BAA-894 genome (276 CDS) was used to compare 78 
Cronobacter isolates obtained from food, environmental and clinical sources (Healy 
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et al. 2009). The authors used constant cut-offs for classification of Cronobacter 
genes and trinary classification of genes into present/unknown/absent categories.   
 
4.2. Bacterial species, genome plasticity and mobile 
genetic elements 
The CGH data distribution confirmed the taxonomic revision of Cronobacter spp. 
which separated the organisms into five different species (Iversen et al. 2008). C. 
turicensis LMG 23827
T
, C. malonaticus LMG 23826
T
, C. dublinensis LMG 23823
T
 
and C. muytjensii ATCC 51329
T
  clearly displayed a greater level of sequence 
divergence from C. sakazakii BAA-894 compared to the other strains classified as C. 
sakazakii species, which was in accordance with the DNA-DNA hybridization data 
presented by Iversen et al. (2008). Of the 4,382 unique annotated gene sequences 
represented on the microarray 43.3% (1,899) were classified as present in all ten 
Cronobacter strains including five Cronobacter species, and represented the core 
genome defined by the most stringent criteria.  The majority of these genes are 
predicted to encode cellular essential functions such as energy metabolism, 
biosynthesis, DNA, RNA and protein synthesis, cell division and membrane transport. 
80.9% (3,547) genes were classified as present or intermediate in all strains. In a 
microarray-based comparative genome indexing study by Healy et al. (2009), the 
authors reported that 72.5% (200/276) of the CDS represented on the microarray were 
present in all Cronobacter and defined a core set of Cronobacter genes. The species 
core gene set of 72.5% is indeed consistent with the generally accepted notion that 
members of the same bacterial species should share at least 70% of their genome 
content (Stackebrandt et al. 2002). However, the value obtained by Healy and 
colleagues does strictly depend on the choice of the 10% of the genome content used 
for the CGI study, as well as the choice of the constant cut-offs used for classification 
of the genes.   
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Whole-genome clustering based on the gene category assignment by GACK 
correlates with the taxonomic reclassification of Cronobacter proposed by Iversen et 
al. (2008). Cronobacter strains formed two distinct phylogenetic clusters, with all C. 
sakazakii strains clustering together, and all other Cronobacter species C. malonaticus, 
C. turicensis, C. dublinensis and C. malonaticus forming a second cluster. Within the 
C. sakazakii cluster, strains 701 and 767 were the most closely related and clustered 
together with strain 20. Previously, strains 701 and 767 were shown to belong to the 
same pulsed-field gel electrophoresis restriction digestion type (Caubilla-Barron et al. 
2007). Although the clinical details of the source of C. sakazakii strain 20 are 
unknown, the strain belongs to MLST sequence type 4 (as do 701 and 767), which is a 
stable clone of C. sakazakii isolated from both powdered infant formula and clinical 
sources (Baldwin et al. 2009). C. sakazakii strain ATCC 29544
T
 (species type strain) 
formed a separate branch within the C. sakazakii cluster. This correlated well with our 
in-house observations of different growth and heat resistance behaviour of this strain 
compared to other C. sakazakii strains. In future, using more strains of each species, 
as well as using representatives of diverse origin would be advantageous. Our results 
also correlated well with the clustering based on the CGI analysis by Healy et al. 
(2009) who showed that the C. sakazakii strains formed a large cluster, separate from 
the other Cronobacter species. However, Healy and colleagues reported that three 
strains identified as C. malonaticus based on phenotypic criteria described in Iversen 
et al. (2008) clustered together with the C. sakazakii strains, which shows the close 
genetic relatedness of C. sakazakii and C. malonaticus that may causes difficulties in 
distinguishing between these two species, or potentially the danger of 
misclassification of C. sakazakii/C. malonaticus by the current phenotypic criteria. 
There are defined criteria to distinguish between bacterial species, such as 70% 
threshold of DNA–DNA relatedness and the requirement that each species have a 
distinct phenotype that would allow its differentiation (Stackebrandt et al. 2002). 
However, no theoretical framework that would define species as phylogenetic entities 
that would truthfully reflect the bacterial diversity exists (Rossello-Mora & Amann 
2001, Konstantinidis et al. 2006). As formulated by Staley (2009) the current 
definition of species has several drawbacks, such as its dependence on an artificial 
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threshold that has been defined based on phenotypic properties, the fact that it does 
not take evolutionary concepts into account, and its dependence on a single type strain 
that may undergo mutational modification during passaging. Classification of 
bacterial species is further complicated by the vast amount of mobile DNA present in 
bacterial genomes, which blurs the species concept and makes it challenging to 
understand the evolutionary relationship between strains and species.  The CGH 
analysis revealed that a significant part of the variable gene pool of Cronobacter was 
due to gene acquisition via mobile DNA elements.  Typing of such mobile elements, 
or islands, which frequently encode virulence determinants, might be in fact more 
important than trying to identify different species of Cronobacter.   
Extensive genomic diversity and genomic plasticity is not uncommon among both 
Gram-negative and Gram-positive bacteria and other CGH studies examining the 
diversity of a particular species or genus report similar results to our study. Previous 
studies examining the genomes E. coli and Salmonella suggest that gene acquisition 
and gene loss play a major role in the evolution of the  bacterial genomes (McClelland 
et al. 2000, Anjum et al. 2003). A comparative genomics study of pathogenic S. 
aureus strains revealed that ca 22% of the genome was composed of accessory genes, 
which were grouped in large chromosomal regions of difference, were often 
associated with phage genes, integrases or transposases, and most of them contained 
putative virulence factors.  Dorrell et al. (2001) observed that at least 21% of the 
genes present in the sequenced C. jejuni strain appeared dispensable in other C. jejuni 
strains tested by CGH.  
The CGH data also revealed a surprising genetic diversity among the strains of the 
same species, C. sakazakii. An interesting observation made by Konstantinidis & 
Tiedje (2004) was that organisms with larger genomes tend to show larger intra-
species genomic differences compared to bacteria with smaller genomes. The authors 
hypothesized that species with larger genomes are more metabolically versatile and 
therefore able to exploit a larger number of niches, which in turn shapes the content of 
the organisms’ genomes. This is certainly true for C. sakazakii, which is an ubiquitous 
organism successfully colonising various different environments, from water, soil, 
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plant material, foods, herbs and spices, to insects and larvae, livestock and finally, 
human hosts. 
Fifteen clusters of “accessory” genes that were present in less than half of the 
Cronobacter strains were identified.  At least five of these regions were of putative 
prophage origin and included potentially active prophages, as well as putative 
prophage fragments. The variable genomic regions also included: i) four T6SS gene 
clusters, ii) the O-antigen gene locus used for serotyping of Cronobacter (Mullane et 
al. 2008b), iii) a tellurite resistance cluster, iv) a fimbriae cluster, v) a copper 
resistance cluster, vi) regions with hypothetical proteins or uncharacterised conserved 
proteins with no homologs with known function. Some of these “accessory” regions 
have probably been acquired by HGT. For example, the tellurite cluster was entirely 
absent from all other Cronobacter strains except the sequenced strain, but was found 
to be carried on plasmid pK29 of Klebsiella pneumoniae strain NK29, plasmid pEC-
IMPQ of Enterobacter cloacae, plasmid R478 of Serratia marcescens and plasmid 
pAPEC-O1-R of Escherichia coli. Moreover, the cluster encoded two putative 
transposases, which is further evidence of horizontal gene transfer. The sequenced C. 
sakazakii strain probably acquired the tellurite resistance cluster via a plasmid 
integration.  
According to Staley (2009) “the bacterial species are in a state of dynamic genetic 
flux”.  Bacteria must be well adapted to the lifestyle in their niche, but at the same 
time, be equipped to move into another niche should the conditions change (Staley 
2009). This means that genomes that readily undergo modifications such as gene 
acquisition and gene loss resulting in new combinations of genes and potentially new 
metabolic capabilities or increased fitness have a considerable advantage in rapidly 
changing environments. In whole genome alignments, the vast majority of the non-
homologous sequences are typically attributed to mobile DNA that includes 
integrative plasmids, transposons and prophages (Canchaya et al. 2004). This 
highlights the importance of genome plasticity in general, and the genetic mechanisms 
underlying it, for the survival and propagation of bacterial species.  
With the advent of genome sequencing and comparative genomics, the role of mobile 
genome elements (MGE) in the plasticity of bacterial genomes has been highlighted, 
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and it has been accepted that MGEs have more importance in evolution than 
previously acknowledged. Action of MGEs like conjugative plasmids or prophages 
can indeed turn a harmless bacterium into a deadly pathogen, as in the cases of 
cholera (Karaolis et al. 1999) and diphtheria (Uchida et al. 1971, Karaolis et al. 1999). 
While the role of MGE in genome plasticity is undisputable, the contribution of 
horizontal and vertical elements in evolution of bacteria is the subject of vivid 
scientific debate.   It is likely that on a shorter timescale of years and decades needed 
for emergence of hyper-virulent epidemic strains, HGT has much more impact on the 
evolution of pathogenicity than vertical evolution, which operates on a longer time-
scale. 
 
4.3. Virulence factors in the variable genomic regions 
and other virulence determinants 
The abundance of putative and proven virulence factors in the accessory genomic 
elements has been well documented. Proteases, adherence proteins, iron uptake, 
intracellular survival, capsule formation, antiphagocytic genes, as well as type III, IV 
and VI secretion system genes are frequently associated with these regions (Ho Sui et 
al. 2009). Type III and IV secretion systems, toxins and adherence factors including 
the corresponding effector proteins have been found to be over-represented  in 
genomic islands (Ho Sui et al. 2009). Virulence factors associated with variable 
genomic regions are important targets for typing of virulent strains, as well as 
hotspots of genome plasticity that can clarify the mechanisms pathogenesis of a 
particular bacterium.  Most of the described accessory regions contain suspected or 
proven virulence factors. The genes in GR1, GR9 and GR15 are involved in a type VI 
secretion system, a newly described mechanism for protein transport across the cell 
envelope of Gram-negative bacteria that can increase adherence to epithelial cells 
(Schlieker et al. 2005, Mougous et al. 2006). GR3 contains four genes (ESA_00614–
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ESA_00617) that are homologous to a restriction-modification gene cluster (api49–
api52) in the Yersinia pseudotuberculosis pathogenicity island (YAPI) (Collyn et al. 
2004). As these genes were present in Cronobacter strains 701 and 767 isolated from 
two neonates that died as a result of infection by Cronobacter during an outbreak in 
France (Caubilla-Barron et al. 2007) and are absent in all other strains tested by CGH, 
these genes may be important virulence factors contributing to the pathogenicity of 
Cronobacter.  
Bacterial lipopolysaccharide (LPS) is a conserved structure essential for virtually all 
Gram-negative organisms playing an important role in the activation of the innate 
immune system. Consequently, the structure and and biosynthesis of LPS has been a 
focus of intense research. Characterisation of LPS structure and consequently O-
antigen can be important in developing identification schemes based on serotyping. 
Overall, the biochemical synthesis of lipid A is a highly conserved process; however, 
investigation of the lipid A structures of various organisms shows an impressive 
amount of variation. The LPS is one of the few structural features of Cronobacter 
which has been investigated and it is known that it varies across the Cronobacter spp. 
In C. sakazakii and C. malonaticus, the LPS are composed of various branched 
polymers, whereas they are unbranched in C. muytjensii. In C. sakazakii BAA-894 
(MacLean et al. 2009a) LPS is a branched polymer of pentasaccharide units, in C. 
sakazakii strain 767 it is also a branched polymer but of a repeating heptasaccharides 
(Czerwicka et al. 2010). In C. malonaticus LPS is also a branched pentasaccharide 
unit (MacLean et al. 2009c) whereas in C. muytjensii LPS is a linear unbranched 
pentasccharide polymer (MacLean et al. 2009b).  These considerable differences 
correspond with the lack of sequence conservation in GR5 as revealed in the 
microarray analysis. The individual genes encoding these differences in enzymology 
have yet to be assigned. The CGH analysis identified the region GR 5 (ESA_01179–
ESA_01189) encoding the O-antigen and lipopolysaccharide (LPS) rfb gene cluster as 
one of the regions that varied significantly between Cronobacter strains.  The genetic 
architecture of the O-antigen cluster in the sequenced C. sakazakii strain corresponds 
to the serotype O:1 as defined by (Mullane et al. 2008b). According to our CGH data 
genes galF (ESA_01177) and rfbB (ESA_01178) are conserved among all 
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Cronobacter strains, whereas the rest of the genes from the O-antigen locus are highly 
divergent. This correlates with the findings of Mullane and colleagues, who showed 
that both serotypes O:1 and O:2 had the two genes galF and rfbB in common, whereas 
the rest of the genetic content differed between the two serotypes. As the genes 
located in the variable regions of the rfb cluster were predicted to encode 
glycosyltransferases and sugar modifying enzymes, the genetic heterogeneity of this 
cluster may cause the variations in the LPS structure of Cronobacter strains.   
Homologues of genes required for the processing and assembly of the O-antigen from 
O-subunits, wzy (ESA_01185) and wzx (ESA_01183) were found in the sequenced C. 
sakazakii BAA-894 but were not classified as present in any other Cronobacter 
strains including five C. sakazakii strains according to our CGH data.  Conversely, 
Healy et al. (2009) reported that 23/60 C. sakazakii strains shared the wzy and wzx 
genes. The difference in the results might be simply due to the fact that a limited 
collection of C. sakazakii strains was used in our study compared to Healy et al. 
(2009). Also, as it is known that the genes involved in the O-antigen synthesis are 
highly variable between strains and species, but the general structure of the O-antigen 
is conserved between Gram-negative bacteria, the variability in the presence of wzy 
and wzx might be a result of the gene sequence divergence rather than of the gene 
absence. Mullane et al. (2008b) suggested that the wehC and wehI loci are 
polymorphic and specific to the serotypes O:1 and O:2, respectively. A homolog of 
wehI was not found in C. sakazakii BAA-894 (O:1) which is in line with the finding 
of (Mullane et al. 2008b)  that this locus is specific to serotype O:1. However, despite 
the fact that Mullane suggested using the wehC locus for distinguishing between the 
two serotypes O:1 and O:2, a homolog of wehC was not found in C. sakazakii BAA-
894 by BLASTP, only a protein with a match on  33% of the length (ESA_01187) 
was found. Because of the key role of the LPS in pathologenesis of Cronobacter 
disease, further examination of the LPS biosynthetic genes in a diverse population of 
Cronobacter strains and species is warranted.  
 
Type VI secretion systems (T6SS) are  recently described secretion systems in 
bacteria. Although T6SS are implicated in bacterial virulence, they do not correspond 
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to the classical definition of virulence factors, as they may be equally present in 
commensal non-pathogenic organisms. Five putative T6SS clusters were identified in 
the genome of C. sakazakii BAA-894 with complex patterns of presence in other 
Cronobacter strains. The longest and most complete cluster 4 of 48 genes 
(ESA_03899 – ESA_03948) encodes all the components of T6SS typically conserved 
among different T6SS systems. Interestingly, ESA_pESA3p05494 from cluster 5 
encodes DotU-like protein with a C-terminal extension with similarity to OmpA, a 
protein strongly associated with virulence properties of Cronobacter (Mittal et al. 
2009b, Nair et al. 2009, Kim et al. 2010). It is also of interest that the lipoprotein 
ESA_00145 from Cluster 1 was detected in the most virulent strains C. sakazakii 701, 
767 and 696, whilst the other genes from Cluster 1 were absent from all other 
Cronobacter strains. It would be highly speculative to make any conclusions about the 
functionality of the putative T6SS clusters in Cronobacter based on the sequence and 
CGH data alone. In other bacteria T6SS involve different genomic organisation and 
various combinations of genes. No consensus in the model for the assembly of the 
T6SS has been defined yet and very little is known about the protein interactions of 
the various components of the system (Cascales 2008, Filloux et al. 2008). The 
experimental study of T6SS is challenging, as T6SS genes are usually not induced in 
laboratory conditions and upregulation of most T6SS genes clusters depends on 
contact with the host cell or growth inside the host cell. 
An interesting theory states that the variability in composition and sequence of T6SS 
is due to their specialisation for different purposes and different cellular targets. Many 
of the bacterial species with multiple T6SS clusters that are not paralogous, have 
multiple hosts or diverse environments (Jani & Cotter 2010). The presence of diverse 
T6SS loci in Cronobacter would be in line with the organism’s ubiquitous presence, 
and its lifestyle adapted to survival in many different plant and animal species, 
including humans. Some evidence also suggests that T6SS can limit bacterial 
replication of virulence by changing the state of virulence to commensal or 
mutualistic relationship. It seems that in Salmonella, T6SS induction limits the 
bacterial load in host cells and intracellular replication, which leads to bacterial 
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persistence rather than macrophage death and damage to the host (Parsons & Heffron 
2005). It would be extremely interesting to obtain similar data for Cronobacter. 
 
As the route of infection is probably through attachment and invasion of the intestinal 
cells by Cronobacter, surface appendages such as fimbriae are of interest. There is 
some evidence of fimbriae production in Cronobacter, although this important 
virulence trait has not been studied extensively. Adegbola & Old (1983) reported 
production of a mannose-sensitive hemagglutinin associated with type I fimbriae and 
presence of fimbriae in two strains (n=4) Cronobacter. By combining the CGH 
analysis with searching for known genes associated with fimbriae assembly, we 
identified four putative type I chaperone-usher fimbriae clusters in the genome of C. 
sakazakii BAA-894. Three of the four putative fimbrial clusters (Cluster 2, 3 and 4) 
were specific to C. sakazakii strains, and genes belonging to Cluster 1 were only 
present in 1/6 C. sakazakii strains. None of the putative fimbrial genes were detected 
in the other Cronobacter species. This suggests that there is considerable intra- and 
inter-species variability of fimbrial operons, which may account for some differences 
in attachment of Cronobacter to eukaryotic targets. Our results were in accordance 
with the results of Healy et al. (2009) who reported that Cluster 2 and two genes 
ESA_04070 and ESA_04071 from Cluster 4 were only present in C. sakazakii isolates, 
and that genes ESA_01970 and ESA_01976 from Cluster 1 were only present in  
14/60 C. sakazakii strains. Similar to our study, in several microarray genomic 
comparisons of Salmonella strains, a great degree of variation was observed for 
fimbrial operons, phage genomes and pathogenicity islands (Porwollik et al. 2004, 
Anjum et al. 2005, Scaria et al. 2008). There was not enough evidence for a robust 
annotation of all components of functional type-I fimbriae.  This is because the 
proteins FimA, FimG and FimH shared at least 30% amino acid identity with each 
other and with the corresponding proteins in the model organism for the type-I pili, E. 
coli. Hence we can only speculate whether the putative fimbrial clusters encode for a  
complete set of proteins necessary for functional fimbriae. The presence of functional 
fimbriae in Cronobacter as well as their involvement in attachment and invasion of 
human brain cells needs to be investigated experimentally. 
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The ability of bacteria to sequester copper from the environment and to tightly 
regulate copper homeostasis due to the high toxicity of free copper has been 
recognised. It has been proposed that copper efflux is critical for virulence in some 
pathogenic strains of E. coli, but very little is still known about the role of copper 
uptake systems in pathogenicity. The CGH microarray data highlighted two clusters 
of genes related to copper resistance in the Cronobacter genomes. Firstly, the copper 
and silver resistance efflux system cusCFBA and its regulatory two-component signal 
transduction system cusRS. These were present in strains associated with neonatal 
infections (C. sakazakii ATCC 29544
T
, 701, 767, 696, C. turicensis and C. 
malonaticus), and absent in the other tested strains, which had no association with 
clinical cases of Cronobacter-induced illness.  CusC was found to be homologous  to 
a gene ibeB required for invasion of the blood-brain barrier in E. coli K1 (Huang et al. 
1999), which made cusC and potentially the whole cus operon strong candidates for 
virulence factors implicated in meningitis. Secondly, the putative cop operon was 
identified as one of the genomic regions absent in more than half of the Cronobacter 
strains tested by CGH. As the cop operon was not present in the highly invasive fatal 
strains C. sakazakii 707 and 767, we hypothesized that the cus operon and cusC in 
particular has a more important role in the virulence of Cronobacter. An interesting 
question is whether the increased invasive properties of the strains possessing cusC 
are due to the regulation of copper uptake itself or whether the outer membrane factor 
cusC facilitates penetration of HBMEC by a functionality not-related to copper uptake.  
To test the hypothesis that the cus operon is implicated in the invasiveness of 
Cronobacter, we attempted to delete the genes cusA, cusB and cusC from the C. 
sakazakii BAA-894 strain using λ-Red targeted gene deletion developed by Lee et al. 
(2009). This method has been designed for use in pathogenic strains of E. coli and 
was not successful in generating deletion mutants in Cronobacter. The possible 
reasons include: i) low recombination efficiency during arabinose induction or 
recombination events induced at other loci, ii) insufficient arabinose induction and 
therefore cleavage of donor plasmid, iii) too short overhangs used as the regions of 
homology, iv) action of lambda phages. The most likely explanation is that a problem 
in the cleavage of the donor plasmid occurred, which led to a lack of the linear 
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substrate needed for homologous recombination. This could be explained by improper 
arabinose induction or a malfunction of the I-SceI endonuclease. 
 
Two thirds of all gamma-proteobacteria and low GC Gram-negative bacteria harbour 
prophages (Brussow et al. 2004) and there is an increasing body of evidence that 
phages play a pivotal role in the diversification of bacterial species. Some phages can 
carry additional cargo genes, which are not required for the phage cycle and are 
suspected or proven virulence factors (Brussow et al. 2004). In this study, three 
putative prophage genomes and three putative prophage fragments were identified in 
the genome of C. sakazakii BAA-894 and the presence of the prophage genes was 
evaluated in ten other Cronobacter strains. These putative prophages contain genes 
which are not similar to any other known prophage genes. Given the lifestyle 
constraints of phages, the genes probably encode proteins necessary for the phage life 
cycle or increasing their fitness. It is possible that the unknown genes  encode novel 
proteins or virulence-related factors. So where do we look for putative virulence 
factors that have been brought to the bacterial genomes by prophages that could have 
a significant impact on the organism’s pathogenicity ? As fixation of whole prophages 
does not make much evolutionary sense for bacteria in the long term, and prophages 
tend to be lost from the bacterial genomes as fast as acquired, the prophage genes 
surrounding the virulence factor are likely to be deleted (Canchaya 2004). The regions 
carrying virulence factors or fitness factors that increase the survival of the bacterium 
in its host are therefore most likely isolated phage genes or phage fragments 
conserved in virulent strains of the species.  Further research into these regions is 
warranted. 
There were a number of remarkable observations about the putative Cronobacter 
prophage genomes that might be linked with virulence. Firstly it is the region in 
Prophage 3 that was homologous to genes of the S. enterica serovar Typhi Vi type II 
phage E1 which uses virulence-associated capsular antigen as entry. This region was 
present in C. turicensis and partially present in C. sakazakii strains 707 and 767 
associated with a fatal outbreak. Secondly, A group of restriction endonucleases 
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homologous to genes api49, api50, api51 and api52, from the Yersinia 
pseudotuberculosis adhesion pathogenicity island (Collyn et al. 2004) were also 
present in the hypervirulent C. sakazakii strains 701 and 767 and absent in other 
strains. Thirdly, a cluster of three O-antigen conversion genes that may alter the 
bacterium’s serotype was found in putative prophage 3. 
It has been suggested that prophage genomes consist of combinations of non- 
homologous regions and functional modules which have a considerable variation in 
the population (Aubrey et al. 1992). This mosaic structure results from 
“recombinational promiscuity” – a term used by (Frost et al. 2005) - which describes 
frequent recombination with other prophages and other mobile elements within the 
same bacterial host. This is consistent with our microarray data, which show the 
conservation of distinct phage genetic modules between the Cronobacter strains, 
rather than conservation of complete phages. The prophage mosaicism causes 
difficulties in the classification of phages, which often share very little homology, 
although some conservation in the structure of modules can be observed. For that 
reason, the putative prophages 2 and 3 were classified as lambda-like due to the 
presence of regulatory genes typical for lambda phages, but we made no attempts to 
further classify the Cronobacter phages. The prophages that were unique to the 
sequenced strain (prophage 3, prophage fragments 2 and 3) are likely to be recent 
acquisitions. It is probable that the genome of C. sakazakii BAA-894 contains more 
prophages or prophages fragments than are described here. The annotation of 
prophage genes is complicated by the low sequence similarity of equivalent phage 
functions (Frost et al. 2005), especially if these prophage-encoded genes are 
integrated in other bacterial genomes. In many of the variable regions including 
prophages, genes with no homology to known proteins were found. These “ORFan 
genes” atypically abundant in MGEs, could be rapidly evolving genes potentially 
implicated in virulence. On the other hand, many of them are probably pseudogenes 
with no physiological function. It is important to note that the simple presence of any 
gene in a bacterial genome does not mean expression of a functional protein, and that 
includes phage-encoded factors. It has been documented that in lambdoid phages, 
most genes are not transcribed and constitute a passive DNA (Canchaya et al. 2004). 
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Expression of phage genes may be also regulated by environmental factors. For 
example, Shiga-like toxins in E.coli 0157 are expressed when iron becomes a growth 
limiting factor, signalling  that the bacterium is in its host (Wagner & Waldor 2002); 
and upregulation of prophage genes has been observed in P. aeruginosa upon change 
from planktonic to biofilm growth (Whiteley et al. 2001). This highlights the 
importance of experimental testing of any putative virulence factors discovered by 
genome studies. The putative prophages identified in the genomes of Cronobacter 
strains via analysis of the CGH data may contribute to the spread and pathogenicity of 
this species by harbouring virulence of fitness factors. It is important to bear in mind, 
however, that the sequenced C. sakazakii BAA-894 strain that served as a template for 
the microarray design, was isolated from a can of formula associated with a fatal 
outbreak of meningitis and not a clinical isolate. Although tissue culture and in vitro 
assays showed that C. sakazakii BAA-894 is more virulent than other Cronobacter 
strains including the C. sakazakii type strain, other, more virulent Cronobacter strains 
indeed exist. It would be therefore extremely useful to obtain sequence information of 
the prophages and prophage fragments carried by those strains, which would harbour 
virulence factors with a higher probability.  
 
An attempt to identify additional virulence factors in Cronobacter was made by 
comparing the genomes of the three strains associated with C. sakazakii outbreaks in 
NICUs (BAA-894, 701 & 767) with the C. sakazakii species type strain ATCC 
29544
T
, which showed decreased virulence properties in tissue culture studies 
(Townsend et al. 2008a). Among the one hundred and forty-four genes present in the 
three NICU strains and absent in the type strain, genes encoding proteins associated 
with resistance to different forms of stress including multidrug efflux systems, 
proteins involved in resistance to oxidative stress, and those with a putative function 
in resistance to metals were identified.  Along with the putative virulence factors 
identified as part of prophages, fimbriae and T6SS, these genes will serve as potential 
targets for virulence studies of Cronobacter, that will help us to understand the 
organism’s complex role in pathogenicity of human disease. We acknowledge that a 
major limitation of our study is the fact that the Cronobacter microarray was based on 
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a sequence of Cronobacter strain that was not a clinical isolate directly associated 
with a death, and that other potentially more virulent strains of Cronobacter exist. To 
our defence, at the time of the design of this study, C. sakazakii BAA-894 was the 
only Cronobacter strain sequenced. Please note that in the course of this work, the 
genome of another Cronobacter strains (C. turicensis z3032) was published. For a 
selection of genes (fimbrial clusters, iron acquisition systems, some prophage genes), 
our CGH results were verified by BLAST analysis and correlated well with the 
published sequence data. Just before this thesis was submitted the following paper 
was released (Stephan et al. 2010). This short paper compliments our previous studies 
and does not conflict with any statements in the thesis. 
Genomic regions that are specific to a particular species can reflect acquisition of new 
metabolic potential or adaptation of the species to a particular niche. Note that due to 
the availability of a single sequence of Cronobacter at the time of the design of the 
microarray, only genes from the sequenced C. sakazakii BAA-894 were present on 
the microarray. We could not therefore access the status of additional genes that are 
present in other Cronobacter strains. However, thirteen regions differentially 
distributed between the Cronobacter species (regions that were present in C. sakazakii 
BAA-894 and some but not all Cronobacter species) could be determined. As there 
were unique combinations of these regions for each species, these regions could be 
used for molecular typing of Cronobacter species after thorough verification of the 
method in a larger collection of strains. The analysis highlighted three genomic 
regions related to mannose metabolism SR8, SR10 and SR11. Clusters SR10 and 
SR11, which were only present in C. sakazakii strains, encode some of the component 
of the mannose degradation pathway, such as alpha-mannosidase, phosphomannose 
isomerase, N-acetylmannosamine kinase and acetylneuraminate lyase. As these genes 
encode enzymes from the beginning of the mannose degradation pathway, their 
absence (or absence of close homologs) may result in the inability of Cronobacter 
species other that C. sakazakii to process mannose. Earlier studies did report 
production of acid from mannose in Cronobacter. However, these studies were done 
with “E. sakazakii” strains, which were likely to contain a mixture of Cronobacter 
species, with C. sakazakii being the most prevalent species. The analysis also 
190 
 
highlighted a homologue of a gene encoding ecotin (ESA_02129), which was 
intermediate in C. sakazakii strains and in C. malonaticus, but absent in C. muytjensii, 
C. dublinensis and C. turicensis. It has been shown that ecotins from species that 
come into contact with the mammalian immune system like E. coli, Y. pestis and P. 
aeruginosa protect bacteria against the effects of neutrophil elastase (Eggers et al. 
2004). ESA_02129 might encode a virulence factor that promotes resistance of 
Cronobacter during active infection of the host. Other regions of interest identified in 
this analysis included fimbriae clusters, ABC-type multidrug efflux system, fatty acid 
desaturase cluster and a  toxin-antitoxin RelE/RelB system.  
 
4.4. Concluding remarks 
It is extremely important to experimentally verify the results of any sequence analysis 
data. The CGH technology, as well as homology searches in gene databases do not 
take into account the possible role of adaptive mutation such as occurrence of SNPs or 
other events that may render a gene non-functional, whilst preserving the sequence 
homology to its functional counterparts. It is also important to note that although 
genome sequencing and CGH provides information about the gene content, it cannot 
reveal the true phenotypic potential of the organism as it does not provide enough 
evidence about the expression of a particular trait. Further experiments, such as in-
depth analysis of sequence data to reveal possible mutations leading to inactivation of 
genes, gene expression studies as well as laboratory verification of expression of 
virulence factors are warranted.   
It should be also noted that CGH technology cannot reliably distinguish between 
absence of sequence and sequence divergence. For this reason, it could have been 
useful to include another sequenced bacterium closely related to Cronobacter on the 
microarray to define the relationship between sequence identity and fluorescence 
signal. However, the most closely related sequenced bacterium to Cronobacter was at 
the time when the microarray was designed Citrobacter koseri, and including a more 
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distantly related organism on the microarray might present some more challenges in 
the data analysis. Another limitation of the CGH technology is the DNA information 
contained on the array itself. Typically the array is designed using the genome 
sequenced of a single strain, or in case of a pan-array, available sequences from 
multiple strains. In any case, the useful information that we can obtain from this type 
of experimental design does not include potentially interesting genes present in other, 
perhaps more virulent strains.  The Cronobacter microarray was designed when a 
single complete genomic sequence of Cronobacter was available, originating from a 
can of powdered formula linked to the Tenessee fatal outbreak (Himelright et al. 
2002).  However, the strain was not a clinical isolate of the baby that died, and 
whether it contained the complete genetic arsenal that caused the infant’s death is 
highly speculative. Another obstacle for CGH data interpretation is the fact that it is 
uncertain how much sequence conservation (and the corresponding hybridisation 
signal) is required for preservation of gene function. In some instances even a 
difference of a single nucleotide in the coding sequence of a gene can lead to 
inactivation of the gene product.   On the other hand, a considerable advantage of the 
Cronobacter array was the use of overlapping probes spanning the whole C. sakazakii 
BAA-894 genome. To classify a gene into the present/absent/intermediate category, a 
median of often more than 50 probes was calculated, which decreased the influence of 
any aberrant intensity signals. Despite the possible limitations, comparative genomic 
hybridisation remains a powerful tool for examination of the gene content on the 
whole genome level, which would be otherwise impossible or very costly. 
 Cronobacter is a two-faced organism. It can turn from a harmless, commensal 
organism into a deadly pathogen, causing life-threatening disease with lifetime 
impairments. Is its virulence a direct result of the expression of its virulence genes or 
is it the interaction with its host and activation of the host defence system that triggers 
the final form of the disease?  Killing the host by a severe form of sepsis or meningitis 
within a few days after infection with limited spread of the pathogen, is clearly not the 
best survival strategy for any pathogenic organism. Cronobacter-induced disease is a 
biological mistake, occurring when an ideal commensal relationship gets out of hand. 
It only occurs in an unfortunate combination of conditions, such as when the lack of 
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competing gut flora and low acidity in a neonatal stomach promote the growth of 
Cronobacter that would have otherwise  been eliminated, or when the protection of 
the immune system is weakened in the immune-compromised or elderly. By 
identifying the regions of difference between Cronobacter strains and species, 
highlighting putative virulence factors and compiling comparative genomic 
information about key bacterial structures and virulence mechanisms, our study 
provides ground for a better understanding of this remarkable accidental pathogen. 
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5. GENERAL CONCLUSIONS 
Cronobacter species are dangerous pathogens that can cause life-threatening disease 
including necrotizing enterocolitis, septicaemia and meningitis, with premature 
neonates and infants at particular risk. Several outbreaks of Cronobacter infection 
have been linked to contamination of powdered infant formula at neonatal intensive 
care units, although it is becoming increasingly clear that there may be other equally 
important sources of contamination. The phenotypical diversity of Cronobacter sp. 
(formerly ‘Enterobacter sakazakii’) as well as the vast variation in virulence potential 
of Cronobacter isolates have been known to researchers for several decades. However, 
the genetic basis of the diversity of Cronobacter sp. as well as the basis of the 
variation in their virulence potential have not been known. Sequencing of the first 
Cronobacter strain, C. sakazakii BAA-894, uncovered the organism’s full genetic 
arsenal and opened promising prospects in bacterial pathogenomics. 
The first part of this project was dedicated to the investigation of growth behaviour of 
Cronobacter species and other selected Enterobacteriaceae in powdered infant 
formula products. We determined the generation times of 28 bacterial strains across 
21 bacterial species in casein- and whey-dominant infant formula at temperatures 21, 
27, 37, 41 and 44
o
C, including 11 Cronobacter strains representing five Cronobacter 
species, and lag times of the same organisms at 21
0
C.  The data revealed considerable 
diversity in growth profiles of the Cronobacter genus, as well as remarkably fast 
growth of the organisms at a wide range of temperatures including 44
o
C which is 
inhibitiory for most Enterobacteriaceae. This data was useful in the context of control 
of Cronobacter infection in neonates through providing scientific basis for revision of 
the current formula reconstitution guidelines. 
In the second part of this project, we used the sequenced C. sakazakii BAA-894 
genome to construct the first whole-genome Cronobacter microarray. The 
comparative analysis of isolates representing all five Cronobacter species using a 
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whole-genome 384,030 oligonucleotide tiling microarray revealed that the main 
genetic features that distinguished the Cronobacter strains were putative prophages 
and other variable gene clusters, most of which have been probably acquired by 
horizontal gene transfer. This highlighted the role of horizontal gene acquisition in the 
plasticity of the bacterial geenomes, as well as in evolution of pathogenicity, as most 
of these clusters contained proved or putative virulence factors. The genomic regions 
described in this work such as the type VI secretion systems, fimbriae, LPS, O-
antigen loci and metal uptake systems deserve further in-depth analysis. The putative 
virulence factors identified in these regions or elsewhere in the Cronobacter’s genome 
require further study and experimental verification, including targeted gene deletions, 
expression analysis and tissue culture assays. The comparison of ten Cronobacter 
strains including strains from a fatal outbreak in France (Caubilla-Barron et al. 2007) 
revealed many features of Cronobacter that may contribute to the organism’s 
pathogenicity such as a copper/silver resistance cluster associated with invasion of 
BMEC, efflux pumps or adhesins, which were unique to the three Cronobacter 
species associated with neonatal infections. 
 During the course of the project the diversity of the Cronobacter genus was further 
investigated by multiple-locus sequence typing (Baldwin et al. 2009), which 
confirmed the taxonomic revision by Iversen et al. (2008) and highlighted oversights 
in classification of Cronobacter strains based solely on biotypes.  The Cronobacter 
genus is still not well defined, and further work including MLST and CGH analysis 
with a broader selection of strains representing Cronobacter species of different origin 
and virulence potential should considerably improve the definition of the Cronobacter 
genus, as well as classification methods.  Although Cronobacter is an ubiquitous 
organism present in a wide range of environments, MLST data suggest that some 
clinical isolates are highly clonal. More research needs to be done to clarify the clonal 
distribution of clinical isolates, as well as to correlate genetic markers with the actual 
virulence potential of a particular strain. For this, typing of pathogenicity islands or 
other virulence determinants described in this work and serotyping could prove 
particularly useful.  
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The ultimate goal of this study is to increase the knowledge base that will lead to a 
better understanding of this remarkable organism, which is ubiquitous and mostly 
harmless, and yet capable to cause fatal infectios in neonates and major infections in 
adults. This should lead to improved recognition of this emergent pathogen, and 
ultimately to better identification methods that would be able to identify the strains 
with the greatest virulence potential. To date, there is no available sequence of a 
hypervirulent Cronobacter strain available. This limits any studies using the C. 
sakazakii BAA-894 sequence information for the discovery of virulence factors of 
Cronobacter. The future offers an exciting prospect of sequencing more Cronobacter 
strains of each Cronobacter species, as well as important hypervirulent clinical strains, 
which will provide material for comparative genomics on a larger scale, and help us 
gain insight into Cronobacter’s fascinating  genome dynamics, the role of mobile 
genome elements on the evolution of virulence, its possible plant origin, and many 
more mysteries that are currently left to our speculation. 
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